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ABSTRACT

Author: Wickramathilaka, Malithi P. PhD
Institution: Purdue University
Degree Received: May 2018
Title: Bioconjugation Techniques to construct Spontaneously assembling DNA-Enzyme
Macromolecules
Committee Chair: Bernard Y. Tao
In the past two decades, crosslinking has been a popular choice in synthesizing
bioconjugates in the fields of biotechnology, medical diagnostics, and genetic screening. However,
their efficacy in synthesizing the desired bioconjugates is scarcely analyzed and documented. The
scope of this investigation encompassed studying covalent bioconjugation techniques, and
determining the structural characteristics of the bioconjugates formed via several crosslinking
strategies. The major goal of the study was to determine relatively inexpensive, less complex, and
universal bioconjugation techniques with the flexibility to control the distance between wild-type
enzymes. In this investigation, three different crosslinkers were studied to determine the efficacy
of crosslinking biological molecules.
In the first aim of the study, an adapted strategy from the conventional 1-ethyl-3-(3dimethylaminopropyl) carbodiimide hydrochloride (EDC) was developed to form a novel
phosphoramidated single stranded DNA (ssDNA) bioconjugate. Matrix-assisted laser
desorption/ionization time-of-flight (MALDI-TOF) was used to determine the molecular weights,
and the stability of the bioconjugates formed. A reversed phase high performance liquid
chromatography (RP-HPLC) analytical method was developed to determine the conjugate product
yields. The analytical procedure’s accuracy, precision, linearity, limit of detection (LOD), and
limit of quantitation (LOQ) were determined. Afterwards, the yield of the phosphoramidated
ssDNA bioconjugate was determined using the developed analytical procedure. In our attempts to
determine suitable crosslinkers, another crosslinker (BS3) was also investigated to accomplish
bioconjugation between ssDNA, and a small peptide. However, mass spectrometry results
indicated conjugate molecular weights evidencing only partial bioconjugate formation.

xviii
In the next aim, the successful adapted EDC crosslinking technique was applied to two
wild-type enzymes to synthesize enzyme-single stranded DNA (enzyme-ssDNA) bioconjugates,
in an aqueous system. Like so, glucose oxidase-ssDNA4 (GOD-ssDNA4), and horseradish
peroxidase-ssDNA3 (HRP-ssDNA3) conjugates were synthesized separately. These enzymessDNA conjugates were analyzed, and purified using size exclusion chromatography (SEC).
Fluorescence spectroscopy was used to determine the presence of ssDNA in the GOD-ssDNA4
bioconjugates, while MALDI-TOF spectrometry was used to determine the molecular weights of
the HRP-ssDNA3 bioconjugates. Altogether, size exclusion chromatography, fluorescence
spectroscopy, and MALDI-TOF results suggest that the adapted EDC crosslinking method was
successful in producing the expected enzyme-ssDNA conjugates.
In order to spontaneously assemble the GOD-ssDNA4, and HRP-ssDNA3 bioconjugates,
DNA hybridization was utilized. However, high annealing temperatures used in the general
heating-cooling protocols has the potential to degenerate these enzyme conjugates. Therefore,
possibilities of accomplishing DNA hybridization at lowered annealing temperatures was
investigated as well. After facilitating DNA hybridization between GOD-ssDNA4 and HRPssDNA3, the final enzymatic macromolecule was analyzed on size exclusion chromatography.
Based on the structural evidence obtained from mass spectrometry, UV-Vis spectrophotometry,
reversed phase chromatography, size exclusion chromatography, and fluorescence spectroscopy,
we analyzed the desired bioconjugates at each successive stage in this bottom-up-synthesis.
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BACKGROUND AND INTRODUCTION

1.1

Background

1.1.1

Bioconjugation

Any strategy of covalent or non-covalent bond formation between two or more molecules,
where at least one molecule is a biomolecule, is referred to as bioconjugation. Researchers use
bioconjugation techniques to manipulate a few or several diverse biological molecules with unique
properties, to deliver criteria required in a final biomolecule design or system. Biological
molecules are quite diverse and they exhibit unique properties. By bioconjugation, we have the
capability of manipulating a few or several biological molecules to cater certain criteria we require
for a certain system or a device. Bioconjugation is generally accomplished by a bottom-up
approach, where each building block of a final structure is synthesized successively to obtain the
final structure. Assembly of these building blocks could be via covalent attachments, electrostatic
interactions, or ionic reactions. However, in the field of bio-nanotechnology, top-down approaches
are also heavily used to synthesize nano-structured materials. In a top-down approach, bulk
material is broken down to obtain nano-sized elementary building blocks. These are then
assembled as desired, to obtain the final nanostructure 1.
It is important and relevant to study, and optimize bioconjugation techniques because these
techniques govern the ultimate molecular nanotechnology, i.e., synthesis of supramolecular
assemblies, micro-arrays, and molecular detection probes. In the past, scientists have exploited
both covalent and noncovalent coupling chemistries to synthesize bioconjugates. They have been
used in a variety of biotechnology and translational medicine applications such as diagnostics,
biosensors, detection probes, affinity chromatography, and assays such as ELISA (enzyme-linked
immunosorbent assay). On the exterior, bioconjugation may appear quite straight forward, and
their design possibilities may only be limited by the imagination of the scientist. However, even
with the vast knowledge on bioconjugation techniques, given a new application, these construction
methods have to be optimized from the very beginning. For an example, attaching a fluorescent
label to an antibody is as well-known step in the study/development of binding assays2. Although
the steps are to simply attach a fluorescent dye to a purified antibody, the methodology is much
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more intricate. Before labeling an antibody (Fig.1b), an appropriate fluorescent dye should be
selected based on intrinsic spectral properties (e.g. excitation, emission wavelengths). Next, a
variety of factors such as hydrophilicity of the dye, relative ratio of molecules, buffer systems, and
other reaction conditions should be considered prior to carrying out the bioconjugation between
the fluorescent dye and the antibody. The selected dye should be hydrophilic in order to prevent
antibody aggregation. As many dyes have highly aromatic, hydrophobic regions, they can form
non-specific interactions with the hydrophobic regions of the antibody. This leads to antibody
aggregation, as well as non-specific (electrostatic interactions) interactions between the dye and
the antibody. Such electrostatic interactions are contrary to the desired, stronger covalent bonds.
The selected buffer system should be compatible for both the molecules, and should not lead to
degradation of either. The selected linking reagent (e.g. crosslinker) should also form specific
interactions (covalent) only between the antibody and the dye. If the linking reagent forms
antibody-antibody links, or dye-dye crosslinking, that defeats the purpose of fluorescent tagging.
Another largely important consideration is the relative ratio of dyes: antibody. It is important to
attach more than one dye per antibody molecule in order to facilitate adequate fluorescence
emission in the detection ranges of the instruments use. However, oversaturating one antibody
molecule with too many dye molecules would lead to antibody precipitation, or quench the
potential fluorescence emission output due to dye-dye interactions and energy transfer. Therefore,
for a given antibody-dye complex, there is an optimal level of fluorescence dye conjugation which
will provide the maximum signal in the detection assay. This is attained by controlling the
stoichiometry of the antibody, and dye molecules. Synthesis of an optimal antibody-dye
bioconjugate is only achievable via a carefully structured design of experiments which accounts
for solution stability, fluorescence intensity levels, and assay performance.

(a) Antibody-enzyme
conjugate

(b) Fluorescent dye
labeled antibody

(c) Biotin
labeled antibody

Figure 1: Common antibody conjugates used in bioassays 2.
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1.1.2

Bioconjugate techniques

Bioconjugation is carried out by utilizing functional groups present on biomolecules (e.g.
proteins, enzymes, antibodies), with the aid of external reagents and/or reactants. Methods of
protein bioconjugation includes reacting amines with aldehydes via a Schiff-base, cross-linking
amine groups to an amine surface with gluteraldehyde to form peptide bonds, cross-linking
carboxylic acid groups present on the protein via cross-linking, attaching proteins to proteins based
on disulfide bridge formation between two thiol groups, and the formation of thiol-Au
nanoparticles. Amine groups in proteins are widely used for protein covalent immobilization via
crosslinking, which is a widely used method of accomplishing covalently bounded bioconjugates2.
The 10 amine group of lysine, the thiol group in cysteine, and the hydroxyl groups in serine,
threonine, and tyrosine have been identified as appropriate candidates for modifications. Most
proteins contain lysine and arginine groups at the surface. Although naturally occurring peptides,
proteins, and enzymes may or may not always contain these functional groups, every protein will
contain an N-terminal primary amine, and a C-terminal carboxyl. However, the concern is that the
terminal ends of a protein or enzyme tend to be conserved during their natural 3-D structure (due
to protein folding). Therefore, bioconjugation utilizing surface exposed amino acid residues
remain the best hope for wild-type proteins.
Prior to carrying out any bioconjugation, a thorough review should be conducted on the
physicochemical characteristics (structural and chemical stability) of each biomolecule in the
selected buffer media. Furthermore, careful attention should also be given so that the selected
bioconjugation reaction does not affect the ultimate functionality of the final macromolecules. For
example, if the intended design was to design an enzyme-antibody conjugate as depicted in Fig.1a,
it is imperative that any of the chosen bioconjugation chemistries do not harm the ultimate
reactivity of the enzyme, or the functionality of the antibody.
Over the past few decades, researchers have utilized a vast number of chemistries, and methods
to form bioconjugates. Such bioconjugate techniques can be divided into site-specific
bioconjugation methods and random bioconjugate methods. For a conclusive discussion, they are
further sub-divided into covalent bond forming methods, and non-covalent bond forming methods.
Covalent bonds are stronger than non-covalent bonds, and hence cater higher conjugate product
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stabilities (i.e., they do not dissociate easily over time). They can also withstand buffer condition
alterations and changes in temperature 3. When attempting to control bioconjugation and the extent
of conjugate product formation, many variables such as solvent pH, temperatures, reaction times
and reactant amounts could be tweaked.
1.1.3

Site-specific bioconjugation: Chemoselective
Chemoselectivity refers to coupling one reactive group in one molecule with another

specific reactive group on another molecule, without any side reactions. Therefore, chemoselective
ligation can be carried out in cells, cell extracts, or in vivo models, without cross-reactivity with
other ubiquitous functional groups in the reaction system. Reagents which take part in
chemoselective reactions are also called biorthogonal to each other. An important requirement of
bioorthogonal reagents is their stability in aqueous systems (i.e., resist hydrolysis, or oxidation).
Diels–Alder

cycloadditions,

hydrazine–aldehyde,

aminooxy–aldehyde,

boronic

acid–

salicylhydroxamate, CuI-catalyzed azide–alkyne [3+2] cycloadditions, Huisgen 1,3,-dipolar
cycloaddition, Staudinger ligation, native chemical ligation, and expressed protein ligation are
examples of chemoselective reactions. Bioconjugates obtained from all chemoselective reactions
are formed via strong, covalent bonds.
1.1.3.1 Covalent strategies
(i) “Click chemistry”
A famous method of synthesizing covalently bound bioconjugates is via “click chemistry”.
Since its inception in 2001, click chemistry has been used widely to construct covalently bound
bioconjugates regioselectively. Regioselectivity refers to the preference of one direction (i.e., one
isomer) in a reaction, and hence enables producing a homogenous bioconjugate product. There are
four major click chemistry reactions which have been identified so far; (1) Nucleophilic ring
opening reactions of epoxides and aziridine, (2) Non-aldol type carbonyl reactions (e.g. formation
of hydrazones and heterocycles), (3) Additions to carbon-carbon multiple bonds (e.g. oxidative
formation of epoxides), (4) Cycloaddition reactions.
The latter mentioned cycloaddition reaction has been recognized as one of the best click
reactions due to its high yield2. Generally, “click” chemistries are conducted at elevated
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temperatures and pressures. However, it has been shown that in the presence of a catalyst (CuI),
the reaction kinetics are dramatically accelerated4 (Fig.2). The CuI -catalyzed azide-alkyne [3+2]
cycloaddition (CuAAC) reaction is one example of a DNA click-chemistry that has shown much
potential 5. Azides and unactivated alkynes are not reactive with other functional groups found in
the nature. Therefore, their reactions are highly regiospecific. The product formed from the
reaction of an azide and the alkyne is a triazole, which is extremely stable and non-toxic.

Figure 2: Schematic of the Huisgen 1,3,-dipolar cycloaddition, and the CuAAC reaction 6.
A study conducted by Duckworth and his team used the very selective enzyme (PFTase) to
enzymatically tag a protein-CVIA to an azide modified isoprenoid diphosphate. This azide was
then reacted with an alkyne modified DNA using the Huisgen cycloaddition click reaction
(Duckworth et al., 2007). Alkyne functional groups can be attached to DNA without perturbing
the biophysical characteristics of the naturally occurring DNA. While this is a fascinating approach
to create spontaneously assembling chimeras of proteins, it lacks universal application due to
several reasons; the selectivity of the enzyme, the extremely long lengths of the tagging chains,
the large number of chemical modification steps, and the high amounts of chemicals/catalysts used
in the click reactions. When developing multi-functional enzymes or antibodies, deviations from
physiological conditions poses a risk of deactivating the molecules.

6
In the recent history, copper-free “click” reactions have also been investigated to synthesize
bioconjugates in in vivo 7, as well as in vitro

8

systems. In the first study, they used the strain-

promoted azide-alkyne [3+2] cycloaddition (SPAAC) to create a bioconjugate probe in a living
cell (Fig.3). In the SPAAC method, instead of an alkyne, a cyclooctyne is used to carry out the
“click” reaction. As the cyclic triple bond is activated, the kinetics in the 3+2 cycloaddition
reaction is enhanced (Fig.3). In the latter, SPAAC was used to synthesize proteinoligodeoxynucleotide (protein-ODN) conjugates to demonstrate reaction efficiencies of the
method. Here, they first synthesized azide-functionalized proteins prepared by enzymatic
prenylation of C-terminal CVIA tags with synthetic azidoprenyl diphosphates. Next, they were
“clicked” to ODNs which were pre-modified with a strained dibenzoclyclooctyne 8. Using size
exclusion chromatography, and gel electrophoresis, they reported that the yields, and the reaction
times of the SPAAC bioconjugation reaction are comparable to previously reported coppercatalyzed azide-alkyne [3+2] cycloaddition (CuAAC) reactions. However, since the SPAAC
technique does not utilize any catalyst (CuI), it does not pose a threat of deactivating the
functionality of the biological molecules involved in the bioconjugation (e.g. proteins, enzymes,
antibodies, DNA).

Figure 3: Illustration of the copper-free, strain-promoted [3+2] Azide-Alkyne cycloaddition
(SPAAC), reproduced from 7.
(ii) Staudinger ligation
In the 1920’s, Hermann Staudinger discovered a reaction where phenylphosphine (PPh2)
reacts with azides (N3) to form a phenylphosphine oxide and a primary amine. Later, Saxon and
Bertozzi developed an adapted technique which was termed the Staudinger ligation. In Staudinger
ligation, a modified PPh2-derivative reacts with an N3-derivative, ultimately forming an amide
bond between the two derivatives (Fig.4). The product is essentially a covalently bound
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bioconjugate. Soon after their discovery, they investigated a potential application of their method.
In that investigation, Bertozzi and team used N3-modified mannose derivatives to visualize their
behavior in a biosynthetic pathway. They first created thiazide-modified mannose derivatives, i.e.,
N-azidooacetylmannosamine. Next, they incubated these with Jurkat cells, which are an
immortalized line of human T lymphocyte cells. This facilitated the uptake of the modified
compound into the glycans produced through the sialic acid biosynthetic pathway. Next, using a
PPh2-biotin, they conjugated the azidosaccharides with the PPh2-biotins. This was the Staudinger
ligation step. Afterwards, they used a fluorescein-labeled avidin, facilitating the famous avidinbiotin interaction (discussed in the next section). The fluorescence detection of the final glycanavidin-biotin-fluorescein glycoconjugate was used to detect the amount of glycan output produced
via the pathway 9.
Staudinger ligation is highly amenable to bioconjugation needs in in vivo models, because
azido analogs can be incorporated in biopolymers (e.g. polysaccharides), and also because this
highly bioorthogonal reaction does not contain any cytotoxic catalysts, or byproducts.

Figure 4: Schematic of a Staudinger ligation between an azide-derivative, and a phosphinederivative.
(iii) Native chemical ligation
In native chemical ligation (NCL), a peptide containing a C-terminal thioester reacts with
an N-terminal cysteine residue in another peptide, undergoing a transthioesterification reaction.
The resulting product is a peptide-peptide bioconjugate linked via a strong amide bond (Fig.5).
Although a very useful bioorthogonal ligation, the applications of this method are not broad
because it can not be extended to wild-type peptides. NCL has mostly been used in peptide
chemistry, as opposed to synthesizing bioconjugates in the field of biotechnology. NCL helps
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overcome the shortcomings of Solid Phase Peptide Synthesis (SPPS) by allowing researchers
to synthesize peptides that are greater than 50 amino acids in length 10.

Figure 5: Native chemical ligation 2.

1.1.3.2 Non-covalent strategies
Avidin-biotin interaction
This is perhaps one of the most exploited interactions in the field of bio-nanotechnology, as
biotin-streptavidin bonding is the strongest non-covalent biological interaction known
(dissociation constant, Kd = 10-15 M). Biotin and avidin has molecular weights of 244.3 Da, and
67,000 – 68,000 Da respectively

11

. The biotin-avidin binding is kinetically favorable, highly

specific, and is resistant to extremes of heat, pH and proteolysis. This reaction also occurs very
rapidly, and the avidin-biotin complex is very stable (Fig.6).

9
Biotinylation is the process of covalently attaching biotin (also known as vitamin H) to a
protein, nucleic acid or any other molecule of interest (Fig.6, step 2). Afterwards, previously
immobilized avidin (Fig.6, step 1) is used to bind the biotin, ultimately forming the desired final
complex (Fig.6, step 3). Streptavidin is avidin with tetrameric binding sites, and has an iso-electric
point very close to neutral. This renders streptavidin-biotin based bioconjugates amenable for
biological assays

12

. The avidin-biotin detection systems allows an almost unlimited number of

primary detection reagents (i.e., antibodies, nucleic acids probes and ligands) to be easily captured,
recovered, immobilized or detected. Although the avidin-biotin system is simple to set up and use,
it does have certain limitations. Because any biotinylated molecule will bind to any biotin binding
protein, biotinylated molecules must be used in combination with other detection-probe systems
(i.e., primary-secondary antibodies) for multiplex experiments 11.
Also, because biotin is a biological molecule, endogenous biotin can cause background noise,
and raise specificity issues in assay development on certain biotin-rich tissues and extracts (i.e.,
brain, liver, milk, eggs, corn). In capture-and-release bioconjugate applications (e.g. purification
methods), the strength of the binding interaction between biotin and avidin is a factor that limits
its utility. In order to dissociate the interaction between avidin and biotin, harsh conditions are
required. Such harsh buffer conditions could easily denature the proteins in the bioconjugates. To
overcome this limitation, modified versions of avidin resins, and modified forms of biotin labeling
reagents are commercially available which make the interaction readily reversible. These include
monomeric avidin, cleavable disulfide biotin reagents, and iminobiotin and desthiobiotin
derivatives 11. Regardless, avidin-biotin remains extremely useful in applications without product
purification necessities, and in in vitro bioconjugate applications, which does not involve
biological molecules that naturally contain biotin.

Figure 6: Formation of bioconjugates using the avidin-biotin interactions 10.
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1.1.4

Random bioconjugation
One of the biggest drawbacks in site-specific bioconjugation techniques discussed above

is the necessity for modifying each biomolecule with the desired functional groups. As such
derivatization is time consuming, and are not universal methods to be used on wild-type peptides,
proteins, enzymes, and antibodies, random bioconjugation techniques such as crosslinkers are
perhaps the better choice. However, the trade-off in random bioconjugation techniques is poor
product yield, and lack of control over the chemoselectivity.
1.1.4.1 Non-covalent strategies
(i) Ni2+- Histidine
A common non-covalent, random bioconjugation strategy is binding His-tagged proteins to
Ni2+-chelating supports. A previous study has demonstrated a one-step protocol to remove toxic
impurities from biological assays, by utilizing affinity chromatography principles

13

. Generally,

purification of recombinant proteins expressed in a bacterial system (such as E.coli) is based on
physicochemical characteristics of the proteins such as charge, size and hydrophobicity. These
authors recognized such purification steps laborious, and hence investigated an alternate route to
accomplish purification of His-tagged proteins by using Ni-NTA (Nickel-nitrilotriacetic acid)
beads. After the His-tagged proteins were recovered from the isopropanol washing step, they stated
that the proteins were able to refold into their native structures, ensuring protein functionality.
Their method had succeeded in removing the E.coli bacterial endotoxin debris, as well as
detergents used to lyse the bacterial cell.

(ii) Physical adsorption
It is known that colloidal particles of metals serve as highly useful tools in the magnetic,
plasmonic and optoelectronic fields. Previous work in the nanoparticle fields prove that they could
be used as signal enhancers. One very early study conducted in 1979 used gold and silver
nanoparticle absorbed pyridine molecules to obtain Raman signals. The degree of signal intensity
is strongly dependent on the excitation wavelength. These metal particles are polarizable, and the
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collective excitation resonance oscillations of the electrons on the surface of these colloidal
particles are the reason for the enhanced Raman scattering 14. Furthermore, metal nanoparticles
have many applications in the field of chemical sensors. Biological macromolecules could be
successfully attached to nanoparticles with a high affinity. The adsorption of metal nanoparticles
to biological molecules occurs via electrochemical interactions, as opposed to covalent cross
linking. Therefore, the functionalities of the biological molecule remain unchanged, upon binding
to such metal particles

15

. In the past, colloidal gold has been adsorbed to many biological

molecules in the nature, such as enzymes, hormones, streptavidin, toxins, glycoproteins, and
immunoglobulins. After an antigen is labelled with colloidal gold particles, their relative densities
could be determined because of our ability to quantitate the gold particles. These gold
nanoparticles have high electron densities compared to ferritin, and can be easily detected by TEM
(transmission electron microscopy), even under low magnification. They can be visualized easily
even in thick layers of biological components

15

. Furthermore, gold nanoparticles adsorption is

highly specific and is feasible to be used in affinity cytochemistry. The above mentioned, and
many other advantages of colloidal gold particles, make it a suitable candidate for chemical sensors
and nanostructure fabrication.
1.1.4.2 Covalent strategies
(i) Crosslinkers
The principles of crosslinkers have been used to create covalent bioconjugates in many
bioconjugation studies. Crosslinkers generally have a hydrocarbon chain (i.e., spacer arm) with
one or two functional groups at the terminal ends which are reactive with other functional groups
(Fig.7). The spacer arm refers to the portion of the crosslinker which becomes a part of the final
bioconjugate. The spacer arm dictates the distance between two molecules in a final bioconjugate.
Crosslinkers should be carefully selected based on their water solubility, spacer arm length, and if
applicable, cell-membrane permeability as well.
The main crosslinker classifications are zero-length, bifunctional (heterobifunctional, and
homobifunctional), and trifunctional crosslinkers. The most popular crosslinker functional groups
are NHS-esters, imidoesters, and diazirines. Regardless of the crosslinker used, crosslinker
chemistry optimization is extremely important. Using low molar amounts of crosslinkers would
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result in low bioconjugate yields. Molar amounts which are too high could lead to undesired
adducts, and byproducts. Zero-length crosslinkers contain spacer arms which do not become a part
of the final bioconjugate (e.g. carbodiimide). Homobifunctional, and heterobifunctional
crosslinkers are those which have the same functional groups, and different functional groups at
the two ends of their spacer arm respectively. Trifunctional crosslinkers are those which carry
three functional groups, which are susceptible for reaction with three other biomolecules.
Reactive group

Spacer Arm

Reactive group

Figure 7: The molecular structure of a crosslinker.
The reactive groups undergo reaction with respective functional groups. The spacer arm
generally becomes a part of the final bioconjugate, unless it is a zero-length crosslinker.

The three crosslinkers studied in this investigation (BS3, EDC, and NHS-diazirine) are
discussed in greater detail in chapters 2 and 3.
Homobifunctional crosslinkers: Bis(sulfosuccinimidyl)suberate (BS3) is a homobifunctional
crosslinker which has two NHS-ester functional groups at the two ends of a 11Å carbon spacer
arm. The two NHS-esters are reactive towards primary amines. The advantages of using
crosslinkers owe to their ability to be used with functional groups in naturally occurring
biomolecules. Although NHS-esters have good stability in aqueous conditions, it should be noted
that amide bond formation and hydrolysis of the NHS-ester both occur competitively. Several
studies have reported that both hydrolysis and amination increases with increasing buffer pH. At
a pH 8.6, and 4 °C the half-life of BS3 was only 10 mins 16.
Heterobifunctional
carboxylate

crosslinkers:

(sulfo-SMCC),

Sulfosuccinimidyl

4-(N-maleimidomethyl)cyclohexane-1-

N-(β-maleimidopropyloxy)succinimide

succinimidyl 3-(2-pyridyldithio)propionate (SPDP)

ester

(BMPS),

and

are examples of commonly used

heterobifunctional crosslinkers. In a previous study, sulfo-SMCC and SPDP were used to crosslink
amine modified single stranded DNA to form a tetrahedron of DNA, which was then used to cage
a single cytochrome c molecules 17. In another study, BMPS was used to bring two fluorescence
proteins together, and studied their proximity effects 18.
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Zero-length crosslinkers: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) is a water
soluble zero-length crosslinker which is convenient to use, and is relatively inexpensive. It has
therefore been used in a variety of conjugation techniques to couple carboxyl groups to primary
amines 2. EDC first forms an active ester intermediate with a negatively charged functional group,
which then undergoes nucleophilic substitution in the presence of a strong nucleophile, such as a
primary amine.

Table 1 illustrates a list of the types of reaction, and the functional group in the crosslinker
responsible for the corresponding reaction, modified from 2.
Table 1: Summary of commonly used crosslinkers in bioconjugation studies.
Reactivity

Reactive group in the crosslinker

Carboxyl/phosphoryl-to-amine

Carbodiimide
NHS-ester
Imidoester
Pentaflurophenyl ester
Hydroxymethyl phosphine
Maleimide
Haloacetyl (bromo- or, iodo-)
Pyridyldisulfide
Thiosulfonate
Vinylsulfonate
Hydrazide
Alkoxyamine
Diazirine
Aryl azide

Amine-reactive

Suldhydry-reactive

Aldehyde-reactive
Photo-reactive
Hydroxyl-reactive
1.1.5

Isocyanate

DNA nanotechnology
From the inception of DNA nanotechnology in the 1980’s, synthetic DNA-bioconjugates

have been used in an enormous amount of studies across various fields. Although this field was
initiated by Nadrian Seeman in the early 1980’s, its widespread interest blossomed only about a
decade ago. In DNA nanotechnology, rather than using DNA as the carrier of genetic information,
other chemical and physical properties of DNA is exploited to create stable biological structures.
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Single stranded DNA (ssDNA) has numerous attractive features for the bottom-up design of
diverse supramolecular building blocks for the production of nanostructures, namely, rigidity,
predictable structure, and re-assembly through complimentarity. In molecular biology,
complimentarity is referred to as the lock-and-key relationship followed by two separate
biomolecules. In DNA complimentarity (i.e., complimentary hybridization) when the nucleotides
of one strand are aligned anti-parallel to the complimentary strand, they form very specific base
pairs. The conceptual foundation of DNA nanotechnology is based on the strict base-pairing rules
exhibited by the four building blocks, i.e., nucleotides of DNA (adenine, thymine, cytosine and
guanine). Such strict base pairing of nucleotides allows a scientist to bind desired pieces of ssDNA
to a variety of other molecules, and ultimately facilitate precisely controlled final complex
structures. DNA hybridization is further discussed in chapter 4.
DNA-bioconjugates generated either by covalent, or non-covalent coupling chemistries have
been utilized in nano-biotechnology, bioanalytical chemistry, therapeutics, molecular diagnostics,
biosensors and many other fields. In the past, researchers have exploited these unique features of
DNA in order to create nano-assemblies in the shapes of cubes, tetradehrals, octahedrals, 2D arrays
and fascinatingly complex DNA origami scaffolds

19-21

. Furthermore, researchers have also

succeeded in utilizing DNA as a diagnostic tool to create ultra-sensitive antibody-DNA conjugates
3,22

producing protein chips through DNA-directed immobilization 23, constructing supramolecules

of DNA-streptavidin conjugates for high detection immuno-PCR

24

, and also oligonucleotide-

enzyme conjugates using natural enzymes such as horseradish peroxidase 25.
1.1.5.1 DNA-mediated self-assembly of biomolecules and particles
A disadvantage of random molecular self-assembly methods is their inability to maintain
the engineered intermolecular/interparticle distances. On the contrary, many previous studies
demonstrate that DNA mediated nanoparticle assembly has more flexibility in tuning these
distances

26,27

. In a pioneering work conducted by Mirkin and coworkers, a model to assemble

macroscopic aggregates was discovered. They first attached two sets of non-complementary DNA
oligonucleotides to 13 nm gold particles. These oligonucleotides were capped with thiol groups,
which attached to the gold colloidal particles. Then they added the complementary DNA sequence
with sticky ends to this solution, which caused complementary nucleotides to bind. The result was
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nanoparticle aggregation

28

. Since DNA can be denatured under high temperatures, this self-

aggregation procedure could be thermally reversed 28.
Some studies have also probed the possibility of creating DNA based nano-assemblies in
the shapes of cubes, tetradehrals, octahedrals, 2D arrays, and fascinating DNA origami scaffolds
19-21

. A study conducted in early 2006 informs the ability of DNA to form complex nanoscale

shapes and patterns 21. This probably is the most fascinating work conducted on DNA scaffolding,
where the assemblies were termed DNA origami. The assembly consisted of six different shapes,
namely squares, triangles and five-pointed stars 21. While the creation of arbitrary patterns were
concluded successfully in this study, the use of such scaffolds of long DNA have limitations
brough upon factors such as strand invasion and undesired cooperative effects 21.
In a recent study, nanoparticles coated with small DNA chains were assembled with other
particles to produce a desired nanoparticle aggregate. The nanoparticle assembly involved 3 main
steps; carboxylic group grafting, streptavidin conjugation, and the attachment of the biotinylated
DNA (from step 2) to the nanoparticles (Fig.8). Short mercapto acid ligands, and amphiphilic
polymers (lipid-PEG carboxylic acid) were used on hydrophilic and hydrophobic nanoparticles
respectively.

The

subsequent

two

steps

relied

on

the

1-ethyl-3-(3-

dimethylaminopropyl)carbodiimide (EDC) chemistry and on the specific and strong streptavidinbiotin binding (association constant; Kd = 2.5×1015 M-1).

Step 1
Step 2

Step 3

Figure 8: The three-step strategy for DNA functionalization onto hydrophilic and hydrophobic
nanoparticles 29.
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After functionalizing the desired particles with DNA, they investigated the possibility of
incorporating fluorescent dyes, proteins, and quantum dots into nanoparticle lattices and clusters.
As such, Zhang and his team investigated assembling catalytic/plasmonic nanoparticles, systems
of magnetic/plasmonic nanoparticles, and systems of luminescent/plasmonic nanoparticles. The
catalytic-plasmonic nanoparticles were made with spherical Au, and Pd with three different shapes
(cube, octahedron, and dodecahedron). Magnetic-plasmonic nanoparticles were constructed with
FeO and Au. The quantum dots were constructed with Cd, Se, Te, and ZnS. This mix-and-match
investigation of nanoparticles and DNA opens doors to various opportunities for material
fabrication. The control of the interparticle distance is very important for system functionality, and
their models have been successful in attaining this by controlling factors such as the particle radii,
and ssDNA lengths.
Therefore, as illustrated above DNA-based bioconjugates could be synthesized by either sitespecific methods, or random crosslinking methods. However, to carry out “click reactions” with
DNA, the DNA building blocks must carry either an alkyne or an azide functional group. One
should note that the synthesis of azide‐modified synthetic DNA by solid‐phase synthesis is
intrinsically difficult, as azides are reduced by the PIII atom of the phosphoramidites (Staudinger
reaction) 30. This is a large limitation of the CuAAC approach to DNA labeling, as azide‐modified
DNA is not directly accessible by solid‐phase DNA synthesis. However, this can still be overcome
by functionalizing the DNA with the alkyne group, as opposed to the azide group.
1.1.5.2 Bioconjugates of DNA and proteins or enzymes
Previously, covalent attachments between DNA and proteins have been accomplished by
methods such as chemical cross-linking using a surface modified lysine or cysteine residue
expressed protein-ligation
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, chemoenzymatic methods

32,33

, and via photoaptamers
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,

34

.

Photoaptamers are ssDNA molecules capable of forming covalent bonds with their cognate
proteins, upon electronic excitation. All of the above methods have formed covalently bound
protein-DNA bioconjugates. While a vast number of studies have been conducted on synthesizing
protein-DNA conjugates covalently, there have also been a number of studies on noncovalent
protein-DNA interactions. The majority of such studies on non-covalent methods exploited the
well-known streptavidin-biotin interaction 24.
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A recent study utilized a chemoenzymatic method to regioselectively, and covalently link
proteins and DNA. The enzyme, protein farnesyl transferase, was used to label an engineered
substrate protein containing a C-terminal tetrapeptide (SVIA) with an azide-modified isoprenoid
diphosphate. Alkyne-modified DNA was added to it subsequently. The site specific DNA
conjugation was achieved by a click reaction of the protein-azide with the alkyne-DNA. These
protein–oligonucleotide chimeras were then spontaneously assembled into nano-architectures by
complementary hybridization of the DNA. This strategy yielded a short and compact protein-DNA
linkage that allowed precise control over protein spacing and orientation in the assembled
nanostructure 33.
Attaching single stranded DNA (ssDNA) to enzymes enables synthesis of multifunctional
moieties. For example, by attaching an enzyme to ssDNA, and attaching its complimentary ssDNA
to another enzyme, we could co-localize two enzymes. If the two enzymes could participate in a
continuous reaction, such a co-localized system would enable an enzyme cascade. Glucose oxidase
and horseradish peroxidase are two such enzymes which are already in use to study enzyme
kinetics. This technique of self-assembly of molecules is essentially extendable to other molecules
with different functionalities as well. The attachment of proteins to DNA might also allow us to
artificially model complex wild-type protein assemblies, which are hard to isolate using currently
known protein extraction methods.
Proteins and enzymes offer exposed amino acid functional groups that can be used for
crosslinking with commercially available reagents, to generate protein-DNA conjugates. These
methods are acceptable as long as they do not functionally inactivate the protein, i.e., perturb the
enzymatic activity (in enzymes), or the antigen binding capabilities (in antibodies). If the active
site of enzymes and antibodies are utilized in the bioconjugation step, the enzymatic activities and
efficiencies will be diminished drastically. As many hydrophilic residues such as lysine are present
at protein surfaces the primary amine in these lysine groups renders a very useful functional group
exploitable in creating DNA-enzyme bioconjugates.
1.1.5.3 Bioconjugates of DNA and other small molecules
Gene transfer and drug delivery are also other intriguing applications of DNA mediated
assembly of multifunctional molecules or bioconjugates. Curiel led one such study on gene transfer,
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where they derived virion particle complexes (adenovirus-polylysine-DNA complexes) to which
foreign DNA attached. This was a successful effort to eliminate the limitations on the gene transfer
vectors due to constraints on the size and the functional design of the genetic material that is
desired to be transferred 35. They accomplished this conjugate linkage by using an antibody bridge,
where a monoclonal competent antibody was constructed to carry DNA after a polylysine residue
was attached. This antibody-polylysine binding to the virus was possible because of the antibody’s
specificity to the virion.
In another novel study, site-specific caged plasmid DNA were transfected into cells by
lipofection 36. The conventional caging processes involves random reactions between a photolabile
protecting groups and the phosphate backbone of the DNA
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. Yamagucchi and his team first

created, a site-specific amino-modification by overlap extension PCR, using a 5’amino DNA
primer. Second, the amine group incorporated within the PCR product was reacted with the aminereactive group of a biotinylated caging agent. Lastly, streptavidin was bound to the biotin group
of the site-specifically caged plasmid DNA, as a steric regulator to block transcription factors
binding to the promoter sequence 36.
In a pioneering work in DNA bioconjugation, Corey and Schultz synthesized a covalently
attached enzyme-ssDNA with catalytic functionality. Staphylococcal nuclease hydrolyzes the
phosphodiester bonds in single stranded DNA (ssDNA), RNA, as well as double stranded DNA
(dsDNA). Wild-type staphylococcal nuclease does not have any site-specificity when cleaving
phosphodiester bonds, which are the backbone of DNA and RNA. However, this team synthesized
a hybrid-staphylococcal nuclease which could cleave phosphodiester bonds site-specifically. They
accomplished this by selectively fusing a staphylococcal nuclease to an ssDNA, to create a hybrid
DNase enzyme which cleaves DNA site-specifically 32. Staphylococcal nuclease was covalently
attached to a 3’-thiol containing ssDNA through a disulfide link. The unique cysteine was prederivatized onto the enzyme. Cysteine is a relatively rare amino acid and hence, derivatization of
the staphylococcal nuclease was important. Ultimately, they demonstrated that their hybrid
enzyme was able to selectively cleave incoming single stranded DNA (substrates), in comparison
with the wild-type enzyme, which cleaved DNA nonspecifically. In 2007, Gianneschi and his team
used a similar method to construct a semisynthetic enzyme, with programmable capacity. They
employed an intricate mechanism where two orthogonal DNA-directed processes established
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programmed allosteric activation/deactivation of an enzyme, by a trigger signal provided by
sequence specific binding of ssDNA. Here, they conjugated a ssDNA to an allosteric enzyme,
creating a semisynthetic enzyme-ssDNA. Next, they attached its complimentary ssDNA to the
specific inhibitor of that enzyme.

38

. They were able to intrasterically activate, or inactivate the

enzyme by hybridizing (annealing the two strands) the two ssDNA together, or denaturing
(separating the two strands).
In another study related to DNA bioconjugation, Erben and his team encapsulated a
cytochrome c molecule within a rigid tetrahedral structure constructed from DNA 17. In this novel
architecture, they first constructed the DNA cage by facilitating self-assembly (via complimentary
nucleotide base pairing) of four 20 base paired ssDNA. In one of the ssDNA strands, they
conjugated a model globular protein (cytochrome c). When the final spontaneous assembly of
DNA was facilitated, they were able to position the small cytochrome molecule on the interior of
the DNA tetrahedral cage. Their method was adopted from a DNA cage development strategy
from one of their own previous works 17,19.
1.1.5.4 Applications of DNA-based bioconjugates
DNA based bioconjugation is often a random process that leads to heterogeneous
conjugates with variable stoichiometry and no regiospecificity. Regiospecific conjugation of
proteins and DNA is a requirement for bottom-up design of supramolecular architectures. Albeit
the lack of regiospecificity, DNA directed immobilization is reversible, and could be manipulated
to yield high conjugation efficiencies 23. These characteristics are invaluable for fabrication and
reconfiguration in the fields of biotechnology, medical diagnostics, and translation medicine, and
hence have been utilized in a wide variety of applications.
One of the earliest studies used site-specific DNA bioconjugations to yield fluorophore-taggedDNA as sequencing primers
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. They utilized the widely employed Huisgen’s 1,3-dipolar

cycloaddition chemistry to react alkynyl 6-carboxyfluorescein (FAM) with single stranded DNA
(ssDNA) which have been functionalized with azide. These fluorescein labelled oligonucleotides
were used as the primers in DNA sequencing

39

. This process was lengthy and required high

temperatures (90 °C). However, since their study, attention was diverted to reverse the order of
derivatization. As discussed previously, derivatizing DNA with azide groups is problematic due
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to its potential of undergoing Staudinger reaction with the phosphoramidites

40

. Therefore,

successive studies with fluorescent labeling of DNA using “click reactions” have been centered
on alkyne-functionalizing the DNA, while azide-functionalizing the tagging dye/fluorescent
protein. Many site-specific, as well as random crosslinking reactions have yielded successful
labelled DNA which were used in fluorescent in situ hybridization (FISH) applications
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, high

through-put DNA sequencing 42, chromosome and genetic analysis 43, and direct visualization of
microorganism communities 44.
In an early study, scientist followed an expressed protein ligation procedure to synthesize
protein-nucleic acid conjugates

23

. This is a perfect example of utilizing immobilized DNA to

capture other biomolecules such as proteins. In their expressed protein ligation procedure, they
first expressed the target proteins in E.coli. This target protein contained a chitin binding domain,
which was utilized to bind the protein to a chitin matrix column. Next, the protein was liberated
from the column by a mercaptoethansulfonic acid wash. As a result, the target protein was
derivatized with a C-terminal thioester. This C-terminal thioester was utilized to carry out native
chemical ligation with a polyamide nucleic acid (PNA) containing an N-terminal cysteine, as well
as a Cy5 labeled peptide. PNAs are non-ionic analogs of DNA where the entire sugar-phosphate
backbone is replaced by an N-aminoethylglycine-based polyamide structure. In their final step,
these protein-PNA conjugates and protein-Cy5 conjugates were successfully annealed onto their
complimentary strands which had been previously immobilized onto glass slides. As such, their
protein chip (i.e., protein microarray) was developed via DNA-directed immobilization
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. A

common concern of protein biochips is that when multiple proteins are immobilized on chemically
activated surfaces, their intrinsic instabilities could lead to loss of protein functionalities. However,
DNA microarray matrices involve very few steps involving strong chemical agents, and hence
allows for unique parallel attachment of multiple proteins to the surface of the matrix.
Niemeyer has reviewed another area of application of protein-DNA conjugates in the field of
immunological detection assays and biosensors 24. The devices reviewed in this article indicates
the high potential of DNA-labelled antibodies for immunodiagnostics. Immunoassays are widely
used for the detection of drugs of abuse. The most commonly used counterpart methods for
detection are PCR and GC-MS techniques. These methods are labor intensive, time consuming,
and require usage of many reagents 21,24. However, immunoassays could prove extremely useful
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in overcoming many of the above mentioned problems, without trading off the sensitivity of the
detection assays as well. They can be developed to be highly specific, sensitive, relatively rapid,
require no extraction steps, and they usually require little or no preparative clean up steps too. The
following are types of immunoassays that are used for detection of drugs, analytes and precursors:
enzyme-linked immunosorbent assay (ELISA), enzyme-multiplied immunoassay techniques
(EMIT), fluorescence polarization immunoassays (FPIA) and up-converting phosphor technology
(UCP). While there are many other sub divisions of immunoassays, the basis of all enzyme
immunoassays is the binding of the antibody to the antigen of interest. This binding is detected
using an enzyme, with the enzyme acting on a substrate producing a colored product which is
subsequently measured via colorimetric analysis. Capabilities and future directions of DNA
based nanostructures in sensing and detection of drugs, would be extremely useful for on-site drug
detection in fields such as athletics, law enforcement, and medicine (point-of-care). One
advancement that could be implemented on current immunoassay techniques, is multiplexing
using protein-DNA bioconjugates (simultaneous detection of multiple analytes using different
protein-DNA conjugates). These methods have been successfully used to produce antibody-DNA
conjugates, utilized in ultrasensitive diagnostics such as immuno-PCR 3.
A recent study exemplified the ability of using DNA bioconjugation onto enzymes, as a new
class of protein transfection material. In the last decade, spherical nucleic acid (SNA)nanoparticles have been recognized as new architectures with diverse applications in immunology
and intracellular detection. These SNAs are simply nanoparticles with dense shells of ssDNA.
Brodin and his team applied this concept to create a proSNA (protein-SNA) where β-galactosidase
enzyme was covered with a dense shell of ssDNA. They report that the pro-SNA resulted in
increased cellular uptake while maintaining the enzymes catalytic activity of the where βgalactosidase enzyme 45. Another study which developed an influenza A vaccine utilized the BS3
homobifunctional crosslinker to fuse the extracellular domain of a transmembrane protein (M2e),
to a Leucine zipper domain from the yeast transcription factor (tGCN4), and created a fusion
protein synthetically, which elicited antibodies specific to the influenza antigen

46

. This is an

example of utilizing random crosslinking techniques to construct DNA-enzyme bioconjugates.
As demonstrated all of these previous studies have used random bioconjugation techniques
(e.g.crosslinkers such as BS3, and BMPS), and site-specific bioconjugation techniques (“click

22
reactions”, Staudinger ligation) to synthesize a variety of diagnostic tools, detection systems, novel
transfection materials, and many more.

1.1.6

Enzymatic studies

1.1.6.1 Overview of Enzymes
Approximately 200 enzymes have been discovered up to date, and most of these enzymes
come from a limited number of fungi, yeast, and bacteria 47. Enzymes are considered as a potential
biocatalyst for a large number of reactions. Microbial enzymes have widespread uses in industries
and medicine. The microbial enzymes are also more active and stable than plant and animal
enzymes. In addition, microorganisms provide an attractive source for enzymes because they can
be cultured in large quantities in a short time by fermentation and owing to their biochemical
diversity and susceptibility to gene manipulation. Industries are looking for new microbial strains
in order to produce different enzymes to fulfil the current enzyme requirements 48. While animal
and plant sources require careful and planned collection and storage of raw material, microbes are
convenient and can be grown in fermenters easily. Microbes can also be experimented with
mutagens, to yield alterations in naturally occurring enzymes. Most of the enzymes used in
industrial applications are extracellular enzymes. These extracellular proteins are mainly obtained
from fungal or bacterial sources (ex: Aspergillus, Bacillus, Streptomyces, Escherichia species).
Examples of such enzymes in commercial use are; α-amylase, cellulose, dextranase, protease, and
amyloglucosidase. Other enzymes which are not used in industrial applications are also produced
in small quantities, and they are mostly enzymes produced in intracellular spaces. Examples of
such proteins are asparaginase, catalase, cholesterol oxidase, glucose dehydrogenase, and glucose
6-phosphate dehydrogenase.
1.1.6.2 Methods of Enzyme immobilization
The method of adsorbing enzymes to solid supports, or crosslinking enzymes to solid
surfaces is referred to as enzyme immobilization. If performed carefully, using only the enzyme
surface, this technique could be utilized in the development of a variety of biosensors and
biological assays. Since the active sites of enzymes are generally conserved, there is little risk of
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tampering with the catalytic activity. However, once immobilized, the enzyme has less rotational
freedom, which is not necessarily an advantage for catalytic activity for all enzymes. The two
techniques of enzyme immobilization are entrapment, and surface immobilization (Fig.9). Enzyme
immobilization could be accomplished passively via electrostatic interactions, or covalently by
reacting the functional groups present on the surfaces of the protein.

Figure 9: Enzyme immobilization techniques 49.

Enzyme entrapment and encapsulation are generally achieved by using polymeric networks
and alginate solutions 50. Surface immobilization has been accomplished on many matrices such
as cellulose paper

51

, nanoparticles

52

and gel-silica

53

. Studies on surface immobilization have

reported concerns regarding tortuosity, crosslinker cleavage, spacer arm disorientation/cleavage,
spacer length issues, flexibility, loss of peptide functionality, dissociation at the functional groups,
restricted kinetics, and limited accessibility for the reactants 54,55. These could interplay and result
in a loss of functionality of the molecules.
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However, enzymes in free solution have been speculated to form aggregates, making them less
accessible for their substrates. This in return could lead to poor product formation. Immobilizing
enzymes onto supports could accomplish high densities of enzymes in a localized environment,
which could enhance the enzymatic activities by 100-folds 56. In one previous study, celB and βglucosidase were immobilized on to a polystyrene layer which was treated with plasma 54. They
immobilized the celB enzymes to a polymer binding surface pre-treated with plasma immersion
ion implantation (PII). Afterwards, they studied the enzymatic activity of the immobilized system
via analyzing the Vmax, and Km, values of the carboxymethyl cellulose hydrolysis activity 55. Their
studies showed that the immobilized celB enzyme’s activity was enhanced, compared to that of
the free enzyme during carboxymethyl cellulose hydrolysis. In another study, glucose isomerase
(GI) from Streptomyces rubiginosus was immobilized covalently onto Eupergit® C 250 L made by
copolymerization of N,N-methylene-bis-methacrylamide, glycidyl methacrylate, allyl glycidyl
ether and methacrylamide

57

. GI facilitates isomerization of glucose to fructose. The catalytic

efficiency of immobilized GI was found to be three-fold higher than that of free GI. They also
discussed the similarities in the thermal stabilities of the free GI, and immobilized GI 57.

1.2
1.2.1

Introduction
Overview and objectives
This study explored programmable DNA hybridization in order to co-localize two wild-

type enzymes. Single stranded DNA (ssDNA) attached to enzymes yields conjugate possibilities
limited only by one’s imagination. For example, by attaching an enzyme to ssDNA, and attaching
the complimentary ssDNA to another enzyme, we would be able to program spontaneous
association of the two enzymes. Previous bioconjugation techniques such as chemoenzymatic
labeling methods, and other chemical strategies do not render a universal covalent bioconjugation
method for wild-type proteins, enzymes, or peptides. Because such labeling/derivatization steps
pose a risk of hindering enzyme functionality, our investigation was solely constructed around
utilizing ubiquitous functional groups present on natural enzymes. Therefore, we have essentially
removed the need for extensive modifications on the enzyme’s surface, and immobilization steps.
The main objective in this study was to synthesize two separate bioconjugates with two
complimentary single stranded DNA (ssDNA) covalently coupled to two separate enzymes, in an
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aqueous system. The next objective was to exploit complimentary binding of ssDNA to co-localize
those two enzymes in an aqueous system. The two enzymes chosen for the proof-of-concept were
glucose oxidase (GOD), and horseradish peroxidase (HRP) (Fig.10).
There are several reasons for choosing GOD and HRP as the two enzymes for the proofof-concept. GOD and HRP both have surface amine residues which we would utilize for covalent
bond formation between phosphorylated ssDNA, using crosslinking strategies. This voids the
necessity for performing prior surface modifications on these two wild type enzymes. The fewer
the modifications introduced to any biological molecule, the better the process is. That is because
fewer modifications leads to fewer chances of affecting enzyme activities, improved yields owing
to the fewer steps, and lesser costs.

Figure 10: Illustration of the final assembly of a co-localized enzyme system.
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1.2.2

Gaps in current state-of-art

Molecular immobilization: The major gaps we address in previously reported co-localized
enzymatic designs are mainly molecule immobilization onto intricate DNA scaffolds, as well as
direct enzyme-enzyme conjugation

58,59

. Enzyme immobilization techniques have numerous

limitations such as loss of enzyme activity, cumbersome surface immobilization strategies, bond
cleavage, enzyme leeching, restrictions of spacer flexibility, constricted enzyme orientation at
interface, and poor robustness 54.
Quantitation of conjugated/immobilized enzymes: In an immobilized system, if the enzyme leeches
from the support, the desired microenvironment around the concerted enzymes is no longer
existential. In immobilized bioconjugation studies, in order to quantitate the amount of enzymes
bound to a solid surface, scientists have usually taken an indirect route. First, the enzymebound are
indirectly quantitated by measuring the enzymeunbound leeched out into the wash solution 60. Then,
using the; enzymebound = enzymetotal – enzymeunbound equation, they have determined the amount of
bound enzymes. The other method is using fluorescence imaging/spectroscopic analyses, which
requires tagging or attaching fluorescent or dye molecules to the biomolecules 59. Another direct
method of quantitating enzymes on an immobilized support is via using spectrophotometers
designed for solid samples. Agilent Cary 500 is an example of a specialized instrument which can
detect in the UV-Vis-NIR (ultraviolet-visible-near infrared) region, specifically in the range of 175
– 3300 nm. A previous study which studied enzymatic activity of glucose oxidase (GOD)
immobilized onto Whatman papers utilized the aforementioned spectrophotometer, and analyzed
their samples at 280 nm, with Teflon used as the blank 51. However, the instruments and materials
involved in both of these techniques are expensive, and involves a large no. of steps in the
analytical procedure.
Substrate diffusion limitations: In immobilization, even if a residue on the enzyme’s active site is
not utilized in crosslinking (the desired scenario), the active site could still be oriented in a position
which cannot be accessed by the substrate. For example, if the immobilized enzyme’s active site
is facing towards the solid support, the substrate will have spatial hindrances to get to the reactive
site of the enzyme. Therefore, this could pose as a kinetic limitation to the enzymes catalytic
activity. We recognized that a bioconjugation scheme conducted in an aqueous scheme would not
encounter these pitfalls.
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The other concerted model for developing enzymatic cascades have been direct enzyme
conjugation models where enzyme1 is conjugated to enzyme2 directly via any chosen crosslinking
method 58. The same concern with substrate diffusion limitations are applied to direct conjugations
as well. For example, in a design where a crosslinker with a spacer arm of only 8.3Å (sulfo-SMCC)
is used, the two enzyme molecules could be too close together 58. Although C–C single bonds with
120° rotational freedom could be the best scenario for enzyme-enzyme rotational abilities, by
incorporating DNA to link the two enzymes, we are not trading off the rotational abilities of the
enzymes. All the six bonds in a DNA backbone (C–C, phosphodiesterase etc.) have rotational
freedom compared to hydrocarbon chains as well (C–C single bonds) 61.
Controlling the distance between the enzymes in enzymatic bioconjugates: The optimal distance
between two enzymes for enhanced catalytic activities is not well characterized yet. This is because
the optimal distance of enzymes could easily differ based on the type of enzymes used in a
concerted model. However, the underlying principle is that if the two enzymes in the cascade are
too close, the enzymatic activities could easily undergo product inhibition. The proximity of the
enzymes could be controlled by using crosslinkers with different spacer arm lengths (Å). The
spacer arm of a crosslinker refers to the length of the hydrocarbon chain in between the one/two
functional groups at the crosslinkers terminal ends. If a longer distance is desired between the two
enzymes in the cascade, the choice is to use a longer spacer arm (e.g. BS3, DPDPB). However,
the maximum spacer arm length of the crosslinkers discovered up-to-date is approx. 11 Å.
Therefore, after a certain limit, researchers are unable to use crosslinkers to control the distance
between two biomolecules. On the other hand, using crosslinkers with medium length, or short
spacer arms result in the two enzymes being extremely close together. We recognize this as a
potential pitfall, giving rise to kinetic limitations.
1.2.3

Scope of dissertation

In our design, the factor governing the distance between the two enzymes is the length of the
DNA. The usage of DNA to control the distance between the two molecules is more promising
because the distance will be based on how many base pairs there are in the ssDNA sequence. And
this factor is easily controllable. In chapter 4 of this dissertation, we also report results from DNA
hybridization analyses. The purpose of this experimentation was to validate that the ssDNA used

28
in the study could be thermally programmable, i.e., DNA hybridization facilitated by heating-andcooling.
Additionally, this investigation utilizes cost-effective crosslinkers compared to many previous
studies

18,45,59

, enabling large throughputs. Previous studies have repeatedly used expensive

crosslinkers such as BS3, and BMPS to accomplish crosslinking. This study focused on
accomplishing bioconjugation via three different crosslinkers, and discusses the importance of
optimization of bioconjugation chemistries in order to obtain useful bioconjugates. The
investigation reported herein demonstrates the ability of using a relatively inexpensive, and
universal crosslinker such as carbodiimide to accomplish crosslinking of naturally occurring
enzymes and ssDNA.
Our investigation attempts to address the above mentioned gaps by adapting current knowledge
in the field, and attempts to evade the drawbacks of molecular immobilization, surface
modifications, and direct enzyme-enzyme conjugation. To our knowledge, this is one of the first
attempts to synthesize bioconjugates using wild-type enzymes and ssDNA, in a single-step
crosslinking procedure. As our study only involved naturally occurring enzymes (wild-type
proteins) a greater focus of this study has been devoted to creating a final enzyme macromolecule
in solution, and characterizing the final macromolecule’s structure. A heavy emphasis has been
devoted to characterizing crosslinking strategies (i.e., comparison between EDC, EDC/Im),
developing analytical methods which could be routinely used to separate and purify bioconjugates,
and gathering structural information of the bioconjugates formed via the chosen crosslinking
technique. The reaction schemes, optimized protocols developed in this study will be universally
applicable to a wide variety of peptides, proteins, and enzymes. It is an innovative, improved,
holistic study, and the conclusions drawn from the study could pave a path for simplified
bioconjugation techniques in aqueous phase systems.
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CONJUGATING SSDNA AND ORGANIC COMPOUNDS
VIA EDC CROSSLINKING

2.1

Abstract
An

adapted

strategy from

the conventional

1-ethyl-3-(3-dimethylaminopropyl)

carbodiimide hydrochloride (EDC) crosslinking method was developed to form a covalently
coupled phosphoramidated single stranded DNA (ssDNA). The novel ssDNA bioconjugate was
used to compare the conventional carbodiimide (EDC) reaction with the adapted strategy using
EDC and imidazole (EDC/Im). Matrix assisted laser desorption ionization-time of flight (MALDITOF) results demonstrated that the phosphoramidated conjugate is stable for several days, and that
phosphoramidation was exclusively at the 5’ end of ssDNA. A reversed phase liquid
chromatography (RP-HPLC) method with UV detection was developed to determine the yield of
conjugates. The methods coefficients of variation (%CV) were less than 6%, and biases ranged
from -5.1% – 1.2%. The conjugate yield via the conventional EDC method was 68.3±2.2%, while
that of the adapted EDC/Imidazole method was 79.2±2.4% (n=10). This study demonstrates a
convenient, one-pot strategy for crosslinking biological molecules, which is useful in diagnostics,
biosensor development, and constructing self-assembling macromolecules where there is a lack of
flexibility in adjusting reaction temperature or pH.

2.2
2.2.1

Introduction
EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide) crosslinking.
EDC is a water soluble zero-length crosslinker which is convenient to use and relatively

inexpensive. It has been used in a variety of conjugation techniques to couple carboxyl groups to
primary amines

2,25,62

. EDC first forms an active ester intermediate which then undergoes

nucleophilic substitution in the presence of a strong nucleophile, such as a primary amine. EDC
crosslinking is generally carried out in buffers devoid of extraneous carboxyls or primary amines,
at physiological pH. Although EDC crosslinking chemistry is well known, reverse reactions can
limit its utility 63,64. The o-acylisourea product intermediate can be easily hydrolyzed, reverting to
the original carboxylate molecule 2. To overcome this limitation, sulfo N-Hydroxysuccinimide
(sulfo-NHS ester) has been used to form a more stable second intermediate prior to amidation 64.
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This enhanced EDC/NHS method has been used in a wide range of applications such as
immobilizing carboxymethylated coatings on enzyme-linked immunosorbent assay wells
immobilizing proteins onto grafted solid surfaces
solid supports

68

66,67

65

,

, crosslinking antibodies to functionalized

, peptide functionalized gold nanoparticles

69

, antibody functionalized

superparamagnetic nanoparticles 70, grafting polymers onto porous silicon 71, constructing DNAcellulose nanocrystals 72, and creating nucleic acid functionalized carbon nanotubes 73. Although
EDC and EDC/NHS reactions have been extensively used before, their reaction efficiencies have
only been quantified indirectly 68 or in semiquantative FTIR analyses 74.
In the final step of the EDC/NHS reaction mechanism, amidation is favored at pH 7.5 – 8.
Therefore, when many researchers used the EDC/NHS method, researchers have approached a
two-step protocol

2,63,75

. The initial EDC/NHS reaction had been performed at pH 4.5 – 7.5.

Immediately afterwards, the pH of the reaction mixture had been raised to approx. 8.0 prior to
adding the amine reactant, as amidation is facilitated at higher pH. This two-step process faces the
risk of hydrolyzing the NHS intermediate, as it is has a half-life ranging from 10 min – 1 hr 75. Not
only is this two-step process cumbersome, it can also be prone to poor product yields with enzymes
or immunoglobins due to loss of activity, as these molecules generally have an isoelectric point
(pI) around 7.4. Lastly, NHS esters are expensive, and are highly water labile.
This chapter discusses the synthesis of a novel phosphoramidated single stranded DNA
(ssDNA) conjugate via a convenient, inexpensive, time efficient EDC crosslinking method. A
5’phosphoryl single stranded DNA (phosphoryl ssDNA) was crosslinked to ethylenediamine using
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC). To study the EDC crosslinking reaction,
an ssDNA modality was chosen to address unique problems related to DNA and nucleic acid
bioconjugation techniques. The largest setback of EDC in nucleic acid studies is due to the
formation of non-specific, electrostatic interactions with the phosphate backbone, and open
nucleotide base pairs 2,76. Additionally, EDC crosslinking can also face additional problems due to
self-dimerization of DNA, preventing covalent bond formation between the desired functional
groups. Previous literature does not suggest practical approaches to circumvent such adduct
formation, hence the development of an alternate protocol to address these drawbacks. Therefore,
upon identifying the tedious multi-step reactions involved with EDC and EDC/NHS crosslinking,
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the expenses related to it, and the problematic non-specific binding with DNA, we investigated an
alternate route to address these drawbacks.
The possibility of adding an alkaloid to drive the forward reaction has been previously
proposed and tested in binding DNA to microwells 77, and in immobilizing phosphoproteins onto
collagen

78

. However, to our knowledge, there are no studies which have reported bioconjugate

product characterization, product stability, and product quantitation obtained via an imidazole
mediated EDC (EDC/Im) crosslinking strategy. We quantitatively compared the conventional
EDC and the modified EDC/Im method to crosslink negatively charged functional groups with
primary amines in a one-pot reaction scheme, without adjusting the temperature or pH (Fig.11).
This study also reports chromatographic analytical methods suitable to assess DNA conjugates.
The theoretical reaction mechanism is depicted in Fig.11. At neutral pH, O- in the free
5’phosphate group of the ssDNA attacks the Cδ+ on the EDC molecule, which then forms an
unstable isourea intermediate. Imidazole (Im) at pH 6.0 ensures that one N atom in the ring is
always protonated, and ensures that the other N atom carries a lone pair of electrons which makes
the molecule a strong nucleophile

79

. When imidazole is immediately introduced to the isourea

intermediate, the Pδ+ undergoes nucleophilic substitution by imidazole. The intermediate
phosphorylimidazole is highly reactive, and will undergo a nucleophilic attack by the primary
amine in ethylenediamine (EDA), in an SN2 reaction, resulting in a stable, covalent,
phosphoramidate bond.
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Figure 11: Schematic of the EDC/Im reaction.
– modified from 2.
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2.2.2

Reversed phase high performance liquid chromatography (RP-HPLC).
Liquid chromatography (LC) is a separation technique that is widely used in many

bioanalytical applications. Reversed phase is a famous choice in LC which separates molecules in
an analytical sample based on their hydrophobicity. There are two major “phases” which are often
used in RP-HPLC. The stationary phase is the solid surface which is generally silica particles
functionalized with organic groups/ligands such as alkyl chains, alkane chains or amines. There
are many stationary phases for RP-HPLC columns. The one used in this study was a C18 column,
which has a ligand size of 18 carbons. These functionalized particles are ultimately packed into a
column to create the stationary phase. Smaller particle sizes coupled with smaller column lengths,
increase resolution, and decrease the overall experiment run times.
The mobile phase is the solution which is introduced to the packed beads (i.e., stationary
phase) in the column. The mobile phase moves along the column due to a pressure gradient created.
Optimizing the organic modifier (mobile phase) is one other key factors in chromatography.
Mobile phase gradients could be profiled according to the decreasing polarity; water> methanol>
acetonitrile> N-propanol> THF. Incorporation of ion paring agents is of great importance in RPHPLC, because they impart hydrophobicity into the molecules in the analytical sample. This
improves retention of the molecules in the column’s stationary phase. Typically, TFA
(trifluoroacetic acid) is used for protein and peptide separations, and TEAA is generally preferred
for DNA quantification experiments.
In HPLC, a sample is injected to the column, and the mobile phase is introduced. Next, the
separated constituents in the analytical sample are introduced to a UV spectrophotometer
automatically. Here, the intensity of absorbance (AU) of each constituent in the sample are
detected at the operator prescribed wavelength. The detection method determines the amount of
each constituent in the analytical sample, along with their elution time from the column. Generally,
HPLC instruments (a.k.a. separations module) are equipped with a software manager, which
remotely controls the mobile phase ratios, column temperatures, flowrates, and sample injection
volumes. There are several major HPLC separation techniques, namely, reversed phase, partition,
normal phase, affinity, ion exchange, and size exclusion. Among these, reversed phase is a
commonly used technique because it can be used for both nonpolar, and polar molecule separations.
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2.3
2.3.1

Materials and Methods
Materials
A 12 base paired (bp) single stranded DNA (ssDNA) with the sequence; 5’phosphorylated-

TGT GCA TTA TTT-3’; Tm 29.0 °C; molecular weight, 3721 Da, was purchased by IDT® DNA.
The sequence was designed with a reduced no. of G, C, and a medium length, in order to minimize
the ssDNA forming secondary structures. For the comparison study to determine if the
bioconjugate formation is independent of the ssDNA sequence, we also conducted the EDC
crosslinking experimentation with a 15 bp ssDNA with the sequence; 5’phosphorylated-TGT GCA
TTA TTT GAT-3’; Tm 37.8 °C; molecular weight, 4665 Da.
Imidazole (Im), EDC and 99% v/v ethylenediamine (EDA) were purchased from
ThermoFisher Scientific. 10 mM sodium phosphate (NaH2PO4·H2O), 0.15 M NaCl, buffer
medium was freshly prepared, pH adjusted to 7.2±0.2, and filtered. 0.1 M Imidazole solutions were
pH adjusted to 6.0±0.2.
2.3.2

Methods

2.3.2.1 Crosslinking phosphoryl ssDNA with ethylenediamine.
5’ phosphorylated single stranded DNA (phosphoryl ssDNA) as received was dissolved in
50 μL of PBS (pH 7.2±0.2), and was added to EDC (carbodiimide) at a 150-fold molar excess
amount to the ssDNA. In order to reduce non-specific EDC binding to the ssDNA phosphate
backbone, the molar ratio of EDC: 5’ phospho ssDNA was reduced to 150-fold excess, instead of
the 430-fold molar excess suggested in literature 75. Next, 0.025 M EDA dissolved in PBS (10mM,
pH 6.0±0.2) was added in an equimolar amount to the ssDNA. In order to allow only one covalent
bond per one phosphoryl group, the molar ratio of 5’ phosphoryl ssDNA: EDA was maintained at
1:1. The reaction mixture was gently vortexed, and an additional 120 µL of PBS was added to the
vial prior to incubation at r.t. (room temperature) for approx. 4 hrs. In the EDC/Im reaction, instead
of PBS, Im (0.1 M, pH 6.0±0.2) was used to dissolve EDA in an equimolar amount to the ssDNA.
The molar ratio of 5’ phosphoryl ssDNA: EDA was maintained at 1:1. The reaction mixture was
gently vortexed, and an additional 120 µL of Im was added to the vial prior to incubation at r.t.
(room temperature) for approx. 4 hrs. The phosphate concentration of the PBS buffer was limited
to 10mM so that the free phosphate groups did not bind with EDA (ethylenediamine).
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After the 4 hrs incubation period, each sample was subjected to dialysis against deionized
water for 2 hrs using 2000 MWCO (molecular weight cut-off) dialysis tubes to remove unreacted
EDA, Im, and buffer salts.
2.3.2.2 Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF).
MALDI-TOF spectrometric results were obtained using an Applied Biosystems
(Framingham, MA) Voyager DE PRO mass spectrometer. This instrument utilizes a nitrogen laser
(337 nm UV laser) for ionization with a time-of-flight mass analyzer. Prior to MALDI-TOF, each
sample was purified using a C18 – ZipTip column (Millipore Corporation, Billerica, MA). The
ZipTip columns were conditioned using two 10 μL of acetonitrile followed by two 10 μL of 0.1%
trifluroroacetic acid (TFA). A negative linear mode was used (MH-) to produce singly charged
ssDNA species. In MALDI-TOF, the analyte sample is embedded in a mixture of weak organic
acids, called the “matrix.” The matrix is responsible for desorption of the sample. It also prevents
the analytes in the sample from decomposing. Next, the molecules are ionized by a laser ablation,
causing the molecules to ionize. The protonated/deprotonated molecules are then accelerated in an
electric field, under a fixed kinetic energy, and detected using a time-of-flight mass spectrometer.
2.3.2.3 Confirming phosphoramidation exclusively at the 5’phosphate of ssDNA.
Since ssDNA is comprised of a phosphate backbone, any charged counter ions or species
could interact with these groups, giving rise to weak, unstable electrostatic interactions. To
investigate whether EDA is covalently bound exclusively at the 5’ phosphate group of the ssDNA,
an EDC/Im reaction with nonphosphorylated ssDNA (3641.4 Da) was conducted. In
phosphorylated ssDNA, there is a phosphate group at the end of the strand, while in the
nonphosphorylated ssDNA, it is an OH group. As nonphosphorylated ssDNA lacks an open
phosphate group susceptible for conjugation, it was not expected to observe a mass signal during
mass spectrometry at the otherwise expected conjugate mass region.
2.3.2.4 Stability of phosphoramidate bond.
To investigate the phosphoramidate bond over a prolonged time, MALDI-TOF analyses of
the purified products was conducted after 7days, and 14days (n=4). These subsequent results for
time point 0 (1day), time point 1 (7 day), and time point 2 (14 day) were obtained from the same
product sample which were stored at -20 °C.
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2.3.2.5 IP-RP-HPLC method development.
A C18 XTerra® (Waters, MA) column with 4.6 × 100 mm, 3.5 µm particle diameter, and
a guard column was used for reverse phase separation of the conjugates. High-performance liquid
chromatography (HPLC) was performed on an Alliance 2695 separation module, using Empower
version 2.0 software (Waters Corp., Milford, MA), equipped with a Waters 2496 UV/Vis detector
(Waters Corp., Milford, MA). Detection was carried out at λ260 nm. HPLC analysis was conducted
in 0.1 M TEAA, pH 9.70±0.05 (triethylammonium acetate) buffer with 5% acetonitrile (ACN) and
30% ACN as the two mobile phases. 0.1 M TEAA buffer was prepared by adding 5.6 mL of glacier
acetic acid to 950 mL of deionized water. To this, 13.8 mL of TEA was added gradually, and the
solution was stirred. Afterwards, the pH of the solution was adjusted to 9.70±0.05, and the final
volume was brought to 1000 mL by adding water. This solution was filtered using gravity filtration
and qualitative-grade filter paper, and was stored at 4 °C. Mobile phases were prepared as follows;
A: 5% acetonitrile in TEAA (v/v), B: 30% acetonitrile in TEAA (v/v). The gradient method
incorporated was 90% – 60% A in 16 min, and 60% – 90% A in the next 14 min. A flow rate of
1.0 mL/min, an injection volume of 100 µL, sample and column temperatures of 33 °C, and 38 °C,
were used respectively. The column was equilibrated for 50 mins prior to running samples, and
for 30 mins in between the separate sample injections. The samples were diluted 50% (v/v) in
TEAA buffer prior to HPLC experimentation. Each sample was filtered using a 0.45 µm PTFE
syringe filter.
2.3.2.6 RP-HPLC standards preparation and calibration curve.
In order to validate the HPLC method, a calibration curve was generated using four
concentration values of the starting material (5’phosphoryl ssDNA) in triplicates. 0.4 mg of 5’
phosphoryl ssDNA as received was dissolved in 1 mL of TEAA buffer, and was used as the stock
solution, from which the successive aliquots were used for the standards preparation. The dilutions
yielded 0.57 mg, 0.285 mg, 0.1425 and 0.07125 mg/mL standard solutions respectively. Each level
of concentration was run in triplicates to obtain a total of 12 determinations in the specified range.
The precision of an analytical procedure entails the closeness of agreement between a series of
measurements obtained by multiple sampling of a homogenous sample. This was assessed by the
coefficient of variation (%CV) which was calculated by the following equation: %CV = (standard
deviation of the triplicates/mean) ×100. The accuracy of the method was assessed by the %bias
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from the theoretical concentration, which was calculated by the following equation: %bias=
[(observed concentration – nominal concentration)/nominal concentration] ×100.
Linearity is the procedure’s ability to obtain test results which are directly proportional to
the concentration of the standard (5’ phosphoryl ssDNA), and was assessed by fitting the data into
a linear regression numerical model. The limit of detection (LOD) of a method is the lowest
amount of analyte which can be detected by the method reliably, and was calculated according to
the following equation: LOD = (3.3 × σ)/slope. Limit of quantitation (LOQ) is the lowest amount
of analyte which can be quantitatively determined with suitable precision and accuracy, and was
determined by the following equation: LOQ = (10 × σ)/slope. In both the LOD and LOQ equations,
slope = slope of the average regression line. σ is the standard deviation of the y-intercepts of the
three separate regression lines. Linearity, LOD, and LOQ were assessed according to the ICH
Harmonized Tripartite Guidelines.
2.3.2.7 RP-HPLC product collection and purification.
Baseline separation was obtained allowing fractions corresponding to the conjugate to be
collected. The collected fractions were left open overnight in the fume hood to evaporate the
organics. The sample was then subjected to dialysis against deionized water for 2 hrs using 2000
MWCO dialysis tubes. Prior to usage, dialysis tubes were prewashed in deionized water
thoroughly to remove any glycerin percent in the membranes. The recovered samples were freeze
dried at -80 °C overnight and lyophilized the next day, and the conjugate masses were
characterized on MALDI-TOF. The percentage yield of the conjugate is reported as; [ssDNA
conjugate product (mg)/starting ssDNA (mg)] ×100.

2.4
2.4.1

Results and Discussion
Phosphoramidated ssDNA conjugate analysis; MALDI-TOF.
Conjugates formed via the conventional EDC, and the EDC/Im reaction mechanisms were

characterized by MALDI-TOF. The expected conjugate molecular weight of 3758 Da was
calculated by adding the individual molecular weights of ssDNA and EDA, and subtracting 17 Da
to account for the loss of an -OH during conjugation. Fig.12 illustrates that the observed
phosphoramidated ssDNA conjugate molecular weight was 3758.5±3.6 Da for the EDC/Im
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mechanism (n=14) and 3758.4±3.6 for the EDC mechanism (n=7). The MALDI-TOF spectra of
the starting material, and the conjugates are illustrated in Fig. 4a and 4b respectively. The average
differences between the expected and observed conjugate molecular weights via the EDC/Im and
EDC reaction mechanisms were 1.2 Da and 3.3 Da respectively, indicating successful conjugation.

Table 2: The calculated and experimentally observed molecular weights of bioconjugates.
Average molecular weight (Da)
Reactant or product

12 bp ssDNA (reactant)
Expected conjugate
(product)
Observed conjugate
(product)

EDC/Im

EDC

3714.9 ± 3.1

3714.4 ± 3.1

3757.9 ± 3.1

3757.4 ± 3.1

3758.5 ± 3.6

3758.4 ± 3.6

Reactant/product

Av. molecular weight of conjugate (Da),
EDC/Im

15 bp ssDNA

4660.1

Expected conjugate

4703.1± 4.3

Observed conjugate

4709.7± 3.5
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Molecular weights of Reactant and Products
3770.0

3760.0

m/z

3750.0

3740.0

3730.0

3720.0

3710.0

3700.0
Conjugate (EDC/Im)

Conjugate (EDC)

Reactant (5'phosphorylated ssDNA)

Figure 12: The observed molecular weights of the reactant, and conjugates.
Error bars are represented by ±SD
The EDC/Im reaction scheme was also tested using 15 bp 5’ phosphoryl ssDNA, and
MALDI-TOF results indicated successful and repeatable phosphoramidation of 15 bp ssDNA
(n=5). The expected molecular weight was 4703.1 ± 4.3, and the observed conjugate molecular
weight was 4709.7±3.5 Da (Fig.13c, and Table 2). Given the high mass accuracy of the MALDITOF instrument (approx. ±3 atomic mass units (amu)), the high level of agreement between the
expected, and observed conjugate molecular weights allowed us to conclude that the desired
conjugate was produced. Fig.3b illustrates the MALDI-TOF mass spectra of ethylenediamine
(EDA) dissolved in imidazole (Im) at a final concentration of 0.25 M. The major peak at 61 is that
of EDA, while the major peak at 69 m/z is due to imidazole. The peaks at 212 and 379 are the
matrices used during MALDI-TOF analysis sample preparation (i.e., α-Cyano-4-hydroxycinnamic
acid).
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(a)

(b)
Figure 13: MALDI-TOF spectra of; 15 bp ssDNA (a), ethylenediamine, and imidazole (b), the
phosphoramidated 15 bp ssDNA bioconjugate product after 7 days (c).
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Figure 13 continued.

(c)

2.4.2

Stability of bioconjugate products.
MALDI-TOF indicated that a phosphoramidated conjugate is present, and it would have

prolonged usage (n=5). The conjugate signal at 3758 m/z is observed upon storage at -20 °C
(Fig.14 b,c,d). The major peak corresponding to the phosphoramidated ssDNA conjugate is still
present even after 14 days, indicating that the product remains intact. As covalent bonds are
stronger, these MALDI-TOF results suggest that the formed phosphoramidated ssDNA conjugate
product consists of a stable covalent bond, as we observed its presence after longer term storage.
However, a decrease in the signal intensity (i.e., increasing noise) is observed upon storage at 20 °C. The MALDI-TOF instrument’s software normalizes the entire spectrum with respect to the
most intense peak in the result. If we consider the magnitude of the major peak after 7 days we
recognize that the major peak is weak compared to day 1. The observation is possibly due to
hydrolysis of the product. Therefore, if this conjugate product is to be utilized for further research,
it is recommended that the sample is lyophilized prior to storage at -20 °C.

42

(a)

(b)
Figure 14: MALDI-TOF spectra of 12 bp ssDNA (a), the phosphoramidated conjugate on day 1
(b). The phosphoramidated conjugate after 7 days (c) and 14 days (d) upon storage at -20 °C
(n=4).
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Figure 14 continued

(c)

(d)
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2.4.3

Phosphoramidation exclusively at 5’phosphate of ssDNA.
As suggested in previous literature, the ssDNA phosphate backbone can form adducts with

EDC 77. These adducts arise from non-covalent, electrostatic interactions between the phosphate
groups and EDC. In order to investigate specific covalent bond formation at the open 5’ phosphate
of ssDNA, the EDC/Im reaction was conducted with nonphosphorylated ssDNA. As
nonphosphorylated ssDNA lacks the open 5’ phosphate group, there should not be any m/z signal
owing to the expected phosphoramidated conjugate mass in MALDI results. As expected, no
dominant, single peak was observed around 3758 m/z. Instead, multiple peaks were observed on
MALDI, owing to adducts (Fig.15a). The spectra indicated mass additions to the starting reactant
(5’ phosphoryl ssDNA) ranging from 40 Da – 400 Da. This observation could be attributed to
adduct formation via salt binding to the ssDNA phosphate backbone. It could also be due to
temporary electrostatic interactions between the phosphate backbone of ssDNA and EDC and/or
other small molecules. When MALDI runs were carried out with the same sample after 7 days of
storage at -20 °C, the initially detected adduct peaks were not observed. Therefore, it was believed
that none of the multiple peaks observed initially were due to stable, covalent bonds. It is validated
by the observation that those signals no longer appeared on MALDI-TOF after 7 days, indicating
dissociation caused by hydrolysis (Fig.15b). This indicates that the bonds formed initially were
not covalent bonds. The masses greater than the starting material (<3641 Da) in here are expected
to be gas phase dimerization results during MALDI-TOF analyses.
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(a)
Figure 15: MALDI-TOF spectra indicating multiple peaks attributed to adduct formations (a).
MALDI-TOF indicating deterioration of adducts after 7 days of storage at -20 °C (b).
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Figure 15 continued

(b)
2.4.4

RP-HPLC: Method validation.

2.4.4.1 Linearity.
The calibration curve was constructed by linear regression using four 5’ phosphoryl
standards of known concentrations (Fig.16). The coefficient of determination (r2) of the calibration
curve was 0.9988. The linear regression equation was; y = 129,201·x + 1428205, where; y = area
under the HPLC peak (µV·sec), and x = concentration of the analyte (µg/mL).
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5' phosphoryl ssDNA
standards curve
Area of HPLC peak (µV·sec)

8.E+07
7.E+07
6.E+07
5.E+07
4.E+07
3.E+07

y = 129,201.0512x + 1,428,205.5362
R² = 0.9998

2.E+07
1.E+07
2.E+06
0
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200

300

400

500

600

Conc. of standard (µg/mL)

Figure 16: Standards calibration curve of 5’ phosphoryl ssDNA.
Column dimensions: XTerra® MS C18 2.5 µm, 4.6 mm × 50 mm. Ion pairing reagent: 0.1 M
TEAA, pH 9.70±0.05. Mobile phases: A; 5% acetonitrile in TEAA. B; 30% acetonitrile in
TEAA. Gradient conditions: 90%A – 60%A in 16 min. 60% – 90% A in the next 14 min.
Flowrate: 1.0 mL/min. Column and sample temperatures: 37°C, and 33°C. Injection volume: 100
µL. UV detector: 260 nm. Error bars represent ±SD of the peak areas from triplicate results.

2.4.4.2 Accuracy, precision, detection limit, and quantitation limit.
The accuracy and precision of the developed method are depicted from the %bias and
the %CV respectively (Table 3). The %CV for all levels were well below 3%, and the %bias ranged
from -5.1% – 1.2%. These are in agreement with a previously established acceptance criteria in a
chromatographic study 80. The detection limit (LOD) and quantitation limit (LOQ) determined as
per the ICH Harmonized Tripartite Guidelines were 4.6 µg/mL and 13.9 µg/mL respectively.
During product analysis later, all the detected concentrations of the phosphoramidated ssDNA
conjugates were >278 µg/mL. They are well above the LOQ, and are well within the linear range
of the analytical method.
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Table 3: Recovery analysis and system suitability parameters – RP-HPLC.
(n=12 total determinations).
Nominal concentration

Calculated

(µg/mL)

concentration (µg/mL)

570.0

568.3

99.7%

285.0

288.3

142.5
71.3

2.4.5

%Recovery

SD

%CV

%bias

1.1

0.2%

-0.3%

100.0%

3.7

1.3%

1.2%

144.5

100.0%

3.3

2.3%

1.4%

67.6

94.9%

0.8

1.2%

-5.1%

(±µg/mL)

RP-HPLC: Phosphoramidated ssDNA conjugate quantitation.
After assessing the developed IP-RP-HPLC method for suitability as reported above, the

method was used to determine the phosphoramidated ssDNA conjugate yields obtained via the
two reactions. The retention time (RT) of the reactant ssDNA was 7.5±0.2 min, while that of the
ssDNA conjugate product was 6.1±0.4 min (Fig.17). The injection start point (time point zero) of
both all the spectrographs illustrated here (Fig.17) were the same, as HPLC injections were
performed automatically using Empower 2.0 software manager.
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(a)

Figure 17: RP-HPLC chromatographic results of; The reactant phosphoryl ssDNA (a), the
ssDNA bioconjugate product obtained via EDC/Im crosslinking method (b), the ssDNA
bioconjugate obtained via EDC crosslinking method (c).
Column dimensions: XTerra® MS C18 2.5 µm, 4.6 mm × 50 mm. Ion pairing reagent: 0.1 M
TEAA, pH 9.70±0.05. Mobile phases: A; 5% acetonitrile in TEAA. B; 30% acetonitrile in
TEAA. Gradient conditions: 90%A – 60%A in 16 min. 60% – 90% A in the next 14 min.
Flowrate: 1.0 mL/min. Column and sample temperatures: 37°C, and 33°C. Injection volume: 100
µL. UV detector: 260 nm. Error bars represent ±1 SD of the peak areas from triplicate results.
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Figure 17 continued

(b)
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Figure 17 continued.

(c)

In order to calculate the amount of the bioconjugate product, the area underneath the
major peak of the chromatograph was determined. Table 4 below illustrates raw HPLC peak area
results obtained from bioconjugates formed via 12 independent crosslinking experiments.
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Table 4: Compiled RP-HPLC results of the bioconjugate
yields obtained via EDC/Im and EDC.
Peak area (µV·sec)
Replicate

Retention time.
RT (min)

EDC/Im

EDC

EDC/Im

EDC

1

38886088

37441551

4.060

4.063

2

63556749

55672533

5.867

5.908

3

52793686

50537668

6.067

5.939

4

46294376

38590979

6.501

6.452

5

78428352

66809570

6.737

6.057

6

67143992

55344993

5.786

5.626

A Tukey’s boxplot was used to determine the data outliers based on the peak area as well
as the RT. The 25th percentile (Q1), and the 75th percentile (Q3), as well as the inter-quartile range
(IQR) were determined. IQR is simply Q3 – Q1. Next, the lower bound was calculated using the
equation; Q1– (1.5×IQR), and the upper bound was calculated using the equation; Q3+(1.5·IQR).
Any data point beyond these two values were considered too far out, and hence were eliminated
from the proceeding calculations. Like so, replicate 1 was eliminated from product yield
calculations, as well as the Student’s t-test.
Afterwards, using the area underneath the bioconjugate curve, and the standards calibration
regression equation, the ‘detected product concentration; was determined. Next, the injection
volume, and the starting sample volume was used to calculate the ‘detected amount (mg)’ of the
product. The division of the ‘detected amount (mg)’ and the ‘reacted amount (mg)’ yielded the
conversion efficiency, i.e., product yield (Fig.18).
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Figure 18: Calculations performed to determine the bioconjugate product yield.
Fig.19 illustrates the product yields obtained via the two separate reaction schemes
investigated. Results showed that by following the EDC/Im reaction, the percent yield of the
conjugate product increased by approx. 10%. The phosphoramidated ssDNA conjugate percent
yield via the EDC/Im reaction method was 79.0±2.4% while that of the EDC reaction method
alone was 68.3±2.2% (Fig.19).
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Percent yield of conjugate product
100.0%
79.0%
80.0%

68.3%

60.0%

40.0%

20.0%

0.0%
EDC/Im

EDC

Figure 19: Percent yield of the phosphoramidated ssDNA conjugate obtained by following the
conventional EDC scheme, and the modified EDC/Im strategy.
Error bars represent ±SD of the detected product concentrations from n=5 independent runs per
reaction scheme.
An unpaired, two-tailed, Student’s t-test indicated that there is a statistically significant
difference between the product yields obtained via EDC/Im, and EDC reaction schemes (Fig.20).
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t-Test: Two-Sample Assuming Equal Variances
EDC/Im

EDC

Mean

79.0%

68.3%

Variance

0.0005537

0.0004842

Observations

5

5

Pooled Variance

0.000519

Hypothesized Mean Difference

0

df

8

t Stat

7.4506641

P(T<=t) one-tail

3.63E-05

t Critical one-tail

1.859548

P(T<=t) two-tail

7.26E-05

t Critical two-tail

2.3060041

Figure 20: Comparison of the product yield obtained via EDC vs. EDC/Im methods.

2.4.6

Molecular weight analysis of HPLC fractions.
In order to determine the molecular composition of the three dominant HPLC peaks, the

corresponding HPLC fractions were collected as illustrated in Fig.21. Next, they were analyzed
via MALDI-TOF. Results of the major peak (Fig.21, peak #1) indicated 3764.2±4.2 Da (Fig.22a).
The fractions of one minor peak (Fig.21, peak #2) showed 3720.9±0.7 Da (Fig.22b), while the
other minor peak (Fig.21, peak #3) resulted in 3874.6±1.8 Da (Fig.22c). Peak #1 is attributed to
the product conjugate while peak #2 is attributed to unreacted starting material, 5’phosphoryl
ssDNA, as the theoretical molecular weights agree with the observed molecular weights.
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#1

#2 #3

Figure 21: Chromatograph of the phosphoramidated ssDNA conjugate illustrating each peak
collected for molecular weight analysis.
The fractions were collected for validation of the species in the major peak (#1) as well as the
minor peaks (#2, #3).
Column dimensions: XTerra® MS C18 2.5 µm, 4.6 mm × 50 mm. Ion pairing reagent: 0.1 M
TEAA, pH 9.70±0.05. Mobile phases: A; 5% acetonitrile in TEAA. B; 30% acetonitrile in
TEAA. Gradient conditions: 90%A – 60%A in 16 min. 60% – 90% A in the next 14 min.
Flowrate: 1.0 mL/min. Column and sample temperatures: 37°C, and 33°C. Injection volume: 100
µL. UV detector: 260 nm. Error bars represent ±1 SD of the peak areas from triplicate results.
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(a)
Figure 22: MALDI-TOF spectra illustrating the m/z values of the HPLC peaks (a) peak #1–
phosphoramidated ssDNA. (b) peak #2–unreacted starting ssDNA. (c) peak #3–isourea
intermediate derivative
(n=3).
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Figure 22 continued

(b)
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Figure 22 continued

(c)

In order to determine possible molecular structures of the compound present in peak #3,
(RT ~ 8.0 min), attention was directed to the byproducts possible from EDC side reactions.
Previous researchers have speculated that, in the presence of excess EDC, O-acylisourea
intermediate could react with the neighboring amine in EDC, forming N-acylisourea 2. The
theoretical molecular weight of both O-acyl isourea and N-acyl isourea derivatives are 3871 Da
(Fig.23). MALDI-TOF experimental evidence suggests that molecular composition of the
compounds in HPLC peak #3 could be an acylisourea derivative (Fig.22c).
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Figure 23: Reaction mechanism deduced for a possible EDC side reaction.
– modified from 1.
2.5

Conclusions
A novel phosphoramidated ssDNA was synthesized as a proof-of-concept modality to

compare the conventional carbodiimide (EDC) reaction with an adapted strategy using EDC and
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imidazole (EDC/Im). MALDI-TOF results indicated that a stable conjugate with the expected
molecular weight is formed. The EDC/Im reaction method was compared to the conventional EDC
reaction method in relation to reaction efficiencies. A RP-HPLC chromatographic analytical
method was developed to determine the product yields. This method could also be used to purify
other aminated and phosphorylated DNA compounds. The phosphoramidated ssDNA conjugate
obtained from the EDC/Im method had a percentage yield of 79.0±2.4% while that of the
conventional EDC method was 68.3%±2.2%. The improved EDC/Im method is applicable to
synthesizing programmable DNA moieties, and constructing self-assembling macromolecules
where there is a lack of experimental flexibility in adjusting reaction conditions.
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CONJUGATING SSDNA AND PEPTIDES VIA
HOMOBIFUNCTIONAL AND HETEROBIFUNCTIONAL
CROSSLINKERS

3.1

Abstract
This chapter discusses the preliminary results from the attempts to crosslink peptides to

single stranded DNA (ssDNA). Results from experimentation with crosslinkers from the two major
classes are reported herein. BS3 (bis(sulfosuccinimidyl) suberate) was the homobifunctional
crosslinker utilized to crosslink amino ssDNA with peptides. Succinimidyl 4,4-azipentanoate
(NHS-Diazirine) was the heterobifunctional crosslinker utilized to crosslink and amine modified
ssDNA bioconjugate with peptides.
In the BS3 studies, we carried out experiments to determine the effect of reactant
stoichiometry, reactant purity, buffer pH, sequence of reaction, the incubation temperature, and
the peptide sequence. Matrix assisted laser desorption ionization time-of-flight (MALDI-TOF)
was used to analyze the molecular weight of the bioconjugates formed. A reversed phase high
performance liquid chromatography (RP-HPLC) method with detection at λ260 nm was implemented
to purify the starting amino ssDNA material. This method could be routinely used for both
purifying and quantifying single stranded DNA, and their conjugates
The two-step reaction method with a 1:50:100 stoichiometry of amino ssDNA: BS3
crosslinker: peptide4, at an incubation temperature of 4 °C yielded the desired amino ssDNA-BS3peptide conjugate. However, all the subsequent MALDI-TOF results indicated conjugate
molecular weights evidencing only partial bioconjugate formation (i.e., only one end of the
crosslinker successfully reacting with one of the two biomolecules).
Although NHS-Diazirine crosslinking efforts with amino ssDNA bioconjugate and
peptides did not indicate the expected final ssDNA–peptide bioconjugates, results showed that the
crosslinker was successful in synthesizing a peptide4–peptide4 final bioconjugate.
At the conclusion of both BS3 and NHS-Diazirine crosslinking studies, we recognized that
the key factor governing peptide conjugation is perhaps complete deprotonation of the peptide’s
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ammonium groups. Deprotonation is converting ammonium groups (NH3+) into amino groups
(NH2). If a peptide sequence with a high pI was chosen, complete deprotonation of the lysine
groups would require a buffer media with very high pH values. This in return poses hydrolysis
threats to the sulfo-NHS group in the BS3 crosslinker. Therefore, acidic peptide sequences such
as peptide4 used in this study would render more suitable for BS3 and NHS-Diazirine crosslinking.
Due to lack of selectivity, SDA crosslinkers might be best suited for large scale studies as opposed
to micro-scale bioconjugation studies.

3.2 Introduction

BS3 (bis(sulfosuccinimidyl) suberate)
BS3 is a selective, homobifunctional crosslinker with a 11Å length, 8-carbon spacer arm,
with two negatively charged sulfo-NHS esters at both ends (Fig.24). DSS (disuccinimidyl suberate)
which is the water immiscible analog of BS3 was not suitable for this study where the reactions
are conducted in aqueous phase. Many non-sulfonated forms of NHS ester reagents are water
insoluble, and must be used in organic solvents, such as DMSO and DMF. The solubility of NHSester reagents varies with buffer composition and the physical properties of the remainder of the
molecular structure (e.g., spacer arm). The choice of buffer pH (ideal at ~7-9), and the type of
conjugation buffer (amine free) will play a major role in preventing the NHS ester group’s
hydrolysis, and improve the selectivity of the coupling reaction. The sulfo-NHS groups are reactive
towards primary amines and hence could be utilized to react naturally occurring peptides, enzymes
and other biomolecules.
The sulfo-NHS functional group in the BS3 crosslinker is sensitive to the pH of the buffer
and the type of buffer. It was important to carry out the reaction at a pH in the range of 7 – 9 in
order to deprotonate the primary amine group. This facilitates the nucleophilic attack to the
carbonyl carbon in the sulfo-NHS functional group. However, highly basic pH conditions could
potentially hydrolyze the N-hydroxysulfosuccinimide (NHS) group. As extraneous amines present
in the buffer could prevent conjugation, as opposed to Tris, glycine or imidazole buffers, we used
a carbonate buffer at pH 8.5.
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Figure 24: BS3 crosslinker depicting the two sulfo-NHS ester groups.
Although all previous reports used the BS3 crosslinker to link peptides and proteins, in this
study, we utilized BS3 to react an amino ssDNA with a peptide (Fig.25).
While designing the ssDNA sequence for the study, we refrained from using too many
Guanine (G) and Cytosine (C). Sequences rich in higher G and C contents are relatively
inconvenient to synthesize. They also cause the Tm of the oligonucleotide sequence increase 81. As
we extended these crosslinking methods to ultimately crosslink enzymes with DNA, we
maintained the melting temperature (Tm) of the DNA sequence as low as possible. The higher the
Tm, the higher temperature we would need to provide in accomplishing DNA hybridization. Since,
long oligonucleotide sequences can cause hindrances in the oligonucleotide synthesizing steps,
and very small sizes could cause drawbacks in DNA hybridization (chapter 4), an average size was
chosen after referring to several literature reports.

Figure 25: 5’ amino-ssDNA obtained from IDT DNA®.
Succinimidyl 4,4-azipentanoate (SDA, NHS-Diazirine)
There are many crosslinkers in the heterobifunctional, Succinimidyl-diazirine (SDA) class,
and only have begun to draw the attention of scientists very recently 75. This class of crosslinkers
have different spacer arm lengths, and are membrane permeable. The membrane permeability can
prove very useful in post-purification steps such as dialysis. Succinimidyl 4,4-azipentanoate (SDA,
NHS-Diazirine) is a member of the class heterobifunctional crosslinkers. In heterobifunctional
crosslinkers, the two functional groups at the two ends of the spacer arm, are different. SDA has a
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molecular weight of 225 Da, and has a 3.9 Å long spacer arm, with two different reactive groups
at the end of it. At one end is a N-hydroxysuccinimide (NHS) ester which reacts with primary
amine functional groups. On the other end is a diazirine ring in which, the nitrogen atoms very
reactive (Fig.26a). The photoreactive groups available for crosslinking are diazirines, azides, and
benzophenones

82

. The photoactivatable functional groups negate highly reactive free-radical

intermediates upon photolysis. These intermediates exhibit almost no chemo-selectivity towards
other functional groups. In SDA (succinimidyl 4,4-azipentanoate) class crosslinkers, the diazirine
ring is photoactivatable, and readily undergoes reaction with any functional group. One major
disadvantage of SDA class crosslinkers is the lack of specificity. Hence, this is more of a “shot
gun” approach, and could lead to higher noise levels.

(a)

(b)

Figure 26: N-hydroxysuccinimide succinimidyl diazirine (NHS-Diarizine) (a) NHS-SSDiazirine (SDAD) (b).

Figure 27: Schematic of the NHS-Diazirine (SDA) crosslinking reaction.
–modified from 83.
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The reaction scheme of NHS-Diazirine is depicted in Fig.27. First, the NHS-ester is reacted
with the primary amino groups in the first biomolecule. This reaction is most efficient in buffers
with pH 7 – 9. After step one, the NHS acts as the leaving group while forming an amide bond
between the crosslinker and the first biomolecule. In step 2, after introducing the protein into the
sample, it is exposed to UV light (approx. 350 nm). The UV energy activates the diazirine ring (on
the right side of the crosslinker), and creates a reactive carbine intermediate which is susceptible
to react with any amino acid side group present on a protein. This reaction is a covalent bond
formed in an ‘addition’ type reaction. The spacer arm of the crosslinker ultimately becomes a part
of the final bioconjugate molecule. The molecular weight of the spacer arm is 83 Da. Therefore,
the final molecular weight of any bioconjugate formed via this crosslinker is the summation of the
crosslinker’s spacer arm, and the molecular weights of the individual biomolecules (e.g. proteins,
antibodies, peptide, DNA).
Albeit the non-selectivity of the diazirine ring, a variety of previous bioconjugate studies
have been accomplished with diazirines. In one previous study, synthetic peptides, and myoglobin
were used to demonstrate covalent bond formation by utilizing NHS-SS-Diazirine (SDAD)

83

.

Their MALDI mass spectrometry results indicated high numbers of crosslinks 84. Furthermore, the
disulfide bond in the middle of SDAD crosslinkers could be particularly of interest in proteinprotein interaction mapping. The chemical structure of SDAD is depicted in Fig.26b. Although
SDAD and SDA are somewhat structurally different, the two functional groups of interest are the
same.
In a different study, SDA was used to create photo-crosslinkable elastin-like proteins (ELP).
These ELPs were next crosslinked to a common implant material Titanium, in a variety of
geometries such as discs, screws, and rods 85. They first reacted the crosslinker’s NHS-ester with
the amines present in ELPs. Next, these samples were spin coated onto the Titanium surfaces.
Finally, diazirine ring was activated by exposing the spin-coated surface to 365 nm UV light,
which facilitated the ELPs to functionalize on the Titanium surfaces.
NHS-Diazirine has also been used to synthesize photoactivatable crosslinking sugars to
capture glycoprotein interactions

86

. In this study, monosaccharides were synthesized with
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diazirine crosslinkers, and these sugars were incorporated onto cell surfaces, in order to study
glycoprotein interactions.
Evidently, NHS-Diazirine has been used in previous academic applications to crosslink
biomolecules and biomaterials. As the non-selectivity was viewed as an advantage, we attempted
to use NHS-Diazirine in a controlled reaction. As any extraneous functional groups could bind to
the activated diazirine ring, the salt concentrations in the buffer medium was heavily reduced in
our experimentation.

Design of peptides
Some universal key design features were accounted for while designing the synthetic
peptides for this study. Peptides are comprised of amino acids. Amino acids are also the building
blocks of proteins in living organisms. There are over 500 amino acids found in nature. However,
the human gene only directly encodes 20. Fig.28 illustrates the 20 essential amino acids and their
characteristics. Among the considerations were water solubility, number of 1° amines, and the
peptide purity. The solubility of a peptide is strongly influenced by the amino acid composition.
Hence, amino acids with a high content of hydrophobic residues such as Leu, Val, Ile, Met, Phe
and Trp should be avoided if the desired solvent system is polar. Peptides with hydrophobic amino
acid contents higher than 50% could be partially or even completely insoluble in aqueous media.
Additionally, in order to yield a peptide with very high solubility, it is best if at least 20% of the
amino acids contain polar side groups. At pH values ~7 Asp, Glu, Lys, and Arg have charged side
chains. From a synthesis perspective, peptides containing multiple Cys, Met, or Trp residues are
cumbersome because these residues are prone to oxidation

87

. One other important structural

concern is beta-sheet formation of peptides. Peptides tend to fold into secondary structures such
as beta sheets or alpha helices in order to enhance its native stability.
But when beta sheets form, the peptide could undergo deletions and even truncations,
resulting in a poor synthetic yield of the desired product. In order to avoid beta sheet formation,
peptides with neighboring aromatic and hydrophobic residues such as Val, Ile, Tyr, Phe, Trp, Leu,
Gln, and Thr are avoided 88,89.

68

Figure 28: Properties and the chemical structures of the common amino acids
[New England Biolabs].

The deduced electron pushing mechanism of this reaction is of SN type (Fig.29, 30). The
only functional groups involved in the reaction are esters and amines. The stoichiometry of amino
ssDNA: BS3 crosslinker is important to ensure that amino ssDNA does not attach to both the sulfoNHS ester moieties at the end. One end of the crosslinker should attach to the amino-ssDNA, while
the other end attach to the amine in the peptide (Fig.30).
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Figure 29: Electron pushing mechanism predicted for the SN2 reaction between the 1° amine in
amino ssDNA and one NHS-ester in BS3.
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Figure 30: Electron pushing mechanism predicted for the SN2 reaction between the 1° amine in
a peptide and the other NHS-ester in BS3.
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3.2

Materials and Methods

3.2.1

Materials – BS3 crosslinking.

3.2.1.1 Amino single stranded DNA (amino ssDNA).
The amino single stranded DNA (amino ssDNA); 5’amino/GTA GAT CAC TAT CAT 3’,
Tm 35.8 °C, molecular weights of 4730 Da was directly purchased from IDT® DNA.
3.2.1.2 Peptides.
The BS3 crosslinking was carried out using a small peptide and an amino ssDNA. In this
study, we tested three different peptide sequences separately. The first and third were designed
with several lysine groups in order to maximize the number of 1° amines available for amination
with the crosslinker. The peptide properties calculated via the PepDraw 1.0 tool (Tulane University)
are represented in table 5 below. Peptide sequence 2 and 4 were designed such that the pI of them
was closer to, or less than physiological pH. Therefore, we expected their N-terminal ammoniums
to be easily deprotonated at buffers near physiological pH, and react with the crosslinker. Peptide5
was designed with several lysine groups in order to maximize the number of 1° amines available
for amination with the crosslinker. Peptides 1 – 4 were directly purchased from NeoBioLab
(Woburn, MA), while Peptide5 was synthesized in-house.

Table 5: Properties of the synthetic peptides used in crosslinking studies.
Peptide #

Molecular weight (Da)

Sequence

Isoelectric point (pI)

Net charge

1

616.4

KRADK

10.6

2

2

457

GHTSG

7.91

0

3

643.4

KLKQK

10.86

3

4

576

DAEQD

2.71

-3

5

686

KRADGK

10.56

2
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(a)

(b)

(c)

(d)

(e)
Figure 31: Molecular structures of Peptide; 1 (a), 2 (b), 3 (c), 4 (d), 5 (e).

3.2.2

Methods – BS3 crosslinking.

3.2.2.1.1 Crosslinking amino ssDNA with peptides.
Amino modified ssDNA; 5AmMC6/GTA GAT CAC TAT CAT (Fig.25) were purchased
from Integrated DNA Technologies (Coralville, IA). In a general crosslinking reaction the oligo
samples were dialyzed using 2000 MWCO tubing prior to each experiment. First, amino ssDNA
dissolved in 200 mM carbonate buffer was transferred to pre-weighed BS3. Unless specified
otherwise, pH of the buffer was 8.5±0.2. Table 6 and the discussion below describes the
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stoichiometry of reactants, incubation temperatures and various buffer pH values tested. In order
to push the reaction towards amination, and reduce the effects of sulfo-NHS hydrolysis, a higher
molar amount of peptides was used. Next, the mixture was incubated at the defined conditions
(Table 6). After the incubation period, each sample was dialyzed against DI water at r.t. using 2000
MWCO tubes (ThermoFisher Scientific, IL) to remove any unreacted reactants and byproducts.
The preliminary reactions were conducted with peptide1, as this peptide sequence
contained a high no. of primary amines (a higher no. of lysine groups). We carried out sets of
experiments to determine the effect of stoichiometry of reactants, purity of the reactants, peptide
sequence, buffer pH, sequence of reaction and the incubation temperature (Table 6). In the initial
experiments, we tried a one-pot reaction protocol. The peptide was added to the amino ssDNA,
BS3 mixture within 5 s. By doing so, we allowed minimum time for the NHS to hydrolyze. The
reactant stoichiometry in these experiments was maintained as indicated in *a, Table 6. They were
incubated at room temperature (r.t.) and the incubation time period was 5 – 18 hrs.

Table 6: Illustration of the multiple alterations to the crosslinking protocols.
Designation

Step

Results Figure

Stoichiometry of amino ssDNA: BS3: peptide1 = 1:50:50
One-pot reactions
*a (n=3)
*b (n=2)

*c (n=2)

Amino ssDNA • BS3 • peptide1
Reacting amino ssDNA with BS3, dialyzed the sample,
then reacted with peptide1.
Reacting peptide1 with HPLC purified amino ssDNA.

34
34

39

Stoichiometry of amino ssDNA: BS3: peptide = 1:50:100

*d (n=1)

Increased peptide1 molar amount.
Amino ssDNA: BS3: peptide1 = 1:50:100

40
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Table 6 continued
*e (n=3)

Increased buffer pH with peptide1 (pH = 9.5).

41

Two-step reaction. Amino ssDNA reacted with BS3,
incubated for 1 hr at the specified temp., then reacted with
peptide2.
*f (n=2,1,1)

(a) ↓temperature (4 °C)

42 (a, b, c)

(b) ↑temperature (40 °C)
(c) conjugate from (b) acid washed using 6M HCl to
remove adducts.
*g (n>5)

Replicates of *f(a)

43, 44

*h (n=3)

Replicated *f(a) with peptide3.

45

*i (n=1)

Conjugating peptide4 and peptide5 in a one-pot BS3

47

crosslinking method.

In another experiment, the amino ssDNA was crosslinked with BS3, followed by dialysis.
After incubating the amino ssDNA-BS3 at r.t. for about 1 hr, the product was purified using 2000
MWCO tubes. The recovered sample was then reacted with peptide1 (*b, Table 6).
As impurities present in the starting material was suspected to be a plausible culprit for the
lack of the desired bioconjugates, we developed a reversed phase HPLC procedure to remove
truncated products from the starting material. The HPLC purified amino ssDNA was then
crosslinked with peptide1 utilizing BS3 (*c, Table 6). The procedure below discusses analytical
chromatographic methods as well as preparative chromatographic methods.
3.2.2.2 Purifying amino ssDNA: Reversed phase high performance liquid chromatography
(RP-HPLC)
If the truncated products in the starting amino ssDNA were reacting with BS3 crosslinker
and peptide1, the molecular formula of the final product would be unknown, and hence we would
be unable to recognize it in our MALDI spectrographs. Therefore, we further purified the amino
ssDNA ‘as received’ using RP-HPLC.
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A C18 XTerra® (Waters, MA) 4.6 × 100 mm column with 3.5 µm particle diameter, and a
guard column was used for reverse phase separation of the conjugates. High-performance liquid
chromatography (HPLC) was performed on an Alliance 2695 separation module, using Empower
version 2.0 software (Waters Corp., Milford, MA), equipped with a Waters 2496 UV/Vis detector
(Waters Corp., Milford, MA). Detection was carried out at λ260 nm as this is the wavelength that
exhibits absorbance maxima of nucleotides. The two mobile phases were 0.1 M TEAA, pH
9.70±0.05 (triethylammonium acetate) buffer with 5% acetonitrile (ACN) and 30% ACN
respectively. 0.1 M TEAA buffer was prepared by adding 5.6 mL of glacier acetic acid to 950 mL
of deionized water. To this, 13.8 mL of TEA was added gradually, and the solution was stirred.
Afterwards, the pH of the solution was adjusted to 7.3±0.05, and the final volume was brought to
1000 mL by adding water. Next, the mobile phases were prepared as follows; A: 5% acetonitrile
in TEAA (v/v), B: 30% acetonitrile in TEAA (v/v). Finally, the solutions were filtered using
qualitative-grade filter paper. The incorporated gradient is illustrated in Fig.32.

Figure 32: Calculations of the gradient incorporated into the Empower 2.0 software.

76
Analytical RP-HPLC methods.
Prior to conducting preparative RP-HPLC experimentation with the relatively expensive
amino modified ssDNA, an analytical RP-HPLC procedure was conducted utilizing 15 bp ssDNA.
These samples contained no modifications at the terminal ends, and had the same nucleotide
sequence as those used in the amino ssDNA used for the crosslinking experiments. 15bp ssDNA
‘as received’ were resuspended in 0.1 M TEAA (pH 7.3) at a final oligo concentration of 2.4
mg/mL. It was then transferred to an HPLC vial, tightly secured with a septum, (Waters
Corporation, MA) and placed in the auto sampler placeholder. A final gradient method with
acetonitrile (ACN) percentage ranging from 7% – 13% was established (Fig.32). Suitability of the
gradient was based on adequate baseline separation of the chromatograms.
Next, the same methods and column conditions were tested for the 5’amino 15 bp ssDNA
‘as received’ from the manufacturer. Initially, several injection volumes (10, 50, 100 µL) were
used to test whether there would be an overloading limit in the C18 column. Upon confirming that
there appear to be no such overload limit, 100 µL were used which enabled us to collect larger
amounts of the desired fraction (described in “preparative methods”).

Preparative HPLC methods.
Afterwards, 5’ amino modified sample set ‘as received’ was resuspended in TEAA as
previously described. Three runs were conducted, with an injection volume of 100 uL/run. With
the aid of the real-time UV-detector screen, the fraction at RT= 16.9 min was collected from three
injections. The total collected purified sample volume was approx. 12 mL. Next, the collection
tube was left open in the fume hood overnight to evaporate acetonitrile in the sample. Afterwards,
the sample was dialyzed using pre-washed 2000 MWCO dialysis tubes (ThermoFisher Scientific,
IL). Each dialysis reservoir consisted of 1 L of DI water, and it was changed two times over the
course of two days.
Next, the samples were recovered, and the volumes were further reduced by rotavapp’ing
at 30 °C and -85 kPa for approximately 30 mins. The sample volume was reduced to 1 mL.
80 uL of the sample was predissolved in TEAA buffer, and re-run on the HPLC instrument
using the same column, and methods. The purpose of the re-run was to confirm that we had
removed all the truncated products observed in the amino ssDNA as received.
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3.2.2.3 Crosslinking amino ssDNA with peptides contd.
The amino ssDNA samples collected from RP-HPLC were then crosslinked with increased
peptide1 molar amounts as indicated in *d, Table 6.
The pH of the reaction buffer was addressed next. As we deduced that deprotonation of the
primary amines in the lysine groups was important, we pre-dissolved peptide1 in carbonate buffers
with pH 9±0.5. When the pH of the solution increases, the acidic and basic groups in a peptide or
protein deprotonates. Furthermore in this case, the carboxylate anion converts from R-COOH to
R-COO-, and the ammonium cation converts from R-NH3+ to R-NH2. The deprotonated amines
are now more susceptible to undergo an SN2 reaction with the sulfo-NHS group of the BS3
crosslinker (*e, Table 6). Since hydrolyzing peptide bonds at pH >10 was a risk, we did not attempt
to reach to the pI 11 of the peptide (PepDraw 1.0, Tulane University).
Several variables were changed in the experimental procedure in *f. First, trials were
conducted with peptide2. Secondly, the one-pot reaction protocol used up until now was altered
into a two-step reaction. Thirdly, the incubation temperatures were altered. In *f, *g, *h
experimental procedures listed in Table 6. After reacting amino ssDNA with 50-fold molar excess,
the sample mixture was incubated at 4 °C for one hour. Next, the sample was purified using 2000
MWCO dialysis tubes against DI water at room temperature (r.t.) for approx. 1hr. Next, the mixture
was reacted with a 100-fold molar excess with respect to amino ssDNA. The final mixture was
then incubated at 4 °C for approx. 5 hrs. Afterwards, the final sample mixture was dialyzed using
2000 MWCO dialysis tubes against DI water at r.t. overnight.
We altered the temperature conditions, as we questioned the stability of the crosslinker at
r.t. In case the sulfo-NHS groups hydrolyze prior to undergoing amination, our MALDI-TOF
observations (lack thereof) are quite explicable. Previous studies have indicated that the sulfoNHS group is highly water labile, and that it has a half-life ranging from 10 min – 1 hr at r.t. 16,75
In order to prevent the hydrolysis of the sulfo-NHS group, we carried out experiments at 4 °C
(*f(a), Table 6).
We also conducted the crosslinking reaction at 40 °C (n=1). This is slightly above the
reported melting temperature (Tm) of the amino ssDNA. By doing so, we expected to loosen any
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of the possible hairpin loop formations the amino ssDNA might have self-formed. We expected
that increasing the temperature would relieve ssDNA from its secondary structures and increase
the exposure of the terminal primary amine. This was expected to render the primary amine more
accessible to react with the sulfo-NHS group (*f(b), Table 6).
As we consistently observed adduct formations, we also attempted to clear the result
spectra by removing some of the adducts. In order to do this, we measured the pH of the final
sample, and then neutralized it. The measured pH of the mixture was approx. 10, and this was
brought down to a physiological pH of 7.4 by careful addition of 6M HCl.
Although results from *f(a) at 4 °C indicated successful conjugation, we were unable to
replicate these results (*g, Table 6).
We conducted *f with peptide3, to test whether the sequence plays a role in the success of
bioconjugation (*h, Table 6). Lastly, we attempted crosslinking two different peptide molecules
using BS3. In these attempts peptide1 was reacted with peptide4 in equimolar amounts, with
incubation at 4 °C, followed by dialysis against DI water at r.t. (*i, Table 6).
Table 3 illustrates the molecular weights of the expected conjugates. The expected final
conjugate molecular weight is calculated from summing the molecular weight of the amino
ssDNA, the spacer arm of BS3, and the peptide. The ‘spacer arm’ of BS3 becomes a part of the
final bioconjugate. The two sulfo-NHS groups at the two ends of BS3 are leaving groups.

Table 7: Molecular weights of the reactants and expected conjugates.
Reactant or conjugate

Molecular weight (Da)

Amino ssDNA (15 bp)

4724

BS3 crosslinker

572

Spacer arm of BS3

140

Sulfo-NHS group

200
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Table 7 continued
Expected final bioconjugates

3.2.3

amino ssDNA-BS3-peptide 1

5480

amino ssDNA-BS3-peptide 2

5321

amino ssDNA-BS3-peptide 3

5507

Materials – NHS Diazirine crosslinking.
10 mM sodium phosphate (NaH2PO4·H2O), 50 mM NaCl, buffer medium was pH adjusted

to 7.2±0.2, and filtered. At the beginning of each experimentation, a 100 mM stock solution of
NHS-Diazirine was freshly prepared in dimethyl sulfoxide (DMSO) immediately before use.
NHS-Diazirine was purchased from ThermoFisher Scientific (Hanover Park, IL). All the
crosslinking experimentation was conducted in a laboratory illuminated with very little light.
NHS-Diazirine crosslinking was carried out with a phosphoramidated single stranded DNA
(phosphoramidated ssDNA) conjugate obtained from EDC crosslinking. Peptide4 and peptide5
were utilized for the NHS-Diazirine experiments (Table 5).
3.2.4

Methods – NHS Diazirine crosslinking.

3.2.4.1 Crosslinking two peptides with NHS-Diazirine.
The preliminary experimentation with NHS-Diazirine was conducted on two peptides.
Prior to synthesizing ssDNA-peptide bioconjugates, it was important to discover whether the
crosslinker could be used successfully to conjugate two different peptides together.
Peptide5 was dissolved in 50 μL of PBS (pH 7.2±0.2). Into this, either a 50-fold, or 20-fold
molar excess of NHS-Diazirine (with respect to peptides) was added from the 100 mM stock
solution. The sample was incubated at room temperature (r.t.) for 30 min. Next, peptide5 predissolved in PBS was added in molar equivalence to peptide4. The final molarity of the peptides
was approx. 0.0012 M, while the final concentration of NHS-Diazirine in the reaction mixture was
0.003 M. Finally, the reaction mixture was gently vortexed, and exposed to 360 nm UV light using
a 4 Watt, compact UV lamp (UVP, Upland, CA) for approx. 30 min. Afterwards, the sample was
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incubated at r.t. for another 1 hr, and finally, the reaction was quenched by adding 50 mM Tris
buffer to alter the pH of the reaction mixture. Next, the unreacted reactants and byproducts were
removed by dialyzing the mixture against DI water, using 2000 MWCO dialysis filter tubes. The
molecular weight of the constituents in the recovered reaction sample were analyzed on MALDITOF.
3.2.4.2 Crosslinking peptides and phosphoramidated ssDNA with NHS Diazirine.
Next, NHS-Diazirine was used to crosslink peptide5 and peptide4 separately with an inhouse synthesized phosphoramidated ssDNA. In these experiments, the no. of mols of the
phosphoramidated ssDNA was approx. 2×10-7 mols. A 20 – 50 molar excess of peptides was used
in the crosslinking experiments. The procedure is the same described in the above section (3.2.4.1).
The phosphoramidated ssDNA has a primary amino group available for amide bond formation
with the NHS group in the NHS-Diazirine crosslinker. The method of synthesizing the
phosphoramidated ssDNA bioconjugate is described in greater detail in chapter 2.
3.2.5

Bioconjugate analysis: (MALDI-TOF).
All the conjugates were analyzed using mass spectrometry to determine the conjugate

molecular weights. MALDI-TOF results were obtained using an Applied Biosystems
(Framingham, MA) Voyager DE PRO mass spectrometer. This instrument utilizes a nitrogen laser
(337 nm UV laser) for ionization with a time-of-flight mass analyzer. Prior to MALDI-TOF, each
sample was purified using a C18 – ZipTip column (Millipore Corporation, Billerica, MA). The
ZipTip columns were conditioned using two 10 μL of acetonitrile followed by two 10 μL of 0.1%
trifluroroacetic acid (TFA). As ssDNA contains functional groups which readily lose a proton,
generally a negative linear mode was used (MH-) to produce singly charged species.
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3.3
3.3.1

Results and Discussion – BS3 crosslinker.
Mass spectra of the reactants (peptides and ssDNA): MALDI-TOF
The mass spectra of the starting material are illustrated in Fig.33.

(a)

Figure 33: Mass spectrum of; amino ssDNA as received (a), Peptide1 (b), Peptide2 (c), Peptide3
(d), Peptide4 (e), Peptide5 (f).
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Figure 33 continued

(b)

(c)
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Figure 33 continued

(d)

(e)
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Figure 33 continued

(f)
3.3.2

Amino ssDNA-BS3-peptide conjugate analysis: MALDI-TOF
MALDI-TOF results from the experimental procedure listed in *a , Table 6 indicated a

major peak at 4731 m/z and a secondary peak at 4889 m/z (Fig.34). The peak at 4731 m/z
corresponds to unreacted amino ssDNA. The secondary peak was attributed to the possible
formation of a partial conjugate, and is discussed in greater detail later in Fig.46a. These mass
spectrometry results indicated that the conjugation attempts with peptide1 were not successful, as
the expected amino ssDNA-BS3-peptide1 conjugate signal at 5480 m/z was not observed.
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Figure 34: MALDI mass spectrum of conjugate obtained from experimental procedure, *a,
Table 6.
Next, we purified the reaction sample using 2000 MWCO dialysis tubes after the first
reaction (amino ssDNA with BS3). This was then reacted with 50-fold molar excess of peptide1
(*b, Table 6). The MALDI spectrum of the resulting conjugate still indicated salt adducts at 4940
m/z, and partial conjugation structures at 4884 m/z, and 5078 m/z (Fig.35). The molecular
structures of the possible partial conjugates are discussed in greater detail in Fig.46.
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Figure 35: MALDI mass spectrum of conjugate obtained from experimental procedure, *b,
Table 6 – with product purification in the intermediate step.

3.3.3

Analytical RP-HPLC method.
This sub-section discussed how RP-HPLC (reversed phase high performance liquid

chromatoraphy) was used to purify the amino ssDNA as received. The RP-HPLC experiments
with the standard 15 base pair ssDNA resulted in baseline resolved peaks, with one major
component eluting at RT= 16.94 mins (Fig.36), and some significant, more hydrophilic impurities
eluting initially. There was also some indication of additional truncated products eluting after the
major component (Fig.36).
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Figure 36: Standard 15 bp phosphoryl ssDNA chromatograph.
Column: XTerra® MS C18 2.5 µm, 4.6 mm×50 mm. Mobile phases: A; 5% acetonitrile in 0.1 M
TEAA (pH 7.01), B; 30% acetonitrile in 0.1M TEAA (pH 7.01). Flowrate: 1.0 mL/min.
Gradient: 80% A to 20% A in 22 min. Column and sample temperatures: 33 °C and 35 °C.
Injection volume: 100 µL. Detection: UV 260 nm.
The results of the isolated fractions indicate one highly resolved peak at a retention time
(RT) of 16 min, as well as some indication of impurities much at retention times of 0.4 min, and
21 min. These could be due to residual material from the chromatographic column, the connection
loops, or residual material from the dialysis tubes (glycerin). We ruled out all of these possibilities
– (1) A “purge injector” and a column equilibration was performed in between each sample. (2)
The MWCO tubes were always pre-washed using DI water for about 15 min. Therefore, the
impurities attributed to any salts or truncated products in the material as received.
Afterwards, the developed RP-HPLC method was used to obtain chromatograms of the
actual starting material; amino ssDNA. The results indicated truncated products in the amino
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modifed ssDNA, just as it did on the 15 bp ssDNA (Fig.37). The largest peak corresponds to the
desired material (60% peak area, RT=16.429 min).

Figure 37: 15 bp amino ssDNA chromatograph.
Column: XTerra® MS C18 2.5 µm, 4.6 mm × 50 mm column. Mobile phases: A: 5% acetonitrile
in 0.1 M TEAA, pH 7.01, B: 30% acetonitrile in 0.1M TEAA, pH 7.01. Flowrate: 1.0 mL/min,
Gradient: 80%A to 20%A in 22 min. Column temperature: 33°C, Injection volume: 100 µL.
Detection: UV 260 nm.

3.3.4

Preparative RP-HPLC results confirmation.
A sample of the collected and purified fractions were further tested using the same

analytical RP-HPLC method to determine whether we successfully removed all of the impurities
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present in the original sample. Reults indicated that the method as well as the fraction collection
steps were successful (Fig.38).

Figure 38: RP-HPLC purified 15 bp amino ssDNA.
Column: XTerra® MS C18 2.5 µm, 4.6 mm × 50 mm column. Mobile phases: A: 5% acetonitrile
in 0.1 M TEAA, pH 7.01, B: 30% acetonitrile in 0.1M TEAA, pH 7.01. Flowrate: 1.0 mL/min,
Gradient: 80%A to 20%A in 22 min. Column temperature: 33°C, Injection volume: 100 µL.
Detection: UV 260 nm.

3.3.5

Amino ssDNA-BS3-peptide conjugate analysis contd.: MALDI-TOF
Fig.39 illustrates the mass spectrum obtained from the crosslinked conjugate sample with

the experimental conditions from *c, Table 6. These crosslinking experiments were conducted
with the RP-HPLC purified starting material (i.e., carefully fraction collected, desalted and
lyophilized 5’amino ssDNA). The largest peak appearing at 4935 m/z is attributed to a carbonate
salt adduct of the the major product at a peak 4885 m/z. The amino ssDNA-BS3 conjugate is
present at 5077 m/z. However, the desired amino ssDNA-BS3-peptide1 peak at 5320 m/z is not
observed (Fig.39).
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Figure 39: MALDI mass spectrum of conjugate obtained from experimental procedure, *c,
Table 6 – RP-HPLC purified starting material (15 bp amino ssDNA).
The reaction carried out with an increased molar amount of peptide1 (designation *d, Table
6) yielded a cluster of peaks (Fig.40). The peak at 4985 m/z is attributed to a salt adduct of the
peak at 4884 m/z, which is the partial conjugate structure depicted in Fig.46b. The peak arising at
5082 m/z is attributed to the partial conjugate structure depicted and discussed in Fig. 46a. Results
indicate that increasing the molar amount of peptide1 does not have an impact on the extent of
bioconjugation.
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Figure 40: MALDI spectrum of conjugate obtained from experimental procedure, *d, Table 6 –
Increased peptide1 mols (1:50:100).
Our results with increased buffer pH did not indicate any bioconjugate products (Fig.41a).
The major signals in Fig.41a correspond to the unreacted starting material amino ssDNA at 4730
m/z, and unreacted peptide1 at 595 m/z. There is a peak arising at 981 m/z, which was attributed
to a peptide3-BS3 crosslinked. Another peak at 784 m/z could be due to the attachment of BS3
onto peptide3 with one of the NHS groups hydrolyzing away. However, as these peaks are quite
low in magnitude compared to the major two peaks, we conclude that increasing the pH of the
reaction buffer does not result in the desired ssDNA-peptide conjugation.
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(a)
Figure 41: MALDI spectrum from *e, Table 6 – with peptide1 at buffer pH near its pI
Our attempts with a 100-fold molar excess of peptide2, followed by a two-step protocol
yielded the desired amino ssDNA-BS3-peptide2 conjugate (Fig.42a). In these experiments, the
intermittent incubation was conducted at 4 °C (*f(a),Table 6). The peak arising at 5324 m/z
corroborates with the theoretical molecular weight of the desired final bioconjugate where amino
ssDNA is linked to the peptide2 via BS3. Although we observed peaks corresponding to partial
conjugation (at 4884 and 5081), we also observed complete bioconjugate formation (Fig.42a).
When the reaction was conducted at an increased temperature of 40 °C (*f(b), Table 6), we
observed several peaks corresponding to salt adducts formed with the starting amino ssDNA
molecules (Fig.42b). The major peaks were at 5104 and 4986 m/z, owing to salt adduct formations
of a partial conjugate. The secondary peak was at 5061 m/z corresponding to a partial conjugate
formation where the crosslinker is only attached to amino ssDNA (detailed discussion at Fig.46a).
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The measured pH of the final reaction sample mixture was approx. 10. The pH was
neutralized to 7.4 by careful addition of 6 M HCl (*f(c), Table 6). After neutralizing the sample,
we expected to remove some of the salt adducts which appeared in the MALDI spectrum illustrated
in Fig.42b. We observed that the peak at 5104 m/z had disappeared, but the adduct at 4907 m/z is
still present (Fig.42c). Although the acid wash was able to yield more clarified peaks, we still
observe the peak at 5062 m/z corresponding to the partial conjugate amino ssDNA-BS3, in these
spectra as well (Fig.42c).

(a)
Figure 42: MALDI results indicating successful linkage of ssDNA to the peptide2 (*fa, Table 6).
(a). MALDI spectrum of the conjugate obtained from crosslinking at 40 °C (*fb, Table 6) (b).
MALDI spectrum of the conjugate sample from after acid washing to remove adducts (c).
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Figure 42 continued

(b)
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Figure 42 continued

(c)

The successful two-step protocol with a 100-fold peptide molar excess, at 4 °C was
repeated to confirm successful duplication abilities of the experiment (*g, Table 6). Although we
observed a very weak peak around the expected m/z of 5082, the predominant peaks were still at
4728, and 4884 m/z (Fig.43a). Albeit adding a large molar excess of BS3 crosslinker to the amino
ssDNA, we noticed the possibility of unreacted amino ssDNA (4728 m/z). The peak at 4884 reappeared in the replicate experiment as well (Fig.43a). The expected bioconjugate molecular
weight was not observed in these MALDI results as well.
In Fig.20, the peaks arising at 2444, and 2544 Da are the doubly charged species of the
major peaks at 4887 and 5082 m/z respectively. Doubly charged species arise when the molecules
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in the analytical sample are ionized in the MALDI-TOF ionization chamber. If two electrons are
knocked off from a single molecule in the ionization process, the charge on that molecule is now
doubled, and hence the mass to charge ratio is 0.5. Hence, the doubly charged species of the same
molecule will have an exact m/z signal at one half of the molecules molecular weight. For example,
half of 4887 is 2444 Da.
There were no peaks at 4724 m/z. This observation could be attributed to two possibilities
– Either there were no unreacted amino ssDNA, or, the unreacted amino ssDNA did not ionize in
the MALDI-TOF laser ablation step. However, the strongest peak of the analytical sample occurs
at 4887 Da. As one of the major peaks observed is at 5082 m/z, we concluded that the amino
modified ssDNA was attached to one end of the BS3 crosslinkers (n>5) (Fig.43).

Figure 43: MALDI spectrum of *g, Table 6
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When the same experiment was replicated, we obtained the same conjugate molecular
weight at 4884 m/z (Fig.44). The peak arising at 4884 m/z was consistent in almost all of our mass
spectrometry results.

Figure 44: MALDI spectrum from replicates of *g, Table 6.
To discover a plausible attribute to the peak consistently arising at 4882 m/z, we performed
mass calculations of the possible moieties. We deduced that this observation could be due to
hydrolysis of one of the NHS groups in the BS3 crosslinker. If the amino ssDNA attached to one
end of the BS3 crosslinker, while the other sulfo-NHS moiety was hydrolyzed, then the theoretical
molecular weight of the resulting molecule is 4882 (Fig.46b). When one of the sulfo-NHS in the
crosslinker does not undergo any reaction, it can hydrolyze, as these NHS groups have been
recognized as water labile functional groups 16,75. Therefore, the experimentally observed peak at
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4884 Da could be explained by this phenomenon. Although NHS esters have good stability in
aqueous conditions, it should be noted that amide bond formation and hydrolysis of the NHS ester
both occur competitively. Which means that the susceptibility for hydrolysis is very high. There
are several studies which have reported that both hydrolysis and amination increased with
increasing the pH. An early study in 1972 reported that at a pH 8.6, and 4 °C the half-life of BS3
was only 10 mins

16

. Therefore, our observation could be attributed to this possibility. Another

possibility is one end of the BS3 crosslinker successfully attaching to the amino group at the end
of the amino ssDNA, while the other end remaining unreacted. In this case, the corresponding
molecular weight of the partial conjugate structural molecular weight is 5079 Da (Fig.46a).
In order to determine whether another peptide sequence with high levels of lysine groups
would deliver the expected bioconjugate, *f(a), Table 6 was conducted with peptide3 (*h, Table 6).
Results indicated peaks clustered around 5016 – 5762 m/z. These still indicate adducts and partial
conjugation products (Fig.45).
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Figure 45: MALDI spectrum of *i, Table 6 – Peptide3 crosslinked with amino ssDNA under
*f(a) conditions.

MW = 5079 Da

(a)
MW = 4882 Da

(b)
Figure 46: Molecular structures of partial conjugation; Amino ssDNA attached to one end of
BS3 (a). Amino ssDNA attached to one end of BS3, while the other end hydrolyzes (b).

As a final attempt to demonstrate BS3 crosslinking, we tested whether the BS3 crosslinker
would be successful in crosslinking two peptides. MALDI results does not indicate the expected
peptide4-BS3-peptide5 bioconjugate (Fig.24). The molecular weight of the expected bioconjugate
is 1402 Da, which was obtained by summing the molecular weights of peptide5, BS3 spacer arm,
and peptide4.
However, two strong pieces of evidence suggest that we conjugated two molecules of
peptide4 together (Fig.24). First, the final bioconjugate molecular weight of peptide4-BS3-peptide4
is approx. 1250 Da. In our MALDI results, we observe an extremely minor peak in this region.
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Furthermore, the major peak is at 686 m/z, which corresponds to unreacted peptide5, hinting that
peptide5 did not participate in the reaction.

Figure 47: MALDI-TOF spectrum of *i, Table 6 – Peptide5 crosslinked to Peptide4 using BS3.
3.4
3.4.1

Results and Discussion – NHS Diazirine crosslinker.
Phosphoramidated ssDNA-peptide bioconjugate analysis: MALDI-TOF.
The conjugate product samples were characterized via MALDI-TOF. The mass spectra of

the starting material phosphoramidated ssDNA is illustrated in Fig.48. The mass spectra of
peptide4 and peptide5 are illustrated in Fig.31e and 31f.
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Figure 48: MALDI mass spectrograph of the phosphoramidated ssDNA.
MALDI results from the NHS-Diazirine crosslinking procedures did not indicate a peak at
the theoretical molecular weight. The theoretical molecular weight is the summation of the
molecular weights of phosphoramidated ssDNA, peptide, and the spacer arm of NHS-Diazirine.
The expected MALDI peak of the conjugate was at a m/z of 4528 Da (Fig.49a). However, after
the NHS-Diazirine crosslinking procedure was conducted, the resulting sample’s MALDI-TOF
scan did not indicate a peak at the expected molecular weight (Fig.49b). The peak at 3714 indicates
unreacted ssDNA material (from the previous ssDNA crosslinking step), while the peak at 3760
m/z is indicative of the phosphoramidated ssDNA.
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(a)

(b)
Figure 49: Schematic of the conducted crosslinking reaction, and the expected final
bioconjugate (a). Observed MALDI-TOF results of the ssDNA bioconjugate (b).
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3.4.2

Peptide-peptide bioconjugate analysis: MALDI-TOF.
As an attempt to understand whether the crosslinker could conjugate two separate peptides

together, peptide4 and peptide5 were crosslinked using the same experimental procedure. The
molecular weight of the expected peptide4-diazirine-peptide5 conjugate is 1347 Da, which was
obtained by summing the molecular weights of the individual peptides and the NHS-Diazirine
spacer arm. However, the observed results only indicate the unreacted peptide5 (at 687 Da), salt
adducts of peptide5 (at 701 Da), and what we could speculate as a partial conjugate obtained by
NHS-Diazirine crosslinking with one peptide5 molecules (at 768 Da) (Fig.50a).
The NHS-Diazirine crosslinking experimentation conducted with phosphoramidated
ssDNA, and peptide5 did not indicate a peak at the expected bioconjugate molecular weight of
4526 Da (Fig.50b). The major peak at 3711, and 3754 indicates the unreacted phosphoryl ssDNA,
and phosphoramidated ssDNA.
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(a)
Figure 50: Observed MALDI-TOF results of; peptide4-diazrine-peptide5 (a). Phosphoramidated
ssDNA-diazirine-peptide5 (b).
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Figure 50 continued

(b)

When peptide4 and peptide5 were reacted with only a 20-fold molar excess of NHSDiazirine (as opposed to the previously used 50-fold molar excess w.r.t to the peptides) results
indicated successful peptide4-diazirine-peptide4 conjugation. Although the desired peptide4diazirine-peptide5 conjugate was not observed, interestingly, we observed two peptide4 molecules
conjugated together. The theoretical molecular weight of a peptide4-diazirine-peptide4 conjugate
is 1235 Da. And the observed molecular weight from MALDI was 1228 Da (Fig.51).

106

Figure 51: MALDI-TOF results indicating peptide4-diazirine-peptide4 conjugate formation.
3.5

Conclusions
In conclusion, we were able to crosslink BS3 to the amino terminal end of the 5’amino

ssDNA. However, the primary amines in the peptides did not crosslink to the BS3 crosslinker.
Results from Fig.24 (*i, Table 6), as well as Fig.19 (*fa, Table 6) both indicate that perhaps the
most important factor to consider during peptide crosslinking is the pI of the peptide. Both of these
figures illustrate that when peptide2 and peptide4 were used, the BS3 crosslinker was successful in
crosslinking with them (albeit with low yields).
We report our results from Fig.19 and Fig.24 as the major evidence to state that the net
charge of the peptide sequence should be seriously studied prior to conducting crosslinking with
BS3. Although we chose three peptides (peptide1, peptide3, peptide5) which has several amino
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groups, and conducted experiments in pH 8 – 9.9 buffers, in order to deprotonate the ammonium
groups we were unable to observe successful bioconjugate formation using the BS crosslinker.
The purpose of increasing the buffer pH was to increase the nucleophilicity of the ammonium
group in the lysine residues. The conjugate base of ammonium is always a stronger nucleophile,
as nucleophilicity increases with increasing electron density on an atom. However, our
experimental evidence suggest that unless the buffer solution pH does not exceed the pI of the
peptide, the peptide is perhaps not fully deprotonated, and hence does not undergo any crosslinking.
Therefore, if highly basic peptide sequences (pI >10) are used, we must use a solution which has
a buffer pH >10 as well. Our results indicate that such high buffer systems do not yield any BS3
crosslinking. At such high pH values, the sulfo-NHS group in the BS3 crosslinker also faces high
risks of hydrolyzing. When the sulfo-NHS group is hydrolyzed, the crosslinker no longer holds a
reactive functional group to react with external primary amines.
The isoelectric point (pI) of a protein or peptide is defined as the pH at which the molecule
contains no net charge. When the pH of the buffer used to dissolve the peptide is greater than the
calculated pI of the peptide, the peptide will carry an overall negative charge, and vice versa (i.e.,
pH > pI, peptide has a negative charge). We obtained successful peptide conjugation results when
we used peptides which contained a positive charge when dissolved in a buffer at pH 7.5 – 9.5. At
a pH of 8.5, the acidic peptide sequence (peptide4) is fully deprotonated at pH = 7.5. This may
have caused complete deprotonation of the amino groups present in the lysine groups, resulting in
a successful SN reaction, leading to bioconjugation.
These results from the NHS-Diazirine experimentation also point in the direction of the
major speculation derived from the BS3 experimentation results. Perhaps the pI of the peptide
plays the biggest role in crosslinking with heterobifunctional crosslinkers as well. This is supported
by the evidence we obtained from the crosslinking trials with peptide4 and peptide5. When equimolar amounts of peptide4 and peptide5 were crosslinked with NHS-Diazirine, peptide5 did not
indicate any reaction at all. Instead, peptide4, with the lowest pI value indicated successful
bioconjugation with another peptide4 molecule. This is perhaps due to the fact that when peptide4
(having the lowest pI out of all the peptides used) was dissolved in the buffer system (PBS, pH
7.2±0.2), either the NH2 in the Glutamine, or the N-terminus were fully deprotonated, allowing for
a successful SN2 type reaction with the NHS group of the NHS-Diazrine crosslinker.
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In conclusion, if either BS3 or NHS-Diazirine crosslinkers were to be used in crosslinking
trials, instead of choosing a peptide sequence which has a high pI (i.e. a basic sequence), a more
acidic sequence should be chosen. This way, converting the ammonium groups (NH3+) to amino
groups (NH2) could be accomplished at pH values which does not hydrolyze the sulfo-NHS group
in the BS3 crosslinker.
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DEMONSTRATING THERMALLY PROGRAMMABLE
HYBRIDIZATION OF DNA

4.1

Abstract
This chapter discusses our studies related to determining the ability of single stranded DNA

(ssDNA) to spontaneously hybridize with its complimentary sequence in an altered annealing
protocol. In our altered protocol, the generally used hybridization temperature of 90 °C was
reduced to 45 °C. In DNA hybridization protocols, the ssDNA mixture (i.e., equimolar amounts
of ssDNA, and its complimentary ssDNA) is heated to very high temperatures in order to relieve
the single strands from secondary structures such as hairpins. Secondary structures hinder proper
DNA base pairing, leading to poor DNA hybridization. However, in thermal facilitation of glucose
oxidase-ssDNA, and horseradish peroxidase-ssDNA conjugate assembly, utilizing such high
annealing temperatures would degenerate the enzyme conjugates. Therefore, possibilities of
accomplishing DNA hybridization at lowered annealing temperatures was investigated. The theory
of hyperchromicity effect (UV absorption) was utilized to obtain qualitative data (n=6). UV study
results indicate that even at a lowered annealing temperature of 45 °C, the expected
hyperchromicity effect was observed. These results were also comparable to the annealing
protocols conducted at the general temperature of 90 °C.

4.2
4.2.1

Introduction
Deoxyribonucleic acid (DNA)
A double stranded (i.e., double helical) DNA is comprised of two strands that run anti

parallel to each other. The building blocks of the DNA structure are four nucleotide bases namely
Adenine, Thymine, Cytosine, and Guanine (Fig.52a). Each base attaches to a sugar molecule, and
a phosphate molecule. Altogether, the base, sugar, and the phosphate are referred to as a nucleotide.
The phosphates form phosphodiesterase bonds to form a long oligonucleotide strand which is also
referred to as single stranded DNA (ssDNA) (Fig.52a). The conjugated electrons in the ring
structures of these nucleotide bases causes DNA to exhibit absorbance properties in the UV range.
In UV-Vis spectrophotometric analyses, DNA has an absorbance maxima at 260 nm.
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Each Guanine in one strand will form two H-bonds with a Cytosine in the opposite strand.
Each Thymine in one strand will form three H-bonds with Adenine in the opposite strand (Fig.52b).
This process alongside stacking interactions between nucleotides allows for DNA hybridization,
and stabilizes the final double stranded DNA (dsDNA). In DNA complementarity (i.e.,
complimentary hybridization) when the nucleotides of one strand is aligned anti-parallel to the
complimentary strand, they form very specific base pairs. This complementarity was first
demonstrated by Watson and Crick. DNA denaturation, and/or DNA melting refers to the process
of breaking the H-bonds between the base pairs, forming two single stranded DNA. For the
purpose of all discussions in this thesis, DNA hybridization, annealing and DNA renaturation are
used interchangeably.

(a)
Figure 52: Illustration of the four building blocks (A, T, G, C nucleotides) of DNA, attached to a
phosphate backbone (a). Deoxyribonucleoside base pairing facilitated by H-bonds (b).
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Figure 52 continued

(b)

4.2.2

DNA profiling
DNA molecules are long strands found tightly wound in chromosomes which are contained

in the nucleus of each human cell. Within each DNA strand are numbers of genes that determine
the particular characteristics of an individual. DNA profiling which is also known as DNA
fingerprinting, is the process of determining an individuals genetic makeup called a DNA profile.
These DNA profiles differ in each individual. Therefore, it is a very common methodology used
in forensic investigations, to identify individuals involved in a crime incident, by collecting
biological samples (e.g. hair follicles, saliva, blood, skin) from the crime scene. It is also
commonly used in paternity tests. Currently, there are three very common methods for DNA
profiling.
The most common method is the famous polymerase chain reaction (PCR) technique. In
this technique, extremely small amounts of DNA are collected from biological samples. Next
millions of copies of it are made from it, using the PCR amplification steps. This creates enough
DNA to allow scientists to generate the DNA profile of the individual. Another method called
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restriction fragment length polymorphism (RFLP) analyzes the length of the strands of the DNA
molecules with repeating base pair patterns. While about 5% of the gene compositions on DNA
contain genetic information, the other 95% do not. These non-coding genes contain identifiable
repetitive sequences of base pairs, which are called variable number tandem repeats (VNTR). In
this technique, a Southern blot is performed and the DNA is analyzed via a radioactive probe. The
restriction fragment length polymorphism analysis is used to detect the repeated sequences by
determining a specific pattern to the VNTR, which becomes the individual’s DNA fingerprint. The
drawback with this system is that it requires a considerable amount of DNA in order to be
used. Another method called short tandem repeat (STR) is a technique which is also based on
features of PCR. It determines how many times the base pairs repeat themselves on a particular
location on a strand of DNA 90.
4.2.3

Determining DNA characteristics
As opposed to DNA profiling, in many life science fields, scientists wish to reveal

information about the DNA’s identity, size and abundance. PCR techniques discussed above
determines the DNA make up, but not physical characteristics of it. Southern Blotting is a famous
technique used to separate DNA fragments from a sample, based on the fragments size. In this
technique, DNA are first digested (i.e., not denatured, but cut into smaller pieces) using restriction
enzymes. Next, they are separated according to the size of each fragment via non denaturing gelelectrophoresis. Afterwards, the DNA fragments are transferred to a nitrocellulose or nylon
membrane support resulting in immobilization of the DNA. Due to this immobilization, the
membrane carries a semi-permanent reproduction of the banding pattern of the gel. The
immobilized DNA is covalently attached to the nylon membrane by briefly exposing the
membrane (i.e., blot) to UV light. Transferring the DNA to the sturdy membrane is necessary
because the fragile gel would fall apart during the next two steps in the process. Next, the
membrane is bathed in a solution to denature (double stranded made single stranded) the attached
DNA. Then a hybridization solution containing a small amount of single-stranded probe DNA that
is complementary in sequence to a target molecule on the membrane. This probe DNA is labeled
using fluorescent or radioactive molecules, and if the hybridization is performed properly, the
probe DNA will form a stable duplex only with those DNA molecules on the membrane that are
exactly complementary to it. Then, the non-hybridized probe is washed off and remaining
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radioactive or fluorescent signal will appear in a distinct band when appropriately detected.
Detection methods include autoradiography, Ethidium Bromide exposed to UV light, SYBR green
fluorescent dye gel scanned with laser, and silver staining followed by photo development. The
bands represents the presence of a particular DNA sequence within the mixture of DNA fragments
91

. The overall procedure of the Southern Blotting technique is illustrated in Fig.53.

Figure 53: Schematic of the Southern Blotting procedure
[Copyright© Pearson Education, Inc.]

Native or non-denaturing gel electrophoresis is performed in the absence of sodium
dodecyl sulfate. On the contrary, SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel
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electrophoresis) is a bioanalytical method where the proteins in a given sample are first denatured
using the anionic surfactant SDS, and heating. This treatment forces unfolding of the preliminary
tertiary structure of proteins. Next, these treated protein sample containing a mixture of fragments
is introduced to the separation medium, which is the polyacrylamide gel. The electrophoretic
mobility of protein fragments depend primarily on their molecular mass.
4.2.4

Optimizing DNA hybridization
As mentioned previously, DNA hybridization is the phenomenon of forming hydrogen

bonds formed in between the A=T, and G≡C base pairs. To hybridize DNA in an aqueous system,
optimizing and determining the synergistic effect of at least three main factors was important –
The melting temperature, salt concentration of the buffers, and the level of ssDNA selfdimerization. In order to control the melting temperatures (Tm) of DNA, two key features could be
controlled. The length of the ssDNA, and the nucleotide sequence. Shorter ssDNA fragments
indicate high specificity during hybridization
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. Longer ssDNA fragments result in higher Tm.

However, the length of the sequence is not the only governing factor of Tm in an ssDNA. The
amount of Guanine, and Cytosine present in the sequence largely contributes to the Tm as well. For
our study, we require a balance in between these two features. If the Tm is too high, when we
attempt to assemble different bioconjugates via DNA hybridization, the high temperatures applied
to the bioconjugates could denature the enzymes. This dismantles the final anticipated
macromolecular structure even before it is formed. If the Tm of the ssDNA is too low, it could
result in poor molecule stability at room temperature. Therefore, the Tm of the single stranded
DNA (ssDNA) used in this study was always approx. 32°C.
Melting temperature (Tm) – Since the two complimentary single stranded DNA will be obtained
separately, it is important to calculate the correct effective melting temperature, in order to ensure
hybridization. The DNA Tm is the temperature calculated at which, 50% of the ssDNA have
recognized its exact complimentary sequence, i.e., the temperature at which, 50% of the mixture
is in ssDNA form while, 50% is in the dsDNA form
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. For ssDNA with lesser than 20 bps, an

initial approximation for the melting temperature could be estimated by following a simple
multiplication rule as such; 4·(G+C) + 2·(A+T). Generally, a 20 bps sequence with ~50% guanine
and cytosine (G, C) content will have a Tm higher than 50 °C. Increasing the G, C content of an
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ssDNA will further increase the melting temperature of the final sequence. This factor alongside
with the difficulty of synthesis of high G, C content sequences owes to choosing a sequence
containing a 33% G, C content. For more accurate Tm calculations for the final dsDNA duplex, the
base stacking effects need to be considered as well. This “nearest neighbor effect (NN)” is
mathematically solved using software tools, which uses experimentally determined
thermodynamic parameters 81,92.
In order to predict the hybridization of DNA, it is important to study the kinetics and
dynamics of the molecular binding. It is difficult to quantitatively characterize dsDNA
hybridization or denaturation, because it is challenging to study hybridization or denaturation of
specific base pairs individually. The level of complementary sequence annealing will be directly
related to the temperature, at which each hybridization experiment is designed. In many PCR
studies, the optimal hybridization temperature has been reported to be 2 – 5 °C below the calculated
duplex Tm 93.
Buffer salt concentration – The desired hybridization should be mediated by using appropriate
hybridization buffer such as SSC (saline sodium citrate) or a phosphate buffer at pH values of ~7.4.
As the concentration of the salts (K+, Na+) in the solvent system increases, the Tm of the DNA
duplex tends to be increased. High salt concentrations in the solvent refers to more cations floating
in the system, which also means that these cations favor binding to the dsDNA, as opposed to their
counterpart single strands. Therefore, with higher Na+ concentrations, we could expect a better
stabilized system of hybridized DNA 81,94.
Self dimerization – The OligoAnalyzer 3.1® tool allows us to determine and calculate the selfdimerization possibilities, and the possible hairpin structures of a given ssDNA sequence. Selfdimerization refers to two molecules in the sample interacting/binding with a complimentary
nucleotide. In such a situation, the observed molecular weight the sample will be doubled. Hairpin loop formation refers to the secondary structure formed when the same molecule bending and
twisting in order to find a complimentary nucleotide within its own molecule. The molecular
weight observed, remains the same. In our study, we minimize the probabilities of hairpin loop
formation by carefully engineering the nucleotide sequence, and the length. In order to allow
maximum hybridization probabilities with its complimentary strand, the Tm of the overall sequence
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should be larger than any of the individual Tm numbers calculated for each hairpin structure. The
dynamics of the hairpin folding are assumed to follow a two-state model, where the any ssDNA
hairpin formation will alternate in between the folded loops and unfolded coils 95.

Figure 54: Illustration of possible hairpin loop formation of a single stranded DNA.
The contemporary method of synthetic oligonucleotide (i.e., ssDNA) synthesis is by
sequential addition of one nucleotide at a time. Each reaction consists of five different steps –
deprotection, coupling, capping, oxidation/stabilization and cleavage/detritylation/deblocking.
After each nucleotide addition is accomplished via a cycle consisting each of these steps, they are
desalted to remove any salts or contaminants. For ssDNA in nanomol amounts used in this study,
further purification using HPLC or PAGE would result in significant product loss. Therefore, the
ssDNA ‘as received’ were simply desalted prior to bioconjugation reactions.
4.2.5

Characterization techniques to analyze DNA hybridization
A recent study illustrated several physical and chemical DNA denaturation methods to

study levels of DNA hybridization. DNA denaturation refers to the process of breaking the Hbonds between the base pairs, forming two single stranded DNA. They utilized physical methods
such as heating, bead mills, and indirect & indirect sonication methods to first denature dsDNA.
They also used chemical treatments such as sodium hydroxide (NaOH), and dimethyl sulfoxide
(DMSO) to accomplish dsDNA denaturation. Next, they allowed the separated ssDNA strands to
hybridize back into dsDNA, and studied the level of DNA hybridization accomplished after each
denaturation method. After all of these treatments, the DNA denaturation and hybridization levels
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were determined by means of hyperchromic effects. Fundamentals and methods related to
hyperchromic studies are discussed further in section 5.4.1.
These dynamic physical denaturation techniques were not suitable for our studies because
they are capable of disrupting the structural integrity of both enzymes and DNA in our final
biomacromolecule. Since, the final biomacromolecule in our study consists of covalent linkages,
using an extensive physical denaturation method could run the risk of bond cleavage. Moreover,
using a chemical DNA denaturation technique such as alkaline (NaOH, formamide) could lead to
undesired adducts with the nucleotides of ssDNA, i.e., sticky ends

96

. Therefore, we pursued

thermal methods to accomplish DNA hybridization. In thermal denaturation and hybridization, a
mixture of ssDNA and their complimentary ssDNA is heated to extremely high temperatures
(generally, 90 °C). Afterwards, the mixture is slowly cooled down to room temperature (r.t.),
which enables the strands to hybridize spontaneously, ultimately forming the double stranded,
helical DNA structure.
Heating double stranded DNA (dsDNA) above their indicated melting temperature (Tm)
disrupts the non-covalent H-bonds formed between the base pair nucleotides, which results in the
two single stranded DNA strands to separate apart. This is referred to as denaturation, or melting
of DNA. Fig.55 illustrates the how DNA hybridization is mediated thermally. Experimentally,
DNA hybridization occurs when a mixture of ssDNA and its complimentary ssDNA strands are
mixed together, heated, and cooled back down. Heating the mixture relieves secondary structures
formed by single stranded DNA (ssDNA) self-folding on its self.

Figure 55: Principle of thermally induced DNA hybridization.
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Many studies on bioconjugation have utilized Förster resonant energy transfer (FRET)
techniques, autoradiography, and microscopy to study DNA hybridization (i.e., determining the
proximity of molecules). FRET is a distance-dependent interaction between the electronic excited
states of two dye molecules. The donor molecule in its electronically excited state transfers energy
to an acceptor molecule without emission of a photon. The efficiency of FRET is dependent on the
inverse sixth power of the intermolecular distance. Therefore, FRET is sensitive to very small
changes in distances, making the technique highly useful in the dimensions of biological
macromolecules. Although a highly successful technique, such fluorescent labelling was deemed
unnecessarily complex in accomplishing our specific aim.
4.2.5.1 UV absorption hyperchromic effect
UV-Vis spectroscopy determines how well molecules absorb energy in the UltravioletVisible region of the electromagnetic spectrum (200 – 700 nm).


= ··

Where; ε= molar absorptivity, b= path length of cuvette, c= concentration of analyte.
The absorbance is in arbitrary units (au), and given the concentration of the analyte is in mol/L,
and the pathlength is 1 cm, the molar absorptivity would be in M(-1)cm(-1)

DNA exhibits absorbance properties in the UV spectrum. Therefore, measuring the
absorbance levels at 260 nm (Abs260) could be used to determine the degree of regularity, i.e.,
degree of hybridization. Hyperchromicity studies is a label free detection method, and is unique
compared to other methods of analyzing DNA hybridization.

With an increase in the polymer formation (DNA renaturation), the general observation is
a decrease of the absorbance intensity (Fig.56). The separated two single stranded ssDNA, will
have up to 40% higher absorbance, compared to that of its hybridized dsDNA structure 96. As the
ordered regions of stacked base pairs in the DNA duplex are disrupted, the UV absorbance
increases. This difference in absorbance between the duplex and single strand states is due to an
effect called hyperchromicity ("less color"), which is the result of NN (nearest neighbor)
interactions of the base pairs. In the dsDNA state, interactions between base pairs causes the UV
absorbance to decrease relative to that of single strands. When DNA is in the single strand state,
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the interactions are much weaker due to the decreased proximity, and the UV absorbance is higher
97

. Upon denaturation (i.e., single strand state), the absorbance of the strands approaches that of

the free bases

96,98

. In the hyperchromic method, it is assumed that DNA hybridization does not

undergo intermediate states. This holds a valid assumption if we minimize the possibilities of
hairpin formation of the ssDNA, and optimize the DNA hybridization conditions. Previous studies
have successfully used hyperchromicity to measure DNA hybridization 96,98.

Figure 56: Illustration of the principle of hyperchromic effect observed in DNA hybridization.

4.2.5.2 Intercalating reagents and Fluorescence spectroscopy.
To characterize DNA hybridization, intercalating agents, and fluorescence spectroscopy
were used. Intercalators are small dye molecules which insert themselves in the region where
hydrogen bonding occurs between the specific DNA base pairs (Fig.57a). There are several types
of intercalating agents which bind to different areas of a double stranded DNA (dsDNA); minor
groove binders, major groove binders, external binders, and intercalators (Fig.57b). Since the DNA
used in this study does not involve any nucleotide or DNA backbone modification, we had the
major advantage of being able to use all three classes of the binder dyes. However, water solubility
of the dye should be an important aspect to consider. Ethidium bromide (EtBr) was chosen given
its high water solubility. Ethidium bromide (EtBr) binds with little or no sequence preference at a
stoichiometry of one dye per 4–5 base pairs of dsDNA 99. EtBr could be excited with wavelengths
in the visible – near visible range. They are hence suitable for fluorescence microscopy, confocal
laser-scanning microscopy, and fluorimetry. Once an intercalating agent such as ethidium bromide
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(EtBr) are bound to nucleic acids, their fluorescence could be enhanced by approximately 10-fold
(Fig.57c). And their excitation maxima are shifted ~30 – 40 nm to the red and their emission
maxima are shifted ~15 nm to the blue 100.
Fluorescence spectroscopy is a technique which uses fluorescence emitted by molecules
that absorb energy from electromagnetic radiation. At room temperature, most molecules reside in
their “ground state” which is their lowest electronic vibrational state. When light energy (photons)
is absorbed by these molecules, they are elevated to higher energy levels, which are called “excited
states.” However, they do not reside in such excited higher vibrational states because those states
are unstable. These molecules soon drop down into their subsequent lower vibrational states, and
eventually reach their ground state again. In the process of a molecule dropping to its ground state,
it emits the initially absorbed energy, emitting photons. This process of re-emitting the absorbed
photons is termed as fluorescence. Generally, the absorption spectrum resembles the emission
spectrum. The difference between the absorption maxima and the emission maxima is termed as
the Stokes shift 101.
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(a)

Intercalator

Major groove binder

Minor groove binder

Bis-intercalator
External binder

(b)

(c)
Figure 57: Ethidium bromide molecule (a). Depiction of where different types of intercalating
agents bind to dsDNA (b). Schematic illustrating how EtBr increases its fluorescence after
intercalating into dsDNA (c).
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4.3
4.3.1

Materials and Methods
Materials
A 15 base pair ssDNA and their complimentary strands were purchased from IDT® DNA.

The sequences were was designed with reduced G, C contents, and a medium length in order to
avoid secondary structure formation. For the convenience of the reader, the sequences were termed
as ssDNA1, and ssDNA3 while their complimentary strands were termed as ssDNA2, and ssDNA4
respectively (Table 8). It must be noted that the last two (ssDNA3, and ssDNA4) are the exact
nucleotide sequences used in the DNA-Enzyme conjugation studies. In the conjugation study, 5’
phosphorylated ssDNA3 and Enzyme 1 were conjugated. Next, separately, Enzyme 2 and 3’
phosphorylated ssDNA4 were conjugated. Lastly, the final DNA-Enzyme macromolecule was
assembled by thermally programmed DNA hybridization.

Table 8: Physical properties of ssDNA.
*

Data obtained from OligoAnalyzer 3.1

Term

DNA Sequence

ssDNA1

Molecular

*

Tm

*

Highest Tm

weight (Da)

(°C)

(°C) of hairpin

5’-GTAGATCACTATCAT-3’

4551

35.8

32.1

ssDNA2

5’-ATGATAGTGATCTAC-3’

4591

35.8

29.3

ssDNA3

5’phosphoryl-TGTTTTAGCTTATAT-3’

4643

32.7

21.6

4657

32.7

N/A

ssDNA4 5’phosphoryl-ATATAAGCTAAAACA-3’
4.3.2

Methods

4.3.2.1 Hyperchromicity effect.
The annealing PBS buffer (10 mM phosphate, 0.15 M NaCl) was freshly prepared, pH
adjusted to 7.3±0.2, and filtered using laboratory grade filter papers.
In a general experimental procedure, the ssDNA sequence and its complimentary sequence
were separately dissolved in PBS buffer in equi-molar amounts. It was imperative that both the
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ssDNA samples were in equi-molar and equi-concentration, in order to prevent residual singlestranded ssDNA remaining after the annealing protocol has been conducted.
For the studies conducted with ssDNA1 and ssDNA2, a stock solution concentration of 100
µM was used. Serial dilution, was conducted to obtain four concentrations; 0.24, 0.12, 0.06, 0.03
mg/mL. Next, 1.75 µL aliquots were removed from each separate tube (i.e., total of eight tubes),
and Abs260 data were gathered on a Thermo Scientific™ NanoDrop™ spectrophotometer
(Wilmington, Delaware). These data were used to generate the ssDNA curve in the
hyperchromicity graphs. For each sample, triplicate Abs260 measurements were obtained by
multiple sampling of the same homogenous sample. Afterwards, the avg. of the data were obtained
from both ssDNA strands (i.e., avg. of six data points) to generate the final ssDNA curve Fig. 10a.
Afterwards, the ssDNA1 + ssDNA2 mixture was used for the DNA hybridization protocol.
The sample was first vortexed vigorously. Next, using a heat bath set to 45 °C, the sample mixture
was heated for 3 – 5 min. Although the protocol published by the manufacturer specifies heating
the ssDNA mixture up to 90 °C, lowered it to 45 °C in our modified protocol. The reason for using
a temperature of 90 °C is to ensure that all the secondary structures present in the single stranded
DNA are loosened. However, the sequence we chose in our ssDNA do not contain such significant
secondary structures. That factor along with our inability to use temperatures higher than 50 °C in
our final enzyme-DNA modality led us to test the ability of forming dsDNA at lowered heating
temperatures. Next, the sample was removed from the heat and cooled down to room temperature
gradually within 45 – 60 min. Next, 1.75 µL aliquots of this sample was used to obtain triplicate
Abs260 data of the dsDNA using the NanoDrop™ spectrophotometer. These data were used to
generate the final dsDNA curve in Fig.61a.
The same procedure was conducted at an annealing temperature of 90 °C instead of 45 °C,
to compare the results qualitatively (Fig.61b).
We also conducted experiments with the actual DNA sequences used in the enzymessDNA conjugate formations too (i.e., ssDNA4 was used in glucose oxidase conjugates, while
ssDNA3 was used for horseradish peroxidase conjugates). The stock concentration of ssDNA3 and
ssDNA4 were used the same as the final ssDNA concentrations enzyme-ssDNA conjugate
reactions. Like so, for ssDNA3 and ssDNA4, the final concentration of the stock solution was 158
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µM (0.74 mg/mL). Serial dilutions were conducted to obtain four concentration levels; 0.74, 0.37,
0.18, 0.09 mg/mL. The annealing protocol was the same as reported above.
The data reported Fig.61 were obtained from two independent replicates (two for 45 °C,
and two for 90 °C). The data reported in Fig.58 were obtained from one annealing experiment (i.e.,
one for 45 °C, and one for 90 °C).
Data analyses was performed in the following manner. First, in the replicate 1, at a specific
concentration (e.g. 0.74 mg/mL), the average of ssDNA3 was obtained from triplicate Abs260 data.
Next, the average of ssDNA4 was obtained from the triplicate Abs260 data at the same concentration.
Next, these two averages were averaged to obtain the final data point for that concentration value
in one replicate. The procedure same procedure was conducted for all the four concentration values.
Likewise, the same procedure was conducted on the replicate 2 data as well. The results illustrated
are the average of the final average Abs260 values of the two replicates. So ultimately, one of the
data points in the ssDNA curve illustrated in Fig.61, is the average of 8 determinations (i.e., avg.
of 8 data points from two independent replicated experiments). The reported error bars in ssDNA
curve are the standard deviations of the 8 independent data points generated at each concentration.
The reported error bars in dsDNA curve are the standard deviations of 4 data points generated at
each concentration.
4.3.2.2 EtBr and fluorescence spectroscopy.
4.3.2.2.1 Fluorescence spectrophotometer calibration.
At the beginning of each experimentation day, the fluorescence spectrophotometer was
calibrated. First, the xenon lamp (i.e., excitation monochromator) was calibrated according to the
Fluoromax-s v.2.0, 2001 operational manual. The excitation monochromator (xenon-lamp)
spectrum generally exhibited a peak maxima of 0.11267 mV at 467 nm, as expected. The emission
calibration check was performed to obtain a water Raman-emission spectrum at 397 nm. However,
the exhibited peak maxima was generally at 394 nm. The water Raman scattering is due to the
vibrations of the water molecule. This is a result of non-elastic scattering where the incident photon
loses energy to the molecular vibrations, and then scatters at a higher wavelength. For a calibration
excitation wavelength of 300 nm, Raman scattering should appear as a sharp emission peak at 397

125
nm
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. Therefore, the water Raman-emission spectrum was always re-adjusted to the true and

corrected wavelength, 397 nm.
4.3.2.2.2 Determination of EtBr excitation wavelength.
The manufacturer reported fluorescence excitation/emission wavelengths for nucleic acids
suspended in different systems are as below.

Table 9: List of manufacturer reported excitation/emission wavelengths for EtBr 103.
Solvent system

Excitation wavelength (nm)

Emission wavelength (nm)

Aqueous

526

605

Phosphate buffered saline (PBS)

360

590

Tris buffer, pH 8.0

525

600

However, we found the optimal excitation wavelength by scanning the emission spectra in
a very broad range of wavelength (320 nm – 900 nm). For scanning the emission spectrum, we
chose an initial excitation wavelength of 300 nm. In order to pass the wavelength at which
Rayleigh light scatter emission will occur, the acquiring start position in the emission spectrum
was offset by 20 nm. Therefore, the starting wavelength for acquiring the emission spectrum was
320 nm. Pure water has two scattering peaks. The first one is Rayleigh scattering, which occurs
when the photon absorbed and emitted, have the same energy level. Therefore, the peak
corresponding to Rayleigh scattering of water will occur at the same wavelength as that of the
excitation wavelength. It is to avoid this emission peak, we start acquiring the emission spectra at
a lagged position from that of the excitation wavelength. The observed emission spectra exhibited
a maxima at 600 nm (Fig.58).
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Figure 58: Emission spectrum exhibited by 5µg/mL of EtBr in 10 mM Tris buffer.
In the next step, the emission maxima was entered into the Fluoromax-3 instrument method,
and scanning was conducted in “Excitation Acquisition” mode. In the excitation spectrum, two
peaks occurred around 360 nm, and 512 nm. However, being the major peak out of the two, the
maxima was determined as the peak appearing at 512 nm (Fig.59).

Figure 59: Excitation spectrum of by 5µg/mL of EtBr.
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After determining the optimal excitation wavelength, the prepared ssDNA and dsDNA
samples were analyzed on the same day, in order to minimize experimental variability. i.e. ssDNA
spectra acquisition was conducted on the same day of dsDNA spectra acquisition. The results
illustrated were obtained from 1.2·10-7 mols, at a molarity of 100 mM.
4.3.2.2.3 DNA sample preparation for EtBr intercalation experimentations.
It is emphasized that all the EtBr protocols were carried out with person protective
equipment (PPE) such as chemical resistant gloves (neoprene), N95 mask, goggles and lab coat.
The annealing Tris buffer (10 mM Tris, 50 mM NaCl, 10 mM EDTA) was freshly prepared, pH
adjusted to 7.4±0.2, and filtered using laboratory grade filter papers.
First, ssDNA1 and ssDNA2 were prepared in Tris buffer at equi-molar, equi-concentration.
Another ssDNA1 sample was also prepared at the equi-concentration, equi-molar to serve the
purpose of the negative control (i.e., to obtain fluorescence intensity spectra of only single stranded
DNA). The no. of mols of ssDNA in a typical experiment was approx. 1.5×10-7 mols, at a final
concentration of 80 µM. Then, the two separate ssDNA1 and ssDNA2 samples were combined and
vortexed vigorously. Next, the hybridization protocol was conducted by heating the ssDNA1 and
ssDNA2 mixture up to 90 °C, and allowed to cool to r.t. gradually. The resulting sample is
hybridized double stranded DNA (dsDNA).
Next, a 10 µg/mL EtBr stock solution was made using EtBr as received (ρ =10 mg/mL,
Sigma Aldrich, St. Louis, MO). Aliquots from the stock solution were added to the ssDNA1 and
dsDNA samples so that the final EtBr concentration in each sample was 5 µg/mL. It is important
to not use a very high final concentration of EtBr in the fluorescence spec analysis samples, due
to possibilities of EtBr oversaturation. Previous studies have discussed that oversaturation would
result in EtBr molecules aggregating, and ultimately resulting in largely erroneous overestimates
of fluorescence intensities
Next, both the samples, (ssDNA1 and dsDNA) were transferred to two separate quartz
cuvette, and analyzed in a fluorescence spectrophotometer, FluoroMax-3 (Horiba Group). After
several trials, the slit width was chosen as 2 nm. A spectrum acquisition increment of 2 nm, and

128
an integration time of 0.1 s was used. The excitation wavelength was set to 512 nm, while the
emission wavelength was set to 600 nm.

4.4
4.4.1

Results
Hyperchromicity effect

4.4.1.1 ssDNA1 and ssDNA2
UV spectra (Abs260 nm) of ssDNA1 and ssDNA2 are depicted in Fig.60a. The four separate
curves in the descending order are of the four concentration levels at 0.24, 0.12, 0.06, and 0.03
mg/mL. As expected, with a decrease in the ssDNA concentration level, the Abs260 nm decreases
as well. Fig.60b illustrates the UV spectra of the dsDNA after ssDNA1 and ssDNA2 and were
annealed after heating the ssDNA1 and ssDNA2 mixture up to 45 °C, followed by cooling. We
observed a visual decrease in the Abs260 levels after the annealing protocol had been completed.

(a)
Figure 60: 260 nm absorbance data obtained at four different concentrations of DNA;
Absorbance of ssDNA1 and ssDNA2 (a). Absorbance after ssDNA1 and ssDNA2 were hybridized
after heating up to 45 °C and cooling (dsDNA) (b).
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Figure 60 continued

(b)

Fig.61 illustrates cumulative absorbance results obtained from a range of concentrations
ssDNA, and dsDNA. Fig.61a depicts the Abs260 nm results from the annealing protocol conducted
at 45 °C, while Fig. 61b is that of 90 °C. The coefficient of determination (r2) of all four regression
lines are greater than 0.999, indicating a high level of goodness of fit.

The regression lines of the dsDNA (yellow curves in Fig.61a and 61b), have similar linear
regression equations. Although this is not quantitative evidence for a comparison between the two
annealing methods (i.e., heated up to 45 °C, and 90 °C), it yields qualitative evidence to suggest
that regardless the heating temperature, the phenomenon of ssDNA1 + ssDNA2
in fact be studied using the hyperchromicity principles.

dsDNA could
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45 °C
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(b)
Figure 61: Hyperchromicity of ssDNA1 and ssDNA2 (before), and after annealing (dsDNA).
Results of the annealing protocol conducted at the reduced temperature of 45 °C (a). Results of
the annealing protocol conducted at the general temperature of 90 °C (n=1) (b).
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4.4.1.2 ssDNA3 and ssDNA4
The two ssDNA sequences used for synthesizing the enzyme-ssDNA conjugates were also
studied. Fig.62 illustrates that there is comparable differences in the Abs260 measurements between
ssDNA and dsDNA states. As the hyperchromicity phenomenon was experimentally observed in
the nucleation process of ssDNA3 + ssDNA4

dsDNA, we could conclude that the heating

method is an adequate approach to achieve DNA hybridization.

Abs260 vs. DNA concentration
ssDNA3 and ssDNA4
45 oC

25
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0.5
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dsDNA

Linear (ssDNA)
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0.7

0.8
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(a)
Figure 62: Hyperchromicity of ssDNA3 and ssDNA4 (before), and after annealing (dsDNA).
Results of the annealing protocol conducted at the reduced temperature of 45 °C (n=2) (a).
Results of the annealing protocol conducted at the general temperature of 90 °C (n=2) (b
Error bars represent ±SD of all the data points of the respective concentration level.
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Figure 62 continued
Abs260 vs. DNA concentration
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In a previous study, Wang and his team suggested that the best method for observing
distinguishable differences between DNA denaturation (i.e., separation) and renaturation (i.e.,
hybridization) was via direct sonication
Abs260

96

. Their characterization method was UV analysis at

nm. Their ultimate choice for DNA hybridization was based on their ability to

quantitatively distinguish the Abs260 curve results before and after DNA hybridization. They
concluded that they did not observe a high enough Abs260 difference between ssDNA, and dsDNA
to validate the hyperchromicity effect experimentally. However, their observation could be
explained as follows. Firstly, in their studies, they obtained DNA in dsDNA state. Their
methodology was therefore in reversal to ours. The results they reported for the DNA in the ssDNA
state were obtained immediately after denaturing (separation) the original dsDNA via heating at
95 °C. The lack of differences in the Abs260 could be explained by a technical limitation in their
experimental method. Regardless how immediately they load their samples onto the NanoDrop
stage, since the volume of the analytical sample is extremely small (2 µL), the sample contents
perhaps undergo instantaneous cooling. Additionally, the heat loss facilitated by convection, as
well as conduction (onto the sample loading stage) could highly likely result in hybridizing the
separated ssDNA strands. In which case, the resulting absorbance measurements are essentially
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from that of hybridized dsDNA. Therefore, when ssDNA, and dsDNA regression curves were
compared, they might not have observed the expected differences in the absorbance levels.
However, since in our study we have measured the absorbance measurements of physically
separated two strands prior to carrying out the annealing protocol, we are able to compare the
differences between the two states (ssDNA vs. dsDNA) successfully.
4.4.2

Fluorescence spectroscopy
In this set of experiments, we attempted to determine if the specific intercalation properties

of EtBr would enable us to illustrate the DNA hybridization process qualitatively. At an excitation
wavelength of 512 nm, and an emission wavelength of 600 nm, and a final EtBr concentration of
5 µg/mL, we noticed a comparable difference between the fluorescence intensities of starting
single stranded DNA (ssDNA), and dsDNA after the annealing protocol was conducted (Fig.63).
The final results show that there is an increase in the emitted wavelength intensities (counts) in the
dsDNA in comparison to ssDNA. The difference was on average approximately 3×106 cps (n=4).
This indicates that the way EtBr interacts with double stranded DNA results in enhancing the
fluorescence emission levels. The theory of intercalation was observed in these experimental
results, as the dsDNA fluorescence emission intensities always indicated higher values compared
to those of the ssDNA.
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Figure 63: Fluorescence spectroscopy results of ssDNA vs. dsDNA at a final DNA
concentration of 8.0×10-5 M, and a final EtBr concentration of 5 µg/mL.
4.5

Conclusions
DNA hybridization is a stochastic process where single strands form a duplex formation

upon being introduced to their complimentary single strand. When the single strands of DNA has
multiple secondary structure formation possibilities, the proceeding DNA hybridization process
has to overcome an extra barrier. This is the enthalpy that needs to be provided to relieve such
secondary structures. The single strands investigated in this study do not contain secondary
structures (i.e., hair pin loops) which contains higher Tm values than the overall Tm of the strand.
Therefore, the possible hairpin loops in these four strands investigated in this study were not
presumed to interfere with DNA hybridization. Both EtBr intercalation studies, as well the UV
hyperchromicity studies qualitatively suggest that DNA hybridization is achievable via simple
heating methods. Accounting for all of the above as well as our experimental evidence, we
conclude that DNA hybridization is a thermally programmable process. Hence, it is promising to
utilize spontaneous DNA hybridization to form a final macromolecule of two separate enzymessDNA complexes.
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SYNTHESIS AND ANALYSIS OF ENZYME-DNA
MACROMOLECULES

5.1

Abstract
Synthesis and characterization of separate enzyme-single stranded DNA (enzyme-ssDNA)

conjugates, and the final enzyme macromolecule (enzyme1-dsDNA-enzyme2), are discussed
herein. EDC/Im crosslinking procedures were implemented to synthesize glucose oxidase-ssDNA4
(GOD-ssDNA4), and horseradish peroxidase-ssDNA3 (HRP-ssDNA3) conjugates separately. The
absorbance maxima of glucose oxidase (GOD) was at 275 nm, while that of ssDNA4 was at 260
nm. The Size exclusion chromatography (SEC) retention times of GOD and ssDNA4 were at 58
min, and 73 min respectively. The GOD-ssDNA4 conjugates produced from the EDC/Im
crosslinking procedure were analyzed on SEC. The elution time of the GOD-ssDNA4 conjugate
was 55.9±0.2 min (n=3 determinations). The elution time of the control sample (an equi-molar
mixture of GOD and ssDNA4) was at 58 min. The elution time of the control sample resembles
that of the GOD standard, while the GOD-ssDNA4 conjugate results indicate a leftward skew (n=3).
Separate fluorescence spectroscopy analyses were conducted with GOD enzyme (negative control),
ssDNA4 (positive control), SEC fractions of GOD-ssDNA4 conjugate, and SEC fractions of the
control experiment (equi-molar mixture of GOD and ssDNA4). Fluorescence spectroscopy results
indicated fluorescence intensity maximums at 21, 440, 150, and 94 AU for the GOD enzyme,
ssDNA4, GOD-ssDNA4 conjugate, and the control experiment respectively.
The absorbance maxima of the horseradish peroxidase (HRP) enzyme and ssDNA3 were
at 415 nm, and 260 nm respectively. The size exclusion chromatography (SEC) retention times of
HRP and ssDNA3 were at 65 min, and 72 min respectively. The elution time of the GOD-ssDNA4
conjugate was 65.45±0.58 min (n=6 determinations). Matrix assisted laser desorption ionizationtime of flight (MALDI-TOF) of the HRP standard indicated m/z peak around 43,078 Da, while
that of ssDNA3 was 4643 Da. MALDI-TOF results of the purified HRP-ssDNA3 fractions
collected from the SEC experimentation yielded m/z peaks at 66,630 Da, and 71,110 Da. This is
indicative of multiple mols of ssDNA3 tethering onto one mol of HRP. These analytical results
provide evidence to suggest that the EDC/Im crosslinking procedure has formed GOD-ssDNA4,

136
and HRP-ssDNA3 conjugates. Finally, SEC chromatographic results also indicate that the expected
GOD-dsDNA-HRP macromolecule was synthesized via spontaneous DNA hybridization.

5.2

Introduction

5.2.1

Glucose oxidase (GOD)
Glucose oxidase is a flavoprotein with a molecular weight of ~160 kDa, and it belongs to

the oxidoreductase, EC 1.1.3.4 category (Fig.64a). It catalyzes oxidation of β-D-glucose at its first
hydroxyl group, utilizing O2 as the external electron acceptor, to produce D-gluconic acid and
hydrogen peroxide (H2O2). Glucose oxidase is a homodimeric enzyme, and has one iron atom, as
well as one flavin adenine dinucleotide cofactor (FAD) molecule noncovalently bound at the active
site of each 80 kDa subunit. Activators are not required for the catalytic activity of this enzyme.
In the reduction half-step, D-glucose is enzymatically oxidized in to D-glucono-δ-lactone. This is
then hydrolyzed into gluconic acid without enzymatic participation. Next, the Flavin adenine
dinucleotide (FAD) of the glucose oxidase enzyme reduces to FADH2. In the oxidation halfreaction, the reduced glucose oxidase is oxidized by the electron acceptor O2, producing H2O2 104.
Glucose oxidase was originally isolated and produced from the fungus Aspergillus niger,
which remains the most common source of GOD production for glucose monitoring applications.
Today, glucose oxidases are readily available commercially. The A. niger derived GOD has a pH
optimum around 5.5, and has a very high substrate specificity for glucose 105. Glucose oxidase is
a very popular enzyme which has been historically used to detect glucose via spectrophotometric
glucose assays, as well as fluorimetric assays
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. Researchers have reported several analytical

methods to determine the enzymatic activity of GOD (i.e., D-glucose oxidation rates) such as
titrometric methods
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, Fourier transform infrared-FTIR methods
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, hydrophilic interaction

chromatography-HILIC 109, and via spectrophotometric analysis from a coupled enzyme assay 110112

The latter which is coupled enzyme assays is the most popular method to determine glucose

oxidase activity. The technique is based on analyzing the amount of product formed in a the
concomitant reaction (Fig.64b). As D-glucose is converted into D-glucono-δ-lactone, H2O2 is
released too. Another enzyme which utilizes the H2O2 (horseradish peroxidase; HRP) is also added
to the solution along with a chromogenic substrate (ABTS or o-dianisidine). Horseradish
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peroxidase utilizes H2O2 as its substrate, and oxidizes the chromogenic substance producing a
spectrophotometrically detectable signal at 420 – 475 nm (Fig.64b).

(a)

(b)
Figure 64: 3-D representation of GOD derived from A. niger (PDB) (a). Coupled enzyme assay
to detect D-glucose conversion kinetics (b).
Most of the GOD surface immobilization research has been conducted to develop glucose
detection sensors or probes. Some of such GOD functionalization have been accomplished on
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noble metal nanoparticles 52, acrylic acid pre-treated polyaniline films 113, Whatman filter papers
via EDC/NHS crosslinking
acid)
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51

, cellulose papers via TBHBA (2,4,6-tribromo-3-hydroxy benzoic

, and gelatin membranes
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. Immobilization of oxioreductases have been shown to

enhance the enzyme’s heat stability, functional stability, pH tolerance, and to enhance the shelf
life of the GOD detection probes 51,115.
As all the conjugation techniques utilized in this study are on aqueous solution phase
systems, suitable analytical systems were researched. Like so, size exclusion chromatography,
UV-Vis spectroscopy, and fluorescence spectroscopy were utilized to analyze the free enzymes,
and the conjugated enzymes.
5.2.2

Horseradish peroxidase (HRP)
Horseradish peroxidase (HRP) is a commercially available, class III peroxidase, in the

superfamily of plant peroxidases. This glycoprotein has two metal centers referred to as heme
groups, and two calcium atoms. It has a globular structure, which mostly consists of α-helices,
with a few β-sheets. There are two domains called distal and proximal, and the heme group (a.k.a.
protoporphyrin IX cofactor) resides in between those. The heme group is typically linked to the
HRP by a coordinate bond between the heme iron, and a conserved His170 residue. The N-terminal
of HRP is blocked by pyroglutamate, however, there are several arginine residues on the enzyme
surface which are susceptible for desired functionalization
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. Furthermore, there are several

surface lysine residues which could be directed towards enzyme immobilization via covalent
linkages. On the surface of HRP C1A, three (Lys174, Lys232, Lys241) out of six lysine residues
have been found accessible to chemical modifications 117.
HRP enzyme utilizes hydrogen peroxide (H2O2) to oxidize a variety of compounds. It not
present in mammalian cells, and is obtained from the plant source, horseradish roots. However,
recently, recombinant HRP has been expressed in eukaryotic systems (yeast)
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, as well as in

prokaryotic systems (E.coli) 119. Studies conducted on HRP dates to the nineteenth century. The
first studies to report isolation, purification and characterization of the physical properties of seven
distinct isoenzymes from HRP were in 1960s 120.
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HRP activity can either be detected by the formation of a chromogenic or fluorogenic
detector molecule product (e.g. ABTS, or o-dianisidine), or by an electrochemical signal due to
the redox nature of HRP catalysis. The majority of studies on HRP in biosensor systems focuses
on the detection of H2O2. Like so, it has been used extensively as a reporter enzyme in
histochemical staining assays 121, biosensors 122, and medical diagnostics 123.
HRP used in bioremediation systems have shown that conjugating the enzyme with
polysaccharides have improved the stability of the enzyme more than 6-fold, compared to the
native HRP systems. The starch-conjugated HRP catalytic activity has been shown to be
unaffected when attempted to decolorize synthetic dyes such as bromophenol blue 124. Furthermore,
in the last two decades, HRP enzyme has also been studied as a drug for cancer treatment. In a
recent study, chitosan nanoparticles encapsulating HRP enzyme were demonstrated to induce cell
death in human breast cancer cells. The encapsulation allowed for enhanced stability at 37 °C
compared to the free HRP enzyme 125.

Figure 65: 3-D representation of HRP isoenzyme C 116.
5.2.3

Size Exclusion Chromatography
This is a separation technique in which the molecules in the analytical sample are separated

based on their hydrodynamic radii, i.e., molecular size. In this type of chromatography, the
stationary phase is composed of gel beads with pores. The mobile phase is the solvent. In size
exclusion chromatography, the larger molecules elute faster because they spend less time getting
trapped inside the gel beads. Smaller molecules have a higher residence time inside the column
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because they enter the gel pores more frequently, and linger around, making their elution slower
(Fig.66).
When size exclusion chromatography is used using organic solvents, the technique is
referred to as Gel Permeation Chromatography (GPC). When size exclusion is performed with
aqueous solvents, the technique is referred to as Gel Filtration.

Figure 66: Illustration of the size exclusion chromatography principle.
Three types of polymers are mainly used in gel permeation beads – dextran,
polyacrylamide, and agarose. The polysaccharide dextran is a composed of glucose monomers
which are linked by α1-6 glycosidic bonds, and α1-3 branch linkages. In order to make gel bread
with various pore sizes, these dextran molecules are crosslinked with epichlorohydrin to various
extents. Such crosslinked dextran structures are called Sephadex. The higher the extent of
crosslinking, the lesser the water retaining ability it has (e.g. Sephadex G-10). On the contrary,
less crosslinked beads (e.g. Sephadex G-200), will swell more in the presence of water. Agarose,
more commonly known as Sepharose, has pore sizes larger than those of crosslinked dextran. It is
composed of D-galactopyranose monomers linked beta 1-4 to another alpha 1-3 linked 3,6anhydro-L-galactopyranose. Whichever stationary phase gel is used, the basis of molecular
separation in this technique is based on the size of the molecules.
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The two enzymes reviewed above (GOD, and HRP) were utilized to synthesize separate
enzyme-ssDNA conjugates. Next, using the complementarity of DNA, these two enzymes were
co-localized to synthesize the final enzyme macromolecule. In the final biomacromolecule
construct, the distance between the two enzymes was maximized. As DNA hybridization occurs
from the 5’•3’ direction, the reactive (via EDC/Im chemistry) phosphoryl groups were placed in
the 5’ terminal of both the ssDNA. The purpose of placing the enzymes as further as possible was
to minimize steric hindrances possible due to the two large enzymes being on the same side.
ssDNA3 was attached to horseradish peroxidase (HRP) while ssDNA4 was attached to
glucose oxidase (GOD). The purpose of heating the separated conjugates up to 45 °C was to relieve
the ssDNA4 and ssDNA3 of their possible hair-pin loop formations. Fig.67 illustrates the
architecture of the final biomacromolecule synthesized via spontaneous DNA hybridization.
This co-localized GOD-dsDNA-HRP macromolecule was separated based on size
exclusion principles. There are several properties of biomolecules which could be exploited for
identifying and separation, such as size, hydrophobicity, charge, ligand specificity and isoelectric
point. Size exclusion chromatography (SEC) is an ideal candidate to separate molecules according
to the size.
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Figure 67: Illustration of the spontaneous assembly of the final biomacromolecule (GODdsDNA-HRP).
Bonds between amine and phosphoryl groups (in green) were formed via the established
crosslinking technique (EDC/Im).

5.3

Materials and Methods
In order to synthesize the desired final enzyme macromolecule, enzyme-ssDNA conjugates

were synthesized separately. Section 5.3.2.1 – 5.3.2.6 discusses the synthesis of separate enzymessDNA crosslinking methods, and characterization techniques. Section 5.3.2.7 discusses the final
enzyme macromolecule assembly via thermally facilitated DNA hybridization.
5.3.1

Materials
The ssDNA used for the glucose oxidase conjugation was, 5’phosphoryl-ATA TAA GCT

AAAACA-3’; Tm 32.7 °C; molecular weight 4657 Da. The chosen sequence for the ssDNA carried
a Tm slightly above room temperature, but below the denaturation temperature of the two enzymes
in the final macromolecule. The ssDNA used for the horseradish peroxidase was its complimentary
sequence, 5’phosphoryl-TGT TTT AGC TTA TAT-3’; Tm 32.7 °C; molecular weight 4643 Da.
These were purchased by IDT® DNA. For the convenience of addressing, the ssDNA used for
glucose oxidase conjugation were termed ssDNA4, while its complimentary sequence used in the
horseradish peroxidase conjugation were termed ssDNA3.
Imidazole (Im) and EDC were purchased from ThermoFisher Scientific. Glucose oxidase
(GOD), and horseradish peroxidase (HRP) were purchased from Sigma Aldrich (St. Louis, MO).
The 10 mM sodium phosphate (NaH2PO4·H2O), 0.15 M NaCl, buffer was prepared, pH adjusted
to 6.2±0.2, and filtered. 0.1 M imidazole solutions were pH adjusted to 6.0±0.2, and filtered.
5.3.2

Methods

5.3.2.1 Crosslinking enzymes and ssDNA via EDC/Im crosslinking chemistry
Crosslinking GOD and ssDNA4.
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In order to manipulate the number of covalent bonds formed between the ssDNA
5’phosphoryl group and the primary amines in glucose oxidase (GOD), the molar ratio of ssDNA4:
GOD was maintained at 1:1. In an attempt to reduce non-specific EDC binding to the ssDNA
phosphate backbone, the molar ratio of EDC: ssDNA4 was reduced to a 150-fold excess, instead
of the 430-fold molar excess suggested in literature 75.
First, ssDNA4 (as received) was dissolved in PBS buffer, and transferred to EDC, followed
by the addition of glucose oxidase pre-dissolved PBS buffer (pH 6). Finally, a molar equivalence
(w.r.t to EDC) of 0.1 M Imidazole (Im) was added to the reaction mixture. EDC: Im molar ratio
was maintained at 1:1 to avoid undesired byproduct formation. The reaction mixture was vortexed,
and allowed to react at r.t. (room temperature) for >5 hrs. This adapted 1-ethyl-3-(3dimethylaminopropyl) carbodiimide hydrochloride (EDC) crosslinking method is reported in
chapter 2 in greater detail (Fig.68).
The GOD-ssDNA4 product samples were subjected to exhaustive dialysis using 7000
MWCO dialysis tubes, to remove salts, unreacted ssDNA, EDC, and any other byproducts. The
recovered sample was lyophilized and subjected to all further analytical methods (size exclusion
chromatography, and fluorescence spectroscopy).
Crosslinking HRP and ssDNA3.
First, ssDNA3 (as received) was dissolved in PBS buffer, and was transferred to EDC,
followed by the addition of enzymes pre-dissolved in PBS buffer (pH 6). A molar equivalence
(w.r.t to EDC) of 0.1 M Im was added to the reaction mixture finally. The reaction mixture was
vortexed, and allowed to react at r.t. (room temperature) for >5 hrs. The HRP-ssDNA3 conjugate
samples were subjected to exhaustive dialysis using 7000 MWCO dialysis tubes. The recovered
sample was lyophilized and subjected to all further analytical, and characterization methods (size
exclusion chromatography, and MALDI-TOF).
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Figure 68: Schematic of the EDC/Im reaction scheme established in the current study.
5.3.2.2 UV-Vis spectroscopy
As the first step of enzyme-ssDNA studies, we conducted a broad UV-Vis wavelength scan of
all the components involved in the bioconjugation study, i.e, glucose oxidase (GOD), horseradish
peroxidase (HRP), and single stranded DNA (ssDNA4, and ssDNA3). The purpose was to
determine the absorbance maxima of these compounds, in order to be utilized in the size exclusion
studies. All UV-Vis studies were performed on a NanoDrop spectrophotometer (ThermoFisher
Scientific, location). The samples were diluted in PBS buffer (pH 6.2±0.2), and 1.75 µL aliquots
of them were analyzed on the NanoDrop machine, blanked against the same PBS buffer used in
the crosslinking reactions.
5.3.2.3 GOD: Size exclusion chromatography
5.3.2.3.1 Analytical Chromatography
After determining the absorbance maxima of the compounds, those values were used in the
size exclusion chromatography experiments to determine the suitability of the column. Size
exclusion chromatography (SEC) was performed on a Superdex™ 200 10/30 GL capable of
separating molecules in the range of 100,000 – 200,000 Da. SEC was utilized to separate unreacted
GOD, and unreacted ssDNA4 from the GOD-ssDNA4 conjugates. Since the molecular weights of
GOD and ssDNA4 are 160 kDa and 4.6 kDa respectively, there is an adequate difference in the
molecular weights to obtain adequate separation. However, we suspect that SEC would not remove
any unreacted GOD enzyme from the GOD-ssDNA4 conjugate samples due to the very small
difference in the molecular weights between the free enzyme and the conjugates. This would be
true unless there is a significant difference between the free enzyme and the conjugate due to
several moles of ssDNA4 (up to 30) conjugating with one mole of GOD.

145
The mobile phase used for separations was phosphate buffered saline (PBS). 10 mM
sodium phosphate (NaH2PO4·H2O), 0.14 M NaCl, buffer medium was prepared with MilliQ water,
pH adjusted to 7.20±0.15, and filtered using Whatman™ qualitative filter papers (Fisher
Scientific). An isocratic method using a PBS buffer mobile phase (pH 7.20±0.15), was developed
to separate and collect fractions of GOD-ssDNA4 bioconjugates. High-performance liquid
chromatography (HPLC) was performed on an Alliance 2695 separation module, using the
Empower 2.0 software (Waters Corp., Milford, MA), equipped with a Waters 2496 UV detector
(Waters Corp., Milford, MA). A flow rate of 0.35 mL/min, and a UV detection at 260 nm, and 275
nm were used to analyze the components in the reaction sample. Prior to conducting
chromatography, each sample was filtered using 0.45 µm syringe filters to remove particulates.
Separate calibration curves were developed for GOD and ssDNA4 standards at detection
wavelengths of λ275 nm, and λ260 nm respectively. For GOD calibration curve, three concentrations
at 1.1, 0.55, and 0.275 mg/mL were tested. For ssDNA4 six concentration levels at 0.81, 0.37,
0.405, 0.203, 0.101, and 0.051 mg/mL were analyzed to determine the methods linearity and range.
Each calibration curve was developed using a minimum of 3 different concentrations in triplicates
(i.e., at least 9 determinations).
5.3.2.3.2 Preparative chromatography on GOD-ssDNA4 conjugates
For preparative chromatography, LC-10AT liquid chromatography system (Shimadzu, city,
state), equipped with a Clarity light software was used to obtain chromatographic data. The
instrument was equipped with two detection systems; a UV-Vis detector capable of analyzing 190
nm – 600 nm (Shimadzu Inc.) and a Varian Star 9040 RI detector. The flowrate of the mobile
phase used in preparative chromatography was 0.3 mL/min.
As preparative chromatography was conducted on a different liquid chromatography
instrument, standards runs were conducted again on the new separation module.
In order to subject GOD-ssDNA4 conjugates for further analysis on fluorescence
spectroscopy, corresponding conjugate fractions were collected. Fraction collection was
performed manually from the tubes exiting the detector. Delay volume calculations were
performed prior to fraction collections. Assuming the UV and RI detectors do not hold the
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analytical sample for any duration, the tube length exiting from the detector is correlated to the
travel time to the tube exit. The calculated delay volume is approx. 5 sec (Fig.69).

Figure 69: Calculations to compute the delay volume in SEC.

Therefore, during preparative chromatography, the real-time display on the detector
monitor and the above calculated time were used to collect component fractions as accurately as
possible. The detector screen was carefully monitored during the fraction collection process. As
soon as the detector indicated an increase in the intensity (AU), approx. 5 sec were allowed to
elapse prior to placing a collection tube at the end of the tube exiting the detector.
5.3.2.3.3 Control experiments on size-exclusion: mixture of GOD and ssDNA4
It was important to validate that single stranded DNA (ssDNA4) was in fact crosslinked to
glucose oxidase (GOD). GOD is a positively charged enzyme, therefore, it can form electrostatic
interactions with negatively charged anions, such as the oligonucleotides used in this study.
Therefore, to test whether the single stranded DNA simply formed electrostatic interactions with
GOD, or whether ssDNA4 was in fact covalently attached to the enzyme, we also conducted a
control experiment. In this control experiment, a sample mixture of GOD and ssDNA4 was
prepared. This control sample consisted each biomolecule at the same molar, and molarity as of
that used in the crosslinking experiment. We did not conduct the carbodiimide/imidazole (EDC/Im)
crosslinking procedure on this sample. Next, the sample was run on the same size exclusion
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column (Superdex™ G-25, 10/30 GL). Fractions corresponding to the GOD enzyme were
carefully collected. Generally, two fractions from two separate injections were collected (100 µL
per injection). This was to ensure adequate sample weights to use in subsequent analytical
characterization. The collected fractions were dialyzed for two days against DI, using 6–8k
MWCO dialysis tubes, and finally lyophilized. The lyophilized samples were re-suspended in PBS
(pH 6.2±0.15), and were subjected to fluorescence spectroscopy.
5.3.2.4 Fluorescence spectroscopy analysis of GOD-ssDNA4 conjugates
The GOD-ssDNA4 fractions collected and purified (exhaustive dialysis using 7000 MWCO
tubes, against MilliQ water) from SEC were subjected to EtBr assisted fluorescence spectroscopy
to determine the presence of single stranded DNA in the sample. Fraction collection was conducted
manually from approx. 40th – 60th minute. This is discussed in greater details in section 5.4.3.
We initially attempted MALDI-TOF mass spectrometry to determine the molecular weight
of GOD-ssDNA4 conjugates, as MALDI-TOF is a high resolution method to obtain definitive
answers regarding molecular weights of compounds. However, the resulting spectrographs did not
indicate any peaks. We suspected this was due to the make-up of the enzyme. Although glucose
oxidase (GOD) consists of ionizable amino side groups, the samples did not ionize in the mass
spectrometry ionization chamber. Therefore, we resorted to an alternative analytical tool which
yields qualitative results for the presence of DNA (i.e., fluorescence spectroscopy).
Fluorescence intensity data were obtained on a Cary Eclipse spectrophotometer (Varian,
CA). The weighed GOD samples were first dissolved in PBS buffer (pH 6.2±0.2). Next, EtBr
volumes from a 0.01 mg/mL stock solution was added to each GOD sample so that the final
concentration of EtBr in the analytical sample was 6 µg/mL.
In order to determine whether GOD exhibits any EtBr intercalation, resulting in enhanced
fluorescence emission, we also conducted calibration experiments using four different GOD
concentrations. The fluorescence spectroscopy analytical concentration range captured the GOD
concentration typically used in a crosslinking experiment. The final concentration of GOD were
0.5, 1.7, 3.8, and 7 mg/mL.
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Fluorescence intensity data were analyzed in the following manner. First, triplicate
fluorescence intensity data points were obtained by multiple sampling of the same homogenous
sample. Next, the averaged result was subtracted from the results of a blank solution (i.e., same
final concentration of EtBr dissolved in PBS buffer; pH 6.2±0.2) to obtain the results demonstrated
in Fig.75 and 76.
5.3.2.5 HRP: Size exclusion chromatography
The sample preparations, analytical chromatography, and preparative chromatography
techniques used to analyze and purify HRP-ssDNA3 conjugates were the same as those described
in GOD-ssDNA3 methods.
Analytical chromatography was conducted on an Alliance 2695 separation module, using
the Empower 2.0 software (Waters Corp., Milford, MA), equipped with a Waters 2496 UV
detector (Waters Corp., Milford, MA). An isocratic flow rate of 0.35 mL/min was used. Both the
column and sample temperature was 25 °C (at room temperature). Analytical chromatography was
conducted to determine the suitability of the Superdex™ 200 10/30 GL column. For HRP, three
concentration levels in triplicates each at 1.3, 0.65, and 0.33 mg/mL were tested to determine the
methods linearity and range (i.e., at least 9 determinations). In the analytical procedure, the
detection wavelength was 369 nm, as the UV detector was only capable of detecting wavelengths
in the UV range. However, as the UV-Vis spectroscopy results from initial testing indicated that
HRP exhibits absorbance at this wavelength, it was still deemed useful to use the 369 nm in the
detection system.
Preparative chromatography was conducted on a LC-10AT liquid chromatography system
(Shimadzu, Columbia, MD). The instrument was equipped with two detection systems; a UV-Vis
detector capable of analyzing 190 nm – 600 nm (Shimadzu Inc.) and a Varian Star 9040 RI detector.
The flowrate of the mobile phase used in preparative chromatography was 0.3 mL/min. As the
separations module used for preparative size exclusion chromatography did not consist of an inbuilt mobile phase degasser unit, the mobile phase (PBS buffer; pH 7.4±0.15) were degassed via
sonication. The purpose of sonication was to remove any air bubbles present in the mobile phase
solution. When air bubbles trap inside the instrument system, the pressure build up poses high risks
to the instrument and the column. For preparative chromatography of HRP, and ssDNA3, UV
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detection was conducted at 415 nm and 260 nm respectively. For the HRP-ssDNA3 conjugates,
UV detection was conducted at both 415 nm, and 260 nm .
5.3.2.6 Molecular weight analysis of the HRP-ssDNA3 conjugates: MALDI-TOF
In order to determine whether EDC/Im crosslinking method was successful in synthesizing
the desired HRP-ssDNA3 conjugate, fractions collected from size exclusion chromatography were
analyzed via MALDI-TOF mass spectrometry. Prior to analysis, each fraction was subjected to
exhaustive dialysis on 7000 MWCO dialysis tubes. MALDI-TOF spectrometric results were
obtained using an Applied Biosystems (Framingham, MA) Voyager DE PRO mass spectrometer,
and Sinapinic acid as the matrix. Prior to MALDI-TOF, each sample was purified using a C18 –
ZipTip column (Millipore Corporation, Billerica, MA). The ZipTip columns were conditioned
using two 10 μL of acetonitrile followed by two 10 μL of 0.1% trifluroroacetic acid (TFA).
5.3.2.7 Assembly of the final enzyme macromolecule via DNA hybridiaztion
First, the GOD-ssDNA4 conjugates (purified SEC fractions) were weighed and dissolved
in 300 µL PBS buffer (pH 7.2) at a concentration of 35 mg/mL. Next, a HRP-ssDNA3 conjugate
(dialyzed SEC fractions) was weighed and dissolved in 300 µL PBS (pH 7.2) at a concentration of
40 mg/mL. Afterwards, the tubes containing the separate samples were heated to approx. 35 °C.
The purpose of heating was to alleviate the single stranded DNA from any secondary structures it
may have formed. Next, these samples were combined together, and the mixture was heated to
45 °C using a heat bath. The sample tube was immersed for 5 mins. Next, the tube was removed
from heat, and was allowed to cool down to room temperature for 2 hours.
Afterwards, the final biomacromolecule sample was dialyzed using 10,000 MWCO
dialysis tubes against MilliQ water for 2 hours. Finally, the recovered sample was analyzed on the
Superdex 200™ 10/300 GL size exclusion column.
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5.4
5.4.1

Results and Discussion
UV-Vis spectrophotometry.
As expected, for both sequences of single sranded DNA, the absorbance maxima was at

260 nm (Fig.70a,b). For glucose oxidase, absorbance maxima occurred at two wavelengths
(Fig.70c). The maxima at 275 nm is general for proteins and enzymes, which is the result of the
Tryptophan (Trp), tyrosine, (Tyr), and Phenylalanine (Phe) amino acid side groups. The peaks
around 200 nm are caused by the peptide bonds present in the primary structures 51. Our UV-Vis
results corroborated well with previous spectroscopy results as well 111.
For horseradish peroxidase, maxima occurred at two peaks (Fig.70d). The peak at 275 nm
is general for proteins and enzymes, which is the result of the Tryptophan (Trp), tyrosine, (Tyr),
and Phenylalanine (Phe) amino acid side groups. Furthermore, disulfide bonds contribute minorly
at 260 nm too 126. The peaks around 200 nm are caused by the peptide bonds present in the primary
structures 51. The Abs maxima at 415 nm is due to the heme group present in HRP, which is also
the reason for the brown color of the enzyme (Gong et al., 2016).

(a)
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(b)
Figure 70: UV spectroscopy results of; ssDNA4 at a concentration of 5×10-5 M (a), ssDNA3 at
6×10-5 M (b), glucose oxidase enzyme (GOD) at a concentration of 8×10-5 M (c), horseradish
peroxidase (HRP) standard at 3.28×10-5 M (d).
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Figure 70 continued

(c)

(d)
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5.4.2

Size Exclusion Chromatography – GOD

5.4.2.1 Analytical size exclusion chromatography (GOD and ssDNA4)
The calibration curves were constructed by linear regression using standards of known
concentrations (Fig.71). The y-axis corresponds to the peak height, which is recorded in AU. The
x-axis is the concentration of the analyte (mg/mL). The coefficients of variation (r2) of both
calibration curves are well above the acceptance criteria. The regression curves demonstrated
linearity in the concentration range tested.
GOD standards calibration curve
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Figure 71: Standards calibration curves of; glucose oxidase enzyme (a), ssDNA4 (b). Error bars
represent ±SD of the peak areas from triplicate results.
Column: Superdex 200™ 10/300 GL. Mobile phase: 10mM sodium phosphate, 0.14 M NaCl,
(pH 7.2±0.15). Flowrate: Isocratic, 0.35 mL/min. Column and sample temperature: 25 °C.
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Injection volume: 100 µL. UV detection: 275 nm, and 260 nm for GOD and ssDNA4
respectively.
5.4.2.2 Preparative size exclusion chromatography: GOD-ssDNA4 conjugates.
Size exclusion results from the glucose oxidase (GOD) standard, and ssDNA4 indicate that
GOD eluted from the size exclusion column at a retention time of 58.4 min, while the ssDNA4
elutes at a retention time of 72.7 min (Fig.72). This corroborates well with size exclusion principles,
as the smaller molecular weight biomolecule (i.e., single stranded DNA) elutes later.

(a)
Figure 72: Size exclusion chromatographic results of; glucose oxidase (GOD) standard, at
3.4×10-6 M (a). ssDNA4 standard at 4.4×10-6 M (b).
Column: Superdex 200™ 10/300 GL. Mobile phase: 10mM sodium phosphate, 0.14 M NaCl,
(pH 7.2±0.15). Flowrate: Isocratic, 0.3 mL/min. Column and sample temperature: 25 °C.
Injection volume: 100 µL. UV detection: 275 nm.
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Figure 72 continued

(b)

After the EDC/Im crosslinking procedure, the GOD-ssDNA4 conjugates were analyzed on
size exclusion chromatography. Fig.73 illustrates the chromatogram profile of the GOD-ssDNA4
conjugate. The elution profile is bimodal. The first peak elutes at 55.9±0.2 min, while the second
major peak elutes at 70.1±0.2 min (n=3). The first peak closely resembles that of free GOD enzyme,
while the second peak closely resembles that of free ssDNA4. However, the major observation is
the leftward shift of both peak and 2. Compared to the GOD and ssDNA4 standards, the elution of
both peak 1 and 2 have shifted to the left. While the GOD standard elutes at approx. 58 min, the
peak 1 in the GOD-ssDNA conjugate sample elutes earlier, at 55 min. This is preliminary evidence
supporting that the expected GOD-ssDNA4 conjugate was formed. Conjugating a molecule with a
4600 Da size to a 160,000 Da sized enzyme would yield a small difference in molecular weights.
However, the GOD enzyme has 30 primary amines available for conjugation, while each ssDNA4
molecule has 1 phosphoryl group available for conjugation. As the ssDNA4 and GOD were reacted
at a molar equivalence, not a molar equivalence of the functional groups, there is a high probability
that several ssDNA4 molecules conjugated with one GOD molecule. The functional group molar
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ratio is described as amine: phosphoryl, while the molar ratio is described as GOD: ssDNA4. The
used GOD: ssDNA4 molar ratio was 1:1. However, the used amine: phosphoryl molar ratio was
30:1. Even if functional group molar equivalences were used, controlled bioconjugation is nearly
impossible to obtain when there are multiple reactive sites present in a biomolecules. i.e., if there
are 5 GOD molecules (each with 30 primary amines), it is nearly impossible to distribute an equal
ratio of the amine-phosphoryl reactions among all 5 GOD molecules.

Figure 73: Size exclusion chromatographic results of the GOD-ssDNA4 conjugate.
Column: Superdex 200™ 10/300 GL. Mobile phase: 10mM sodium phosphate, 0.14 M NaCl,
(pH 7.2±0.15). Flowrate: Isocratic, 0.3 mL/min. Column and sample temperature: 25 °C.
Injection volume: 100 µL. UV detection: 275 nm.
In order to investigate how a mixture of GOD and ssDNA4 behaves during size exclusion
chromatography, a control experiment was conducted. Results indicate a similar elution profile
compared to that of the GOD-ssDNA4 conjugates (Fig.74). However, the elution times of peak 1,
and peak 2 very closely resemble the retentions times GOD, and ssDNA4 standards (Fig.72).
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Figure 74: Size exclusion chromatographic results of the control experiment: An equi-molar
(1.68×10-7 mols) mixture of GOD enzyme and ssDNA4 (not crosslinked).
Column: Superdex 200™ 10/300 GL. Mobile phase: 10mM sodium phosphate, 0.14 M NaCl,
(pH 7.2±0.15). Flowrate: Isocratic, 0.3 mL/min. Column and sample temperature: 25 °C.
Injection volume: 100 µL. UV detection: 275 nm.
In conclusion, the SEC experimental evidence depicted in Fig.74 suggests that the two
biomolecules in the control experiment resemble those of the native GOD, and ssDNA4. However,
the leftward shift in the chromatogram profiles provides preliminary evidence to state that the
EDC/Im crosslinking method had altered the surface of the GOD enzyme (i.e., synthesized a GODssDNA4 conjugate) (Fig.73).
5.4.3

Fluorescence spectroscopy
MALDI-TOF analyses conducted on glucose oxidase standards did not yield any peaks in

the spectrographs. We suspected this was due to the structure of the enzyme. Although glucose
oxidase has several ionizable amino acid side groups, our MALDI attempts were not able to ionize
the glucose oxidase molecules. Therefore, we resorted to an alternative, indirect approach to detect
the presence of single stranded DNA in the GOD-ssDNA4 conjugates. The fluorescence
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spectroscopy results obtained from separate crosslinking reactions are depicted in Fig.75. All the
curves were generated after subtracting the fluorescence emission intensity values of a blank
solution. The blank was made by dissolving EtBr at a final concentration of 6 µg/mL, in PBS; pH
6.2±0.2. This was the same final concentration of EtBr in all analytical samples. GOD-ssDNA4
conjugate fluorescence study replicates were obtained from two SEC fractions collected from two
separate crosslinking experiments. The fraction collection occurred from 40 min – 60 min (Fig.73).
The concentrations of the GOD-ssDNA4 fractions used in replicates 1 and 2 were 1.3 mg/mL, and
1.5 mg/mL respectively, while that of the GOD control was 1.7 mg/mL (1.06×10-5 M). There are
clear indications of an increase in fluorescence emissions between the two curves (Fig.75).
We also observe a notable red shift in the emission spectra among ssDNA4 (positive
control), GOD-ssDNA4, and GOD enzyme (negative control) (Fig.75). The emission maxima of
ssDNA4 occurs at 597 nm, while that of the GOD-ssDNA conjugates occur at an average of 605
nm. The emission maxima of the GOD enzyme occurs at 617 nm. The fluorescence emission
wavelength experimentally observed in our ssDNA samples correlates with the previously reported
maxima wavelength for ssDNA in PBS buffer medium as well
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. Note that the fluorescence

emission results from the positive control (ssDNA4) at the equi-molar amount to that of the
negative control (GOD only) yielded fluorescence intensity results outside the instrument’s range
(max=1000 a.u). Therefore, the ssDNA4 results shown here are from a half-fold molarity. However,
the most important curves (GOD control and GOD-ssDNA4 conjugates) for comparison are at the
same final concentration. Results indicate that there is a notable difference in the fluorescence
intensities as well as the wavelength where the emission maxima occurs (Fig.75).
The control experiments were conducted with size exclusion fractions collected from an
equi-molar mixture of GOD and ssDNA sample. In Fig.75, these controls are labeled as ‘mock’
experiments. The EDC/Im crosslinking chemistry was not conducted on these control samples.
The fractions used in the ‘mock’ experiments were collected during SEC from 40 min – 62 min
(Fig.74). The fluorescence emission intensities of the control experiments indicated higher
intensities when compared to that of only the GOD enzyme (negative control). The increase in the
fluorescence could be attributed to the presence of ssDNA on the control experiment sample as
well. However, this could be due to two reasons. First, although fraction collection was stopped at
minute 62, there may have been coelution of compounds from the neighboring peak. As peak no.2
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is attributed to ssDNA4 (Fig. 74), the increase in the fluorescence spec results could have been due
to such coelution. However, as the fractions collected from SEC were further purified using 7000
MWCO tubes, prior to fluorescence spectroscopy, this is an unlikely scenario. The second
possibility is electrostatic interactions. As GOD enzyme are positively charged molecules, the
highly negatively charged ssDNA could have resulted in forming electrostatic interactions with
the GOD enzyme. Regardless, the fluorescence emission of GOD-ssDNA4 fractions are still
approx. 56 a.u. higher than the control experiment fractions (Fig.75).

Figure 75: Fluorescence spectroscopy results of the conjugates and controls.
The results of the GOD calibration standards are depicted in Fig.76. As the concentration
of GOD was increased, the intensity of the solution color increased proportionally too (Fig.76a).
The fluorescence emission maxima exhibited by GOD was 622.2±7.1 nm (Fig.76). It appears that
there is dismal fluorescence exhibited by GOD. However, we do observe a direct proportionality
in the fluorescence emission intensity vs. the GOD concentration.
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(a)

(b)
Figure 76: Digital images of GOD in PBS (a). Fluorescence spectroscopy results of the GOD
calibration standards (b).
This increasing trend is unlikely to be caused by EtBr intercalation with the GOD enzymes.
However, the observation of intensity increase could be attributed to differences in proton transfer
due to the increase in GOD enzyme concentrations. A previous study conducted on the solvent
effects explained fluorescence quenching of EtBr by proton transfer to the solvent127. Olmsted and
Kearns developed a mechanism using protonated EtBr in ground state (EH+), excited state
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protonated EtBr (EH+*), excited state deprotonated EtBr (E*), and solvent (S) to explain their
speculation. They suggested that EtBr molecules in their excited state (after absorbing the
excitation energy supplied to it) could be quenched by proton transferring into the solvent. They
attributed the increase in fluorescence intensity to reduction in the proton transfer rate. Perhaps the
increase in fluorescence intensity we observe is due to an increase in the localized protons available
in the GOD samples. When the localized protons in a GOD sample increases, the EH+*might be
present predominantly. If the increasing GOD concentrations increases the available protons,
thereby decreasing proton transfer rate from EH+* molecules to the buffer solvent, our observation
could be explained well by the above theory.
5.4.4

Size exclusion chromatography – HRP.

5.4.4.1 Analytical size exclusion chromatography (HRP and ssDNA3)
The HRP enzyme calibration curve was constructed by linear regression using standards
of three known concentrations (Fig.77). The coefficients of variation (r2) of the calibration curve
was well above the general acceptance criteria. The regression curve demonstrated linearity in the
concentration range tested. The y-axis corresponds to the peak height, which is recorded in AU.
The x-axis is the concentration of the analyte (mg/mL).

HRP standards calibration curve
Abs. 369 nm (AU)

0.03
0.025

y = 0.0187x - 0.0006
R² = 0.9969

0.02
0.015
0.01
0.005
0
0
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1
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Figure 77: Standards calibration curve of horseradish peroxidase (HRP).
Error bars represent ±1 SD of the peak areas from triplicate results.
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Column: Superdex 200™ 10/300 GL. Mobile phase: 10mM sodium phosphate, 0.14 M NaCl,
(pH 7.2±0.15). Flowrate: 0.35 mL/min. Injection volume: 100 µL. UV detection: 369 nm.

5.4.4.2 Preparative size exclusion chromatography: HRP-ssDNA3 conjugates
Size exclusion results from the horseradish peroxidase (HRP) standard, and ssDNA3
indicate that HRP elutes at a retention time of 65.4 min, while the ssDNA3 elutes at a retention
time of 72.4 min (Fig.78).

(a)
Figure 78: Size exclusion chromatographic results of; horseradish peroxidase (HRP) standard, at
a final concentration of 1.2×10-4 M, detection at 415 nm (a) ssDNA3 standard at a final
concentration of 1.2×10-4 M, detection at 260 nm (b).
Column: Superdex 200™ 10/300 GL. Mobile phase: 10mM sodium phosphate, 0.14 M NaCl,
(pH 7.2±0.15). Flowrate: 0.3 mL/min. Injection volume: 100 µL. *Note: The y-axis scales of the
two chromatograms are different.
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Figure 78 continued

(b)
SEC was utilized to collect fractions of the HRP-ssDNA3 conjugates from the 45th min –
70th min. Results indicated that the retention time of the conjugate is 65.45±0.58 min (n=6
determinations). Two separate conjugate reactions were conducted, and each conjugate sample
was analyzed on SEC in triplicates. Fig.79 illustrates the resulting chromatographs of the HRPssDNA conjugates.
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Figure 79: Size exclusion chromatographic results of the HRP-ssDNA3 conjugate.
Column: Superdex 200™ 10/300 GL. Mobile phase: 10mM sodium phosphate, 0.14 M NaCl,
(pH 7.2±0.15). Flowrate: 0.3 mL/min. Injection volume: 100 µL. UV detection: 415 nm.
It was important to determine the profile of a mock-experiment. SEC experiments were
conducted with an equi-molar mixture of HRP and ssDNA3 without carrying out the EDC/Im
crosslinking protocol. Fig.80(a) and 80(b) indicate the size exclusion chromatograms obtained
under UV-Vis detection at 260 nm, and at 415 nm respectively. The retention time of major peak
of the HRP, ssDNA3 mixture detected at 260 nm resembles the chromatograph obtained for the
ssDNA3 standard (Fig.80a). The retention time of the major peak of the HRP, ssDNA3 mixture
detected at 415 nm resembles the chromatograph obtained for the HRP standard (Fig.80b).
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(a)

(b)
Figure 80: Size exclusion chromatographic results of an equi-molar (3.86×10-8 mols) mixture of
HRP enzyme and ssDNA3; at 260 nm detection (a), at 415 nm detection (b).
Column: Superdex 200™ 10/300 GL. Mobile phase: 10mM sodium phosphate, 0.14 M NaCl,
(pH 7.2±0.15). Flowrate: Isocratic, 0.3 mL/min. Injection volume: 100 µL.
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5.4.5

Molecular weight analysis of HRP-ssDNA3 conjugates: MALDI-TOF
MALDI-TOF results from the horseradish peroxidase samples indicated a major peak at

43,078 Da (Fig.81a), corroborating well with the manufacturer reported avg. molecular weight
(44,000 Da). The molecular weight of the ssDNA3 is at 4643 Da (Fig.81b).

(a)
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(b)
Figure 81: MALDI-TOF mass spectrum of HRP (a), ESI mass spectrum of ssDNA3 (b).
In order to determine whether the expected HRP-ssDNA3 conjugates were formed,
MALDI-TOF analyses were conducted. Two major peaks (no.1 and 2, Fig.82) were observed at
approx. 66,360 Da, and 71,100 Da. When each of these two molecular weights are subtracted from
that of the HRP standard’s molecular weight, the resulting values are 23,286 Da, and 28,039 Da.
These resulting values indicate how much mass was added to the original HRP enzyme. When
each are divided by the molecular weight of the starting material ssDNA3 (4643 Da), we obtain
the number of ssDNA3 attached to the HRP enzyme. Like so, peak 1 and 2 are the resulting
conjugates from attaching 5 mols of ssDNA3, and 6 mols of ssDNA3 onto one mole of HRP enzyme
(Fig.82).
HRP has six available amino groups on the surface of the HRP enzyme 59. The experimental
procedure was conducted with 1:1 molar ratio of HRP: ssDNA3. Therefore, there is a probability
of more than one ssDNA3 molecules functionalizing onto one molecule of HRP. Like so, up to six
phosphoramidate bonds could be formed in one HRP molecule.
The process of bioconjugation, under the most controlled and optimal conditions, can result
in a number of different structural species making up the final composition. When two components
are reacted together and at least one of them has multiple sites for covalent attachment. Therefore,
with HRP containing multiple amines, the resultant bioconjugate could likely have a distribution
of molecular weights around an average mass. This is the explicable reason for the multiple ssDNA
additions onto one HRP molecule.
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1
2

Figure 82: MALDI-TOF mass spectrum of the purified HRP-ssDNA3 conjugate.
In order to determine whether the SEC fractions collected from the HRP-ssDNA3
conjugates contained any unreacted ssDNA3, we conducted MALDI-TOF analyses on the
recovered samples after exhaustive dialysis on 7000 MWCO tubes. The scans obtained from the
purified HRP-ssDNA3 conjugate fractions indicate no signs of unreacted ssDNA3 (Fig.83). If there
was any unreacted ssDNA3, we would expect to observe a signal around 4657 Da, which is the
molecular weight of ssDNA3. Fig.83 below illustrates that there is no m/z peak in that range,
indicating that our purification steps have successfully removed any unreacted ssDNA3. This is
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important because any residual ssDNA lingering from either enzyme-ssDNA conjugates could
lead to undesired products during the final macromolecule assembly, i.e., residual ssDNA3 and
ssDNA4 remaining in the final samples will lead to dsDNA formations during the DNA
hybridization at final aim in our study. If so, the separate dsDNA material eluting peaks could
confound with the major peak of the GOD-dsDNA-HRP macromolecule.

Figure 83: MALDI-TOF results of the purified HRP-ssDNA3 conjugates, contd.
In a typical enzyme-ssDNA bioconjugate purification procedure via size exclusion
chromatography, approx. 0.0008 g of enzyme-ssDNA bioconjugate was recovered from one SEC
injection (injection volume = 100 µL). Therefore, when scaled-up to the original volume in the
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bioconjugate product sample, the total recovered product was determined to be approx. 0.008 g.
This corresponds to an approximation of 53% enzyme-ssDNA bioconjugate product yield.

5.4.6

Final GOD-dsDNA-HRP macromolecule: Size exclusion chromatography
Size exclusion results of the final biomacromolecules obtained from two independent

reaction samples are indicated in Fig.84. The results showed a single, broad peak spanning from
45th min – 95th min (Fig.84). These chromatographs provide preliminary evidence directing in two
possibilities; (1) DNA hybridization has enabled the formation of the GOD-dsDNA-HRP final
macromolecule. (2) The GOD-ssDNA4 and HRP-ssDNA3 conjugates are all simply co-existing in
the final sample, and are co-eluting.
Firstly, it is important to note that GOD-ssDNA4 and HRP-ssDNA3 fractions were collected
separately. The fraction of the GOD-ssDNA4 collection spanned from 40th min – 58th min (Fig.73).
The fraction of the HRP-ssDNA3 collection spanned from the 45th min – 70th min (Fig.79). Both
the fractions collected from SEC were further purified using 7000 MWCO dialysis tubes.
Secondly, our MALDI-TOF results of the HRP-ssDNA3 did not indicate any unreacted
ssDNA3 in the spectrographs. Lastly, the final reaction sample (i.e., after GOD-ssDNA4 and HRPssDNA3 were annealed via hybridization) was also purified using 7000 MWCO dialysis tubes.
Considering all of the above factors, we can state that the purified enzyme-ssDNA fractions did
not contain any residual ssDNA. Therefore, the singular peak we observe in the final GODdsDNA-HRP macromolecule can not be due to residual single stranded DNA.
The elution time of the final enzyme macromolecule is later than expected. However, it is
important to remember that in size exclusion, it is the Stokes radius of the molecules which
determine their elution from the size exclusion column matrix. Perhaps the shape of the final GODdsDNA-HRP macromolecule was the reason for the inexplicable its elution from the size exclusion
column. When macromolecules vary in shape such as globular, or rigid rod-like shapes, the Stokes
radius does not correlate with the molecular weight. Therefore, based on the final shape, and
orientation of our enzyme-DNA macromolecule, perhaps the Stokes radius contributed largely to
the elution of our final macromolecule at a later time. Therefore, the uniform singular peak
illustrated in Fig.84 was attributed to GOD-dsDNA-HRP macromolecule.
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(a)
Figure 84: Size exclusion chromatographic results of the final biomacromolecule, GODdsDNA-HRP; detected at 275 nm (a), at 260 nm (b), at 415 nm (c).
Column: Superdex 200™ 10/300 GL. Mobile phase: 10mM sodium phosphate, 0.14 M NaCl,
(pH 7.2±0.15). Flowrate: Isocratic, 0.3 mL/min. Column and sample temperature: 25 °C.
Injection volume: 100 µL.
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Figure 84 continued

(b)

(c)
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5.5

Conclusions
Glucose oxidase is an enzyme which contains up to 30 lysine residues on the wild-type

enzyme’s surface. The amino functional groups of these lysine residues, and the terminal
phosphoryl group of a single stranded DNA (ssDNA4) was crosslinked using a previously
demonstrated carbodiimide/imidazole (EDC/Im) crosslinking method. The resulting GODssDNA4 conjugates were analyzed using size exclusion chromatographic (SEC) methods and
fluorescence spectroscopy. The observed differences in the SEC elution times of the GOD-ssDNA4
conjugates compared to those of the GOD and ssDNA control experiments provided evidence to
suggest successful crosslinking. Further analyses on fluorescence spectroscopy conducted from
purified GOD-ssDNA4 conjugates showed that the GOD-ssDNA4 conjugates exhibit enhanced
fluorescence intensities compared to those of the controls. Altogether, these results suggest that
the EDC/Im crosslinking method was successful in producing the expected GOD-ssDNA4
conjugates.
Horseradish peroxidase is an enzyme which contains up to 6 lysine groups on the enzyme’s
surface. The amino functional groups of these, and the terminal phosphoryl group of a single
stranded DNA (ssDNA3) were crosslinked using the same EDC/Im crosslinking technique. The
resulting HRP-ssDNA3 conjugates were analyzed on SEC, and MALDI-TOF. As the elution times
of the HRP standard and the HRP-ssDNA3 conjugates were very close, SEC results alone were not
able to determine successful HRP-ssDNA3 conjugation. Therefore, HRP-ssDNA3 molecular
weight analyses was conducted using MALDI-TOF. These results showed that the crosslinking
procedure has successfully attached several mols of ssDNA3 onto one mol of HRP enzyme.
The two separate enzyme-ssDNA conjugates formed herein were utilized in a final enzyme
macromolecule construction, facilitated by DNA hybridization. The resulting GOD-dsDNA-HRP
macromolecule was re-analyzed on size exclusion chromatography. A singular peak was observed
spanning from 45 – 95 min, which was attributed to the expected hybrid enzyme macromolecule.
The elution time of the final enzyme macromolecule is later than expected. However, it is
important to remember that in size exclusion, it is the Stokes radius of the molecules which
determine their elution from the size exclusion column matrix. When macromolecules vary in
shape, e.g., globular, or rigid rod-like shapes, the Stokes radius does not correlate with the
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molecular weight. Therefore, based on the final shape, and orientation of our enzyme-DNA
macromolecule, perhaps the Stokes radius contributed largely to the elution of our final
macromolecule at a retention time later than expected.

CONCLUSIONS AND FUTURE WORK

6.1

Conclusions
Bioconjugation techniques is a fast growing area of research. These powerful methods

enable researchers to manipulate diverse biological molecules in order to synthesize multifunctional molecules. Multifunctional molecules obtained via bioconjugation techniques are
frequently used in constructing biomaterials, biosensors, bioassays, and next-generation vaccines.
Therefore, there is a need to study and optimize bioconjugation techniques because these powerful
techniques hold the foundation to molecular nanotechnology.
Bioconjugation is generally accomplished via bottom-up syntheses, where small
components of the final macromolecule are assembled sequentially. Bioconjugation techniques
could be divided into two major categories called site-specific techniques, and random techniques.
Site-specific methods such as “click” reactions enable researchers to control the final bioconjugate
product yields. However, one of the biggest drawbacks in site-specific bioconjugation techniques
is the necessity for derivatizing each biomolecule with the necessary functional groups required
for the bioconjugation reaction to take place. Such prior derivatization is time consuming, and are
not universally extensible to wild-type peptides, proteins, enzymes, and antibodies. Furthermore,
if an enzyme’s active site is perturbed during a derivatization step, it could result in loss of enzyme
functionality. On the contrary, random bioconjugation techniques such as crosslinking do not
require prior derivatization of naturally occurring biomolecules. The trade-off in crosslinking is
poor bioconjugate product yields due to possible side-reactions.
Direct crosslinking of enzymes limits the ability to control the distance between enzymes.
The maximum spacer arm length of crosslinkers available up-to-date is approx. 15 Å. Depending
on the enzymes used in a bioconjugation study, the lack of ability to control the distance, could
bring the enzymes too close together. This could lead to steric clashes of the two enzymes, as well
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as potential product inhibition due the proximity of enzymes in the micro-environment. As this
was recognized as a drawback, giving rise to kinetic limitations of an enzymatic system, we
investigated the ability to attach single stranded DNA to enzymes, to synthesize enzymatic
cascades with the flexibility to control the distance between enzymes.
Accounting for all of the above factors, the major focus of this investigation was to determine
relatively inexpensive, less complex, and universal bioconjugation techniques with the flexibility
to control the distance between wild-type enzymes or proteins.
In the first aim of the study, an adapted strategy from the conventional 1-ethyl-3-(3dimethylaminopropyl) carbodiimide hydrochloride (EDC) was developed to form a novel
phosphoramidated single stranded DNA (ssDNA) bioconjugate. A phosphoramidate bond was
formed between a 5’ terminal phosphoryl group in ssDNA, and a primary amine group in
ethylenediamine. Previously EDC has been used to crosslink carboxyl groups with amine groups.
However, the current study demonstrates that phosphoryl functional groups could be used instead
of carboxyl groups to carry out EDC crosslinking. The phosphoramidation reaction between a
phosphoryl and a primary amine was mediated by the crosslinker, EDC. The adapted method
(EDC/Im) was tested where imidazole (Im) was used during the EDC reaction scheme. The
EDC/Im reaction method was compared to the conventional EDC reaction method in relation to
reaction efficiencies. An RP-HPLC chromatographic analytical method was developed to
determine the product yields. The analytical procedure’s accuracy, precision, linearity, limit of
detection (LOD), and limit of quantitation (LOQ) were determined. Afterwards, the yield of the
phosphoramidated ssDNA bioconjugate was determined using the developed analytical procedure.
The bioconjugate yield obtained from the EDC/Im method had a percentage yield of 79.0±2.4%
while that of the conventional EDC method was 68.3%±2.2%. The approx 10% increase in the
yield percentage obtained from the EDC/Im method was statistically significant. MALDI-TOF
results of the ssDNA bioconjugate indicates that the phosphoramidate bond is stable up to 14 days.
If this ssDNA bioconjugate were to be utilized in future studies, it is recommended that the
dialyzed bioconjugate sample is lyophilized and stored at -20 °C. In our attempts to determine
suitable crosslinkers, another crosslinker (BS3) was also investigated to accomplish
bioconjugation between ssDNA, and a small peptide. However, MALDI-TOF results indicated
conjugate molecular weights evidencing only partial bioconjugate formation (i.e., only one end of
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the crosslinker successfully reacting with one of the two biomolecules). At the conclusion of the
BS3 crosslinking studies, we speculated that the key factor governing successful amide bond
formation between the NHS-ester in the crosslinker owes to complete deprotonation of the primary
amine containing biomolecule.
In the next aim, the successful EDC/Im crosslinking technique was implemented to
synthesize glucose oxidase-ssDNA4 (GOD-ssDNA4), and horseradish peroxidase-ssDNA3 (HRPssDNA3) conjugates separately. These enzyme-ssDNA conjugates were analyzed, and purified
using size exclusion chromatography (SEC). Fluorescence spectroscopy was used to determine the
presence of ssDNA in the GOD-ssDNA4 bioconjugates, while MALDI-TOF spectrometry was
used to determine the molecular weights of the HRP-ssDNA3 bioconjugates. Analyses on
fluorescence spectroscopy conducted from carefully purified GOD-ssDNA4 conjugates showed
that the GOD-ssDNA4 conjugates exhibit enhanced fluorescence intensities compared to those of
the controls. MALDI-TOF analyses on HRP-ssDNA3 conjugates showed that the EDC/Im
crosslinking procedure has successfully attached several mols of ssDNA3 onto one mol of HRP
enzyme. Altogether, size exclusion chromatography, fluorescence spectroscopy, and MALDITOF results suggest that the EDC/Im crosslinking method was successful in producing the
expected enzyme-ssDNA conjugates.
In order to spontaneously assemble the GOD-ssDNA4, and HRP-ssDNA3 bioconjugates,
DNA hybridization was utilized. However, high annealing temperatures used in the general
heating-cooling protocols has the potential to degenerate these enzyme conjugates. Therefore,
possibilities of accomplishing DNA hybridization at lowered annealing temperatures was
investigated as well. UV and fluorescence spectroscopy results illustrated that spontaneous DNA
hybridization is achievable via a simple heating-cooling process, at a temperature slightly above
the Tm of the DNA (at 45 °C).
After facilitating DNA hybridization between GOD-ssDNA4 and HRP-ssDNA3, the final
enzymatic macromolecule was analyzed on size exclusion chromatography. Results indicated a
single peak which was attributed to the final expected GOD-dsDNA-HRP macromolecule.
However, albeit consisting of a much larger molecular weight, the macromolecule indicated an
elution at approx. 73 min. We speculate that the unexpected retention time of the final enzymatic
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macromolecule could be due to its final structure or shape. As the macromolecule consisted of two
enzymes with largely disparate molecular weights, the final shape of the macromolecule was
perhaps no longer globular. This difference in shape could have resulted in a Stokes radius which
governed the macromolecule’s elution from the size exclusion column. Future work encompassing
further confirmation of this plausibility are discussed in the next section.

6.2

Future work
The random bioconjugation techniques, reaction optimization, and bioconjugate

characterization discussed in the preceding chapters holds some areas of possible expansion via
future studies. First, further optimization could be implemented on the EDC/Im crosslinking
reaction. As illustrated and discussed in Chapter 2 (Fig.11), the amination reaction is favored under
basic conditions. Therefore, a future design of experiments should encompass increasing the pH
of the solution containing imidazole (Im), and the amine containing biomolecule. Furthermore,
bond characterization techniques such as Fourier transform infrared spectroscopy (FTIR) could be
utilized to confirm formation of a phosphoramidate bond between the phosphoryl group in ssDNA
and the primary amine in ethylenediamine.
Using size exclusion chromatography to purify ssDNA material prior to usage is also a
fascinating approach. As truncated impurities present in starting ssDNA material will consist of
much lesser molecular weights, perhaps size exclusion chromatography (SEC) could be utilized to
further purify the reactant ssDNA. Furthermore, future work should also test the correlation of
Stokes radius to the retention time, by utilizing a variety of biomolecules containing different
molecular weights and shapes.
In order to confirm that DNA hybridization facilitated spontaneous assembly of the final
enzymatic macromolecule, two methodologies could be followed. First, chemical dsDNA
denaturation (i.e., separation of dsDNA into two ssDNA strands) methods such as increasing the
buffer alkalinity could be explored. Superdex™ size exclusion columns generally contain a pH
stability range of 3 – 12. Therefore, if the recovered final product is re-suspended in a more basic
buffer (c.a. PBS; pH 9), and analyzed on SEC, the dsDNA structure could be denatured into their
corresponding ssDNA structure. This essentially means that the final enzymatic assembly is now
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separated into the two separate enzyme-ssDNA bioconjugates. Secondly, enzyme-ssDNA
bioconjugation experiments could be conducted with non-complimentary DNA sequence. Then,
after combining the two separate bioconjugates, we would not expect DNA hybridization to take
place. This would then fail to form the expected GOD-dsDNA-HRP macromolecule.
In both of these approaches, during the SEC analytical procedure, the expected elution
profile would correspond to the respective GOD-ssDNA, and HRP-ssDNA bioconjugate elution
profiles, as opposed to the singular peak owing to the final enzymatic macromolecule.
Lastly, future investigations for this study could be aligned in determining enzyme kinetics
of the co-localized enzymatic model (i.e., GOD-dsDNA-HRP macromolecule), and comparing
them to those of a non co-localized GOD and HRP enzymatic system (i.e., free-floating). A
Michaelis-Menten (M-M) modeling should be performed to compare the differences of kinetic
parameters (Vmax, Km) of the two disparate systems. In such a kinetic study, the experimental
outputs are the time elapsed (min), and the intensity of the spectrophotometric detection signal
(Abs540 nm) (Fig.86b).
The future design of experiments (DOE) of a glucose oxidase-horseradish peroxidase (GODHRP) enzyme assay should include several controls. For example, experimentation for the M-M
parameterization assay should be performed with; (1) free GOD, (2) free HRP, (3) GOD-HRP free
floating, (4) GOD-dsDNA-HRP enzymatic macromolecule. Furthermore, a number of variables
such as the assay temperature, final concentration of enzymes/conjugates, and the buffer medium
pH should also be tested.
Both GOD and HRP enzymes are Michaelis-Menten enzymes, and does not follow
competitive inhibition, noncompetitive inhibition, or allosteric enzyme kinetics. The future work
could be governed by the following two major hypotheses:

H1: Since product1 formed by the first enzyme (GOD) is the substrate of the second enzyme (HRP),
product1 will be continuously removed by the second enzyme, in the final reaction (i.e., no product
inhibition) (Fig.86a). This is because the product of the first enzyme, is the substrate of the second
enzyme.
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H2: Due to minimization of product1 diffusion limitations, and creating a high local concentration
of product1, the co-localized enzymatic modality (Fig.86b) will result in enhanced reaction kinetics
compared to the corresponding free-floating system.
The characteristic kinetic profile of the systems are expected to be a hyperbola, with two
asymptotic parameters; Vmax, and Km. In order to validate the parameters obtained by fitting
experimental velocity data into the M-M mathematical model, a range of substrate (D-glucose)
concentrations should be used to obtain the product formation rates.
The o-dianisidine (probe) used for determining the rate of substrate conversion (kinetics)
has an Absmax at 504 nm. Absmax of DNA, GOD, and HRP are at 260 nm, 275 nm, and 415 nm
respectively. Therefore, in an enzyme assay of the co-localized model, absorbance readings will
not be interfered with those of any components of the GOD-dsDNA-HRP macromolecules. Like
so, interference will not be a concern when analyzing the enzyme kinetics of the GOD-DNA-HRP
macromolecule.
However, o-dianisidine produces an intense pink color at Abs540 only when it reacts with
sulfuric acid. If the addition of the sulfuric acid is foreseen as a contributing factor which would
dissociate the GOD-dsDNA-HRP macromolecules, a different reducing agent (the colorimetric
reagent in the assay) such as 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid (ABTS) could
be easily utilized. The ABTS protocol follows the same procedure, without the addition of sulfuric
acid. The oxidized ABTS2+ exhibits absorbance at 725 nm. The important factor to note is the
stoichiometry of D-glucose to ABTS. As opposed to o-dianisidine, ABTSreduced utilizes two mols
of H2O2 to form ABTSoxidized.
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(a)

(b)
Figure 85: Theory of a continuous assay (a). Detailed schematic of the enzyme cascade reaction,
and detection (b).
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When synthesizing GOD-dsDNA-HRP macromolecules for future M-M kinetic
comparison studies, attention should be directed to the Tm of the DNA. The manufacturer’s
protocol (Sigma Aldrich, St. Louis, MO) reports that the optimal temperature of the GOD-HRP
continuous assay is at 37 °C. However, if the system temperature of the GOD-dsDNA-HRP
macromolecules is increased up to 37 °C, the annealed dsDNA will be denatured (i.e., separated
into two ssDNA strands). This is because the Tm of DNA used in the current GOD-dsDNA-HRP
macromolecule is 32 °C. Therefore, heating the system up to 37 °C could ultimately cause the colocalized GOD and HRP to separate. Therefore, in future experimentation, the kinetics of both
systems (co-localized enzymatic macromolecule vs. free-floating enzymatic system) should be
conducted at a temperature below the Tm of the ssDNA. If not, synthesis of the GOD-dsDNA-HRP
macromolecule should be conducted with ssDNA strands with a slightly higher Tm. In order to
accomplish a higher Tm, either a new sequence, and/or a longer ssDNA could be designed.
However, the Tm of the ssDNA should be maintained below 45 °C in order to not affect the enzyme
functionalities. The optimal temperature range for GOD is 40 – 60 °C 104, while for HRP it is 45 –
50 °C 128.
Furthermore, future work should also encompass determining the optimal distance between
GOD, and HRP in the final GOD-dsDNA-HRP macromolecule. This could be attained by
synthesizing GOD-dsDNA-HRP macromolecules with ssDNA strands consisting of varied lengths,
such as, low, medium, and high (e.g., 10, 20, 40 base pairs).
During the enzymatic reaction, two possible scenarios could occur in the co-localized GODdsDNA-HRP system. (1) Since the HRP enzyme could constantly remove (i.e., utilize) H2O2 from
the microenvironment, the rate of o-dianisidine oxidation should increase ideally. This in return,
would indicate enhanced enzyme kinetics. (2) Due to the concentric nature of the system, the
accumulation of D-gluconic acid in the system could act as a weak competitive inhibitor. Although
this inhibition is not well documented, there are some reports indicating the possibility of Dgluconic acid to act competitively with the substrate, D-glucose

127,128

. The outcomes of an

experimental design constructed with the all the above considerations would be able to address
whether a spatially concerted (i.e., co-localized) enzymatic model could get rid of substrate
diffusion limitations, or whether it would inflict product inhibition.
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o Synthesis of self-assembling and functional macromolecules/bioconjugates.
o Polymeric implantable devices, drug elution studies, and physicochemical characterization.
o Chromatographic assay development and method validation.
o Reaction kinetics, numerical modeling, process (unit operations) simulations.
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Characterization and Evaluation of Zero-Length Covalent Crosslinking Strategies for DNA Based
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Simulated a liquid desiccant dehumidification (LDDS) model, and a condensation model on
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o Purdue ABE Graduate Symposium. “Investigating bioconjugation techniques to construct
spontaneously assembling DNA-Enzyme macromolecules.” – 1st place in Biological
Engineering oral presentations.
February, 2018
o AIChE, Annual Meeting, Minneapolis. “Characterization of Covalent Crosslinking Strategies
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o Purdue, College of Agriculture, Outstanding Graduate Teaching Assistant Award.
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UM, Dept. of Biological Engineering. Treasurer, Graduate Club of Biological Engineering.
2012
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2014 – 2018
o Purdue Summer Undergraduate Research Forum (SURF), Graduate student judge.
2015, 2017
o Lafayette middle school Math Counts mathletes competition, Proctor.
2015
o Purdue International Center Summer Suppers series, “Food Preparer.”
2015
o UW Safe Ride, Radio presenter, Up Until Dawn for St. Jude’s Hospital.
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